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Abstract 
A molecule can crystallise in more than one crystal structure, a common 
phenomenon in organic compounds known as polymorphism. Different polymorphic 
forms may have significantly different physical properties, and a reliable prediction 
would be beneficial to the pharmaceutical industry. However, crystal structure 
prediction (CSP) based on the knowledge of the chemical structure had long been 
considered impossible. Previous failures of some CSP attempts led to speculation 
that the thermodynamic calculations in CSP methodologies failed to predict the 
kinetically favoured structures. Similarly, regarding the stabilities of co-crystals 
relative to their pure components, the results from lattice energy calculations and full 
CSP studies were inconclusive. In this thesis, these problems are addressed using the 
state-of-the-art CSP methodology implemented in the GRACE software. Firstly, it is 
shown that the low-energy predicted structures of four organic molecules, which 
have previously been considered difficult for CSP, correspond to their experimental 
structures. The possible outcomes of crystallisation can be reliably predicted by 
sufficiently accurate thermodynamic calculations. Then, the polymorphism of 5-
chloroaspirin is investigated theoretically. The order of polymorph stability is 
predicted correctly and the isostructural relationships between a number of predicted 
structures and the experimental structures of other aspirin derivatives are established. 
Regarding the stabilities of co-crystals, 99 out of 102 co-crystals and salts of 
nicotinamide, isonicotinamide and picolinamide reported in the Cambridge Structural 
Database (CSD) are found to be more stable than their corresponding co-formers. 
Finally, full CSP studies of two co-crystal systems are conducted to explain why the 
co-crystals are not easily obtained experimentally. 
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Chapter 1: An Introduction to polymorphism, 
co-crystal and molecular modelling 
 
1.1 Introduction 
This thesis investigates the reliability of thermodynamic calculations in crystal 
structure prediction (CSP) and the thermodynamic driving force for co-crystal 
formation. The development of CSP methodologies and the computational strategy 
used in this work are presented in chapter 2. In chapters 3 and 4, the CSP results of 
five different organic molecules are reported and discussed. In chapters 5 and 6, 
stabilities of some experimental co-crystals over their pure components are compared, 
and the CSP studies of two co-crystal systems are carried out. This chapter briefly 
covers the theories behind polymorphism, co-crystal and molecular modelling. 
 
1.2 Crystal, lattice, unit cell and space group 
In contrast to the liquid and gas states, the solid state of matter possesses a very 
limited degree of atomic or molecular mobility. Such motion is merely an oscillation 
about a fixed position. A solid crystalline state is attained only when the constituent 
atoms, ions or molecules are arranged regularly into some fixed and rigid patterns 
called a lattice.
1
 A lattice is a purely mathematical framework in space, and lattice 
points are the intersections of those three-dimensional grid lines in the framework. 
Every lattice point translates to another by a vector v, 
v = n1a + n2b + n3c 





Hence, the spatial distribution and orientation of points around any lattice point will 
be identical.
3
 Figure 1.1 shows two two-dimensional patterns of points: one of them 
constitutes a lattice, but the other does not. Any repeating unit in reality can be 
related to a virtual lattice point, and this relationship must be consistent throughout 
the lattice. Consequently, atoms, ions or molecules in a crystal can be linked to the 
mathematical framework described above, such that their spatial patterns will 
propagate infinitely along the translation vectors a, b and c.
3
 The parallelepiped 
formed by the three adjacent translation vectors a, b and c is known as a unit cell 
(Figure 1.2).
2
 These vectors are taken as the three crystal cell axes which determine 
the geometry of the unit cell. Cell lengths a, b and c are equivalent to the magnitudes 
of vectors a, b and c. By convention, angle α is defined as the angle between vectors 
b and c, angle β is defined as the angle between vectors a and c, and angle γ is 
defined as the angle between vectors a and b. These variables (a, b, c, α, β and γ) are 
collectively known as the lattice parameters. Note that the choice of unit cell is 
arbitrary. In some cases, a unit cell is said to be ‘primitive’ if no lattice point is 
located with the unit cell.
2,3
 Figure 1.1(a) is a two-dimensional analogy, showing that 
the same arrangement of lattice points can be expressed by two different unit cells. 





a.  b.   
Figure 1.1 (a) A two-dimensional lattice which can be expressed by two different 
unit cells: a primitive hexagonal unit cell at the top left hand corner and a non-
primitive rectangular centred unit cell at the bottom-right hand corner, and (b) a two-
dimensional pattern of points which do not constitute a lattice. 
 
 
Figure 1.2 A unit cell defined by three translation vectors a, b and c, and its lattice 
parameters a, b, c, α, β and γ. 
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The three-dimensional lattices (space lattices) may be considered as stacks of two-
dimensional lattices.
3
 In 1835, Frankenheim proposed that there were fifteen space 
lattices in total. However, in 1848, Bravais pointed out that one of the lattices 
proposed by Frankenheim was in fact equivalent to another. Therefore, the fourteen 
space lattices are now known as Bravais lattices. Figure 1.3 shows the unit cells of all 
fourteen Bravais lattices. These unit cells can be described in terms of their shapes 
and sizes, and the positions of additional lattice points in the non-primitive unit cells 
(Table 1.1). The ‘point symmetry elements’ incorporated in these lattices require 
some considerations. These include inversion centre and rotation axes, inversion axes 
or mirror planes running through the same point. Due to self-consistency, only 32 
combinations of ‘point symmetry elements’ are allowed in three dimensions (i.e. 32 
point groups). Note that each of the seven ‘crystal systems’ is defined based on the 
symmetry characteristic(s) shared by certain point groups, rather than the shapes of 
the lattices. For instance, a hexagonal lattice, having triad (three-fold rotation) but no 
hexad (six-fold rotation) symmetry, will be classified into the trigonal system, rather 
than the hexagonal system (Table 1.1). Further inclusion of ‘translational symmetry 
elements’ such as glide planes and screw axes results in 230 possible permutations in 





   
Simple cubic (P) Body-centred cubic (I) Face-centred cubic (F) 
   
   
   
Simple tetragonal (P) Body-centred tetragonal (I) Simple orthorhombic (P) 
   
   
   
Body-centred orthorhombic (I) Base-centred orthorhombic (C) Face-centred orthorhombic (F) 
   
   
   
Rhombohedral (R) Simple monoclinic (P) Base-centred monoclinic (C) 
   
   
   
Hexagonal (P) Triclinic (P)  
   
Figure 1.3 Unit cells of all fourteen Bravais lattices. (Adapted from ref 3) 
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Table 1.1 The relationships between the seven crystal systems and the Bravais 




symmetry  Bravais lattices
a 
Conditions on lattice 
parameters 
Cell lengths Cell angles 
Cubic 4 triads (three-fold 
rotation) equally 
inclined at 109.47° 
Cubic P, I, F a = b = c α = β = γ = 90° 
Tetragonal 1 tetrad (four-fold 
rotation) or inversion 
tetrad axis 
Tetragonal P, I a = b α = β = γ = 90° 
Orthorhombic 3 diads (two-fold 
rotation) equally 
inclined at 90° 
Orthorhombic P, I, C, F None α = β = γ = 90° 
Hexagonal 1 hexad (six-fold 
rotation) or inversion 
hexad 
Hexagonal P a = b α = β = 90°, 
γ = 120° 
Monoclinic 1 diad (two-fold 
rotation) or inversion 
diad axis 
Monoclinic P, C None α = γ = 90° 
Triclinic None Triclinic P None None 
Trigonalb 1 triad (three-fold 








a = b 
 
a = b = c 
α = β = 90°, 
γ = 120° 
α = β = γ 
a P stands for ‘primitive’, I for ‘body-centred’ (German: Innenzentrierte), C for ‘based-centred’, F for 
‘face-centred’, and R for ‘rhombohedral’. b Some hexagonal P lattices are categorised into the 
Trigonal system, depending on point group symmetry in the lattices. 
 
X-Ray diffraction is a useful technique to determine the shape and type of the crystal 
unit cell, and the arrangement of atoms within the unit cell. When an X-Ray is 
directed onto an atom, the electrons around the atom will diffract the incoming X-
Ray. If the atoms are located on a crystallographic plane, the scattering of the X-Ray 
will be mathematically equivalent to the reflection by the plane. Since the 
crystallographic planes are parallel to and equally spaced with each other, there will 
be a path difference between the X-Ray diffracted by two planes.
5
 In figure 1.4,  
 




Figure 1.4 X-Ray diffracted by two crystallographic planes. 
 
For scattering-in-phase, the path difference must be equal to an integral number of 
wavelengths such that,  
nλ = 2dhkl sinθ 
 
where n is an integer, and λ is the wavelength of the impinging X-Ray. This 
condition is known as Bragg’s law.5 The intensity of the diffracted X-Ray can be 
detected at different positions and angles from the crystal sample. The resulting 
diffraction pattern is the summation of all the individual diffracted X-rays. The 
electron density (and thus the atomic positions) in the crystal unit cell can then be 
deduced via a reverse Fourier transform of the diffraction pattern. However, the 
phase difference between any pair of diffracted X-Rays is usually not fully known. 
Various methods such as the Direct methods and Patterson synthesis have been 





1.3 Nucleation and crystal growth 
Most industrial or pharmaceutical crystallisation processes are carried out in solution. 
Supersaturation is an essential state for the process. A supersaturated solution 
contains more dissolved solid than a solution in equilibrium saturation, and is 
thermodynamically equivalent to a solid state at a specified temperature.
1
 The state 
of supersaturation can be classified into ‘labile’ and ‘metastable’ supersaturation.7,8,9 
Spontaneous nucleation takes place in the former, but not in the latter. Crystal 
seeding is required for crystal growth in the metastable zone (Figure 1.5).  
 
 
Figure 1.5 A plot of solution concentration against temperature. The solid line 
represents the solubility curve and the dashed line represents the supersolubility 
curve. Crystallisation will take place spontaneously in the labile zone. Crystal growth 
is probable in the metastable zone only when crystal seeds are present. No 
crystallisation occurs in the stable zone. (Adapted from ref 1) 
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Supersaturation only provides a thermodynamically favourable starting point for the 
crystallisation process. The development of crystal particles must be based on some 
tiny solid clusters (or nuclei) in the solution, although the exact mechanism is not 
certain. If the induction of nuclei does not involve any crystalline particle, it is 
referred to as ‘primary’ nucleation. Otherwise, it is referred to as ‘secondary’ 
nucleation. ‘Primary’ nucleation can be sub-divided into ‘homogeneous’ and 
‘heterogeneous’ nucleation. The former takes place spontaneously, whilst the latter is 
induced by non-crystalline foreign particles (Figure 1.6). The classical theory of 
‘homogeneous’ nucleation deduces that only the nuclei beyond certain critical size 
can grow, by calculating the free energy associated with the process.
10,11,12
 Any 
nucleus formed is constantly subject to two opposing ‘forces’: the surface excess free 
energy, ΔGS, which tends to re-dissolve the nucleus, and the volume excess free 
energy, ΔGV, which tends to increase the bulk of the nucleus. If the nucleus is 
assumed spherical with radius r, the overall excess free energy, ΔG, will become: 





where γ is the interfacial tension between the nucleus surface and the supersaturated 
solution, and ΔGv is the change in free energy of transformation per unit volume. By 
solving d(ΔG)/dr = 0, the critical nucleus size, rc, equals -2γ/ΔGv. Hence, nuclei 
smaller than rc will dissolve and those larger than rc will grow, so that the overall 




Figure 1.6 Schematic diagram of nucleation mechanisms. (Adapted from ref 1) 
 
 
Figure 1.7 Plot of free energy against nucleus size, showing the existence of critical 
nucleus size, rc. (Adapted from ref 1)  
  
 11 
The free energy theory could be extended into the context of crystal growth. 
According to surface energy theories, a growing crystal is assumed to adopt a certain 
shape which yields a minimum surface free energy.
10
 However, considering surface 
energy alone is insufficient to account for the effects of supersaturation and solution 
flow on the crystal growth rate. On the other hand, diffusion theories postulate that 
the process is driven by the concentration difference between the bulk solution and 
the deposition point of the solute species.
13,14
 Other theories include a stagnant liquid 
film on the growing crystal surface, where the solute species re-arrange themselves 
into the crystal lattice. The rate of such a ‘reaction’ also depends on the concentration 
difference.
15,16
 Theories like the adsorption-layer theories suggest that crystal growth 
may take place in a layer-by-layer manner.
12
 Controlling crystal morphology and size 
is of industrial importance because it allows control of the final appearance of the 
product and control of its flow characteristics. 
 
1.4 Polymorphism 
Polymorphism is the phenomenon that a chemical moiety can exist in more than one 
crystalline form.
17
 The prevalence of polymorphism in organic crystals is quite high. 
According to W. C. McCrone, “every compound has different polymorphic forms 
and that, in general, the number of forms known for a given compound is 
proportional to the time and money spent in research on that compound.”18 The 
packing and conformational differences between polymorphic forms result in 
variations in physical and chemical properties. The colour of a pigment may vary in 
different polymorphs. For example, copper phthalocyanine has at least four reported  
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polymorphs, α-,19 β-,20 γ- 21 and ε-forms.21 Only the stabilised α-form of red-shade 
blue and the β-forms of green-shade blue are of commercial interest. The sensitivity 
to stimuli of an energetic material may also vary among different polymorphs. The 
higher the sensitivity, the higher the risk associated with accidental detonation. For 
example, HMX (1,3,5,7-tetranitro-1,3,5,7-tetrazacyclooctane) has three known 
polymorphs, α-,22 β-22 and δ-forms23 (the γ-form was later found to be a hydrate).24 
The β-form, being the least sensitive polymorph, is the only permitted HMX-
polymorph used in the ammunition of the UK army.
25
 In pharmaceutics, many drugs 








32 , 33 , 34 , 35 , 36
 Desirable properties may be obtained 
through the exploration of new polymorphs. The metastable orthorhombic form II of 
paracetamol
37
 is more compressible
38
 than the stable monoclinic form I
39
 and will 
facilitate tabletting in the manufacturing process.
40,41, 42
 However, emergence of an 
unpredicted form can be catastrophic. Ritonavir was formulated as oral solution and 
gel capsule based on the solubility data of form I polymorph. In 1998, an unusually 
stable polymorph (form II) was discovered in all formulation areas. This new form 
has a very different hydrogen bonding motif and very low solubility, and the original 
formulations could no longer be manufactured.
43
 Moreover, the ownership of new 
polymorphs can become the ground of litigations. The form I polymorph of 
ranitidine hydrochloride, an H2-antagonist for stomach ulcer treatment, was patented 
by Glaxo in the United States in 1978.
44
 The form II polymorph was later discovered, 




 and marketed as Zantac® . The patents on 
form I and II would have expired in 1995 and 2002 respectively. Soon before the 
form I patent expired, a generic company, Novopharm Ltd., failed to prepare form I  
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faithfully following the steps in the patent, and postulated that the product is, and has 
always been, form II. In 1991, it sent an application to the Food and Drug 
Administration (FDA) for marketing generic form II later in 1995. Although Glaxo 
sued Novopharm for infringement, the validity of its form II patent was being 
challenged. Glaxo managed to provide more experimental evidence that the 
procedures in the form I patent do invariably lead to form I and have not led to form 
II, and successfully convinced the court that the form II patent was valid.
47
 Litigation 
ensued again when Novopharm turned to market generic form I in 1994. The 
contention was that the form II impurity in the generic form I product would infringe 
on Glaxo’s form II patent.48,49 
 
Thermodynamically, different polymorphs of the same compound have different 
lattice energies. In an enantiotropic system, a reversible polymorphic transition can 
be observed at a particular temperature. However, in a monotropic system, no 
reversible polymorphic transition can be observed below the melting point of the 
compound. These phenomena can be explained in terms of free energy. For 
enantiotropic systems, the more stable form (i.e. the one with lower free energy) 
below the transition temperature (Tc) will become less stable above Tc, while the 
more stable form above Tc will become less stable below Tc. The free energy of the 
two forms will be equal at Tc, and therefore, reversible transition will take place. For 
monotropic systems, one form is always more stable than the other below the melting 
point, resulting in an irreversible transition (Figure 1.7).
2
 To facilitate the 
identification of an enantiotropic or a monotropic system, Burger and Ramberger
50,51
 
formulated four thermodynamic rules, of which the heat of transition rule (HTR) and  
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the heat of fusion rule (HFR) are widely used. The HTR states:
50
 
“If an endothermic transition is observed at some temperature it may be assumed 
that there is a transition point below it, i.e. the two forms are related 
enantiotropically. (Figure 1.8 (top)) 
“If an exothermic transition is observed at some temperature it may be assumed that 
there is no transition below it, i.e. the two forms are either related monotropically 
(Figure 1.8 (bottom)) or the transition temperature is higher. (Figure 1.8 (top))”  
 
On the other hand, the HFR states:
50
 
“If the higher melting form has the lower heat of fusion the two forms are usually 






Figure 1.8 Energy-temperature diagrams of (top) an enantiotropic system and 
(bottom) a monotropic system, illustrating the heat-of-transition rule and the heat-of-
fusion rule. G: molar free energy; H: molar enthalpy; ΔHf: molar heat of fusion; Tf: 
melting point; Tc: transition temperature; α, β: α- and β-polymorphs respectively; l: 
liquid phase. (Adapted from ref 50)  
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Applications of these rules are often seen in literature. For example, pyrazinamide 
has four reported polymorphs,
52,53,54,55
 which are enantiotropically related. Although 
the relative stabilities of some polymorphs is controversial,
56,57
 the HTR still enables 
us to envisage the free energy profiles of the remaining polymorphs. Nicotinamide 
(vitamin B6) is known to be polymorphic. However, only one crystal form has been 




 By applying 
the HFR on the Differential Scanning Calorimetry (DSC) results, it was concluded 
that all nicotinamide polymorphs are monotropically related.
61
 Recently, the crystal 
structure of the second nicotinamide polymorph was solved. The study on the 
thermodynamic relationship between the two forms further confirmed the previous 
findings.
62
 During the crystallisation process, it is likely that the least stable 
polymorph emerges before the more stable form. This is known as Ostwald’s step 
rule.
2
 The process usually begins with cooling the vapour, the melt or the 
supersaturated solution. The free energy of the system gradually decreases with 
temperature and very likely reaches that of the metastable phase, regardless of 
enantiotropy or monotropy of the system.
2
 Benzamide is a classical example. More 
than 170 years ago, researchers noticed that an unstable, silky needle-shaped 
polymorph (form II) was formed first when cooling a hot benzamide solution slowly 
and was transformed into some large, well-defined crystals (form I) after a few hours 
or days.
63
 The crystal structure of form I was solved in 1959,
64
 but that of form II 




Thus, to maximise the potential benefits of polymorphism and to reduce its 
undesirable impacts, it is beneficial to foresee possible crystal structures of a  
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molecule. As nature tends to attain thermodynamically stable structures, it should be 
feasible to predict polymorphs purely from thermodynamic calculations. Details will 
be discussed in a later section. 
 
1.5 Co-crystals 
1.5.1 Controversy on the definition of a co-crystal 
A co-crystal is regarded as a multi-component molecular crystal/complex in this 
thesis. Unlike a salt, a co-crystal does not contain ionic components which may form 
when some or all acidic hydrogens transfer from one molecule to another. However, 
the definition of a co-crystal remains controversial in the crystal engineering field. In 
the early 1960’s, Von Hippel introduced the term ‘molecular engineering’ when he 
laid the foundations of crystal engineering.
65
 Schmidt appeared to be the first 
researcher
66
 to use the term ‘co-crystal complex’ 67  to define multi-component 
crystals, which contained pyrimidine and purine. On the other hand, 
crystallographers had been using the term ‘molecular complex’ since the 1940’s.66 A 
debate over the terminology of a ‘co-crystal’ ensued since its ambiguity fails to 
describe the difference in crystal lattice between product and reactants, i.e. ‘co-
crystal’ can be perceived as the ‘co-existence’ of more than one kind of crystal 
packing in the product, rather than a homogenous crystal packing for more than one 
molecular component.
68
 However, the term ‘molecular complex’ may not be specific 
for crystalline substances.
69
 Some researchers have tried to define a ‘co-crystal’ as a 
‘multi-component crystal in which each component is solid under ambient 
conditions’,70 but controversy continues because it will be difficult to narrow down  
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its definition within the context of a ‘multi-component molecular crystal’.71,72 Figure 
1.9 shows the complicated scenarios in sub-dividing multi-component molecular 
crystals into smaller subsets. 
 
 
Figure 1.9 Subsets of multi-component crystals inherently overlap with one another; 
in addition each subset may exhibit polymorphism. (Adapted from ref 72)  
 
1.5.2 Co-crystals of active pharmaceutical ingredients (API) 
Recently, the discovery of novel co-crystals of active pharmaceutical ingredients 
(API) has drawn researchers’ interest. Crystalline materials exhibit better stability 





 Through supramolecular interactions, co-crystals prepared by 
non-covalent synthesis are expected to balance product stability with bioavailability 
and provide intellectual property protection.  
 
For instance, carbamazepine is a well-studied API for co-crystallisation.
74,75,76
 Two 
categories of hydrogen bonding patterns have been observed:
77
 (1) the 
carbamazepine dimer is formed via the carboxamide groups (homogeneous 
interaction), and each carboxamide group serves as either hydrogen bond donor or 
acceptor to a co-crystallising agent, e.g. the triclinic polymorph of the 
carbamazepine-saccharin co-crystal (Figure 1.10);
77
 (2) the carboxamide group on 
each carbamazepine molecule interacts with a co-crystallising agent (heterogeneous 






Figure 1.10 The triclinic form of the carbamazepine-saccharin (CBZ-SAC) co-
crystal. A dimer of CBZ is formed (homogeneous interaction) via the carboxamide 





Figure 1.11 The monoclinic form of the carbamazepine-saccharin (CBZ-SAC) co-
crystal. The carboxamide group of each CBZ fully interacts with SAC 
(heterogeneous interaction). (Adapted from ref 78) 
 
Apart from carbamazepine and caffeine, a number of API co-crystals have also been 





dicarboxylic acid co-crystals have better dissolution profiles over the pure API. The 
solubility and dissolution properties of itraconazole:maleic acid (2:1) co-crystals 
have been shown to be similar to those of the amorphous compound.
80
 Fluoxetine 
hydrochloride is reported to form a co-crystal with benzoic, succinic and fumaric 
acid via an exceptional amine hydrochloride-carboxylic acid interaction. From the 
dissolution study, the equilibrium concentration of the API in one of the co-crystal 








Figure 1.12 The molecular diagrams of fluoxetine hydrochloride co-crystals with 
(top) fumaric acid, (middle) succinic acid and (bottom) benzoic acid, showing an 
exceptional amine hydrochloride-carboxylic acid interaction. (Adapted from ref 81) 
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1.5.3 Design strategy in crystal engineering perspective 
Traditionally, re-crystallisation from solvent serves as a means of purification. 
Molecules of interest are crystallised through homomeric intermolecular forces and 
therefore separated from impurities. On the contrary, co-crystallisation targets for the 
construction of crystal lattices comprising of two or more molecules through 
heteromeric intermolecular forces. As a result, the two processes compete.
82
 From 
the prevalence of various supramolecular interactions (i.e. synthons) in existing 
molecular co-crystals, heteromeric interactions may have a higher probability which 
outweighs the homomeric forces and thereby achieves some degree of molecular 
recognition which could be used as a synthetic strategy.
82
 These interactions usually 
involve hydrogen bonds, in which the bond energy can be around 5−10 kcal mol−1.83 
Since the 1990’s, the number of hydrogen-bonded co-crystals has been increasing. 
Some supramolecular synthons including carboxylic acid-pyridine, carboxylic acid-
amide and alcohol-pyridine tend to favour co-crystal formation. Surveys in the 
Cambridge Structural Database (CSD) show that the carboxylic acid-pyridine 
synthon (I) is more favoured than the carboxylic acid homosynthon (II) whereas 
calculation shows the carboxylic acid-amide synthon (III) is more stable than the 









Currently, co-crystallisation focuses on pair-wise contact between molecules. If there 
is only one synthon between the components, either a dimer new phase or a 1:1 co-
crystal will be formed (Figure 1.14). In those cases where there is more than one 





Figure 1.14 Schematic diagram showing a single synthon forming pure phases and 
1:1 co-crystal. (Adapted from ref 85) 
 
 
Figure 1.15 Schematic diagram showing a system with two synthons forming pure 
phases, a 1:1 and a 2:1 co-crystal. (Adapted from ref 85) 
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1.5.4 Serendipity in co-crystal formation 
In crystal engineering, hydrogen bonding with its anisotropic nature is regarded as 
the ‘master key’ for molecular recognition. On the other hand, the prediction of co-
crystal formation is considered difficult because a dominant interaction may not exist 
in the system
83
 or sometimes apparently weak interactions may alter the structure by 
strong interactions.
86
 These contradicting comments reflect the fact that the synthon 
approach is unable to depict the complexity of intermolecular interactions in the 
crystalline state. Isonicotinamide and nicotinamide are structural isomers and both of 
them contain an amide group and a pyridine ring. The amide homosynthon and the 
acid-pyridine synthon are observed in the 1:1 isonicotinamide:benzoic acid co-
crystal,
87
 whilst the amide-acid and the acid-pyridine synthon are observed in the 1:2 
isonicotinamide:benzoic acid co-crystal.
85
 Therefore, nicotinamide would be 
expected to form a co-crystal with benzoic acid via similar hydrogen bond 
interactions. However, no nicotinamide:benzoic acid co-crystal has been reported. 
Furthermore, a CSD survey shows that isonicotinamide forms many more co-crystals 
than nicotinamide does.
88
 Nevertheless, the synthon concept can provide a sensible 
strategy for selecting co-crystallising agents but its reliability in predicting co-crystal 
formation is questionable. The true ‘driving force’ steering the whole co-
crystallisation process is far beyond our chemical intuition as will be discussed later. 
 
1.6 Molecular modelling 
Molecular modelling is a simplified or idealised description of a molecular system 
(or a process) to facilitate calculations and predictions.
89
 It usually involves  
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theoretical or computational techniques and can be generally classified into 
molecular mechanical simulations and quantum mechanical simulations, depending 
on the mathematical framework used. 
 
1.6.1 Molecular mechanics 
Methods based on molecular mechanics are also known as force field methods. Force 
fields are sets of relatively simple equations which represent the energy of a system 
as a function of nuclear coordinates. This assumption is considered valid based on 
the Born-Oppenheimer approximation,
90
 by which nuclear and electronic motion are 
treated separately. Thus, the electronic motion, configuration and distribution are 
usually ignored in force fields. The atoms in a system are categorised into various 
atom types. The coefficients in the equations (i.e. the force field parameters) define 
the equilibrium nuclear configurations and account for the energy penalties for any 
change in the equilibrium.
89
 Usually, these parameters can be transferred from one 
molecule to another, provided that the atoms in the molecules are of the same atom 
type.
91
 Many available force fields are parameterised for different purposes. For 
instance, the Dreiding force field adopted simple functions so that users can easily 




 and MM3 
94
force 
fields were developed for the treatment of hydrocarbons. The Consistent Force Field 
(CFF) was parameterised from organic acids and amides, and might be useful for 
modelling larger biomolecules in the future.
95 , 96 , 97 , 98 , 99 , 100
 The Assisted Model 
Building with Energy Refinement (AMBER),
101,102
 Optimised Potentials for Liquid 
Simulations (OPLS)
103,104
  and Groningen Molecular Simulation (GROMOS) force 
fields
105 , 106
 were parameterised for systems involving macromolecules such as 
carbohydrates, proteins and nucleic acids.  
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The mathematical functions in the force fields depict the energy contributions from 
both bonded and non-bonded interactions. Hence,  
Etotal = Ebonded + Enon-bonded 
where Etotal, Ebonded and Enon-bonded are total potential energy in the system, the energy 
arising from bonded interactions and that from non-bonded interactions, respectively. 
The bonded interactions can be sub-divided into bond stretching, angle bending, 
torsional rotation and inversion energies, whilst the non-bonded interactions can be 
sub-divided into electrostatic, van der Waals and hydrogen bond interactions. 
Therefore, 
Etotal = (Estretch + Ebend + Etorsion + Einversion) + (Eelec + Evdw + EHbond) 
where Estretch, Ebend, Etorsion, Einversion, Eelec, Evdw and EHbond are the energies arising 
from bond stretching, angle bending, torsional rotation, inversion, electrostatic, van 
der Waals and hydrogen bond interactions. In the following sub-sections, some 
commonly used energy functions will be introduced. 
 
1.6.1.1 Bonded interactions 
In a molecule with N atoms, the position of each atom can be expressed in terms of 
the three Cartesian coordinates and a total of 3N variables result. Since the atoms are 
connected via covalent bonds, their relative positions are restrained and the molecule 
can be regarded as a rigid body at one time. Six degrees of freedom, including the 
translations in three orthogonal directions as well as the rotations about three 
orthogonal axes, will be lost (five for linear molecules like carbon dioxide). A set of  
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3N – 6 internal coordinates, including bond lengths, bond angles and torsions, is 
therefore sufficient to define the 3D configurations of a molecule (3N – 5 for linear 
molecules).
89
 Hence, the energies arising from bonded interactions can be expressed 
as functions of these internal coordinates. These functions are based on Newtonian 
physics in which all quantum effects are ignored. 
 
I. Bond stretching 
Using the ‘balls and spring’ analogy, bonded atoms are treated as balls linked by a 
spring (Figure 1.16) and undergo simple harmonic motion in which the magnitude of 
the restoring force is directly proportional to the displacement from the equilibrium 
bond length (the Hooke’s law). Hence, the energy associated with the stretching or 




 k (R – Re)
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where k is the force constant in the motion, R is the actual atomic distance and Re is 
the equilibrium atomic distance. The k and Re values may vary if a different pair of 















 is an alternative in the Dreiding force field and provides a 
better description of bond stretching energy up to a point where dissociation takes 
place. 
Estretch = De [ e
 –a(R – Re) – 1 ]2 
where De is the depth of the potential energy well, a = k / 2De with k being the 
force constant of stretching, R is the actual atomic distance and Re is the equilibrium 
atomic distance. However, the Morse potential is not commonly used because it is 
not readily amenable and requires three parameters to describe each bond pair. The 
actual atomic distance rarely deviates significantly from the equilibrium.
89
 
Alternatively, the force field can be improved by introducing higher order terms in a 







 = 71.94 K (R – Re)
2
 [1 – 2.00(R – Re)] 
However, the negative coefficient of the cubic term would lead the energy to 
negative infinity if R is significantly larger than Re or the starting geometry of the 
molecule is fairly poor. In the MM3 force field, a fourth order term is derived to fix 
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II. Angle bending 
When an atom is bonded to two different atoms simultaneously, an angle is formed 
between the two covalent bonds (Figure 1.17). Angle bending interactions can be 
treated in a similar way to bond stretching interactions. Assuming that the bending 




 k (θ – θe)
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where k is the force constant for the bending motion, θ is the actual angle and θe is 
the equilibrium angle.  
 
Figure 1.17 Angle bending interaction. 
 




 and OPLS force 
fields.
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In the MM3 force field, up to sixth order terms are used in order to fit the ab initio 






 = 0.021914 K (θ – θe)
2
 [1 – 0.014(θ – θe) + 5.6(10
−5
) (θ – θe)
2










A torsion angle (or dihedral angle) is defined as the angle between two planes in 3D 
space and is useful for describing a rotation about a single bond. A plane can be 
defined by any two linear independent vectors or by any three points which are not 
aligned in a straight line. If four atoms are bonded to each other as in Figure 1.18, the 
torsion angle, φ, is often referred to as the angle between the plane formed by the 
first three atoms and that formed by the last three atoms. 
 
Figure 1.18 Torsion rotation. 
 
The torsion angle energy function describes the energy barrier involved in the 
rotation and must be periodic in nature. Hence, a Fourier series is used instead of the 
Taylor expansions used in bond stretching and angle bending interactions. In the 
Dreiding
92






 V {1 – cos[n (φ − φe)]} 
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where φ is the torsion angle, φe is the equilibrium torsion angle, V is the energy 
barrier for the rotation and n is the periodicity. In the CFF force field, a third order 







 = V1 [1 – cos(φ – φ1)] + V2 [1 – cos(2φ – φ2)] + V3 [1 – cos(3φ – φ3)] 
In the OPLS force field,
103,104











 Vi [1 − (-1)
i
 cos i(φ − φe)] 
 
IV. Others 
If an atom is bonded to three different atoms at the same time, the central atom may 
remain planar (e.g. the sp
2
 hybridised carbon in benzene) or stay out-of-plane from 
its neighbouring atoms (e.g. the nitrogen atom in ammonia). The energy for altering 




Figure 1.19 Four-body configurations: (middle) planar geometry; (left and right) 
out-of-plane geometries or inversions. 
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The Dreiding force field adopts the spectroscopic inversion concepts with a 
modification such that the energy gradient at planar geometry would be zero. For 
systems with planar equilibrium geometries, the following equation is used:
92
 
Einversion = K (1 − cos ψ) 









 (cos ψ − cos ψe)
2 
where K is the force constant, ψ is the out-of-plane angle (denoted as the angle 
between the plane formed by the central atom with its two neighbour atoms and the 
bond formed by the central atom with the remaining neighbour atom) and ψe is the 
equilibrium out-of-plane angle. In some other force fields, inversion is treated as an 
improper torsion and the definitions of an improper torsion angle may vary. In the 
AMBER force field,
101,102








 K {1 − cos[n(θ – θe)]} 
where θ is the angle between any two planes formed by the central atom with any 
two pairs of neighbouring atoms, n = 3 for tetrahedral centres or n = 2 for planar 










 K (α −αe)
2
 
where α = ψ − φ and φ is the pseudo-torsion angle defined in the MM2 force field. 
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1.6.1.2 Non-bonded interactions 
Atoms which are not directly bonded can interact with each other. These interactions 
are categorised into short range van der Waals interactions and long range 
electrostatic interactions. Empirical equations for van der Waals interaction had been 
developed although its fundamental origin was not fully known until the 
development of quantum mechanical theories. The electrostatic interaction is 
described by Coulomb’s law. 
 
I. van der Waals interaction 
This interaction is named after Johannes Diderik van der Waals, a Dutch physicist 
and Nobel Laureate in Physics in 1910 for his work on an equation of state for gases 
and liquids.
108
 He pointed out that atoms are of non-zero finite sizes and do interact 
with each other. Currently, the term ‘van der Waals interaction’ covers a range of 
repulsive and attractive interactions between atoms in close contact (such as dipole-
dipole, dipole-induced dipole and dispersion interaction). The Lennard-Jones 
potential (sometimes referred to as LJ or 12-6 potential)
109
 serves as a good 




 and OPLS force 
fields.
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where ε is the depth of the potential energy well and ro is the atomic distance at 
which the potential energy attains a minimum. The sixth power term accounts for the 
attractive force as the atoms are fairly far away from each other. The twelfth power  
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term accounts for the strong repulsive force when atomic orbitals overlap with each 
other at extremely short atomic distances. In the CFF force field, a ninth power term 




Another commonly used function to describe van der Waals interactions is the 
exponential-6 potential (sometimes referred to as Buckingham potential).
110
 An 



































 = A’ exp(−C’r) − B’r 
−6
 
where a, b and c are dimensionless scaling parameters for converting the 
exponential-6 potential into a 12-6 potential. This potential function is an alternative 
in the Dreiding
92
 force field and is adopted in the MM2 
93
 and MM3 
94
 force fields. 
Note that the repulsive term tends to a finite number and the attractive term tends to 
−∞ as r goes to zero. Hence, the exponential-6 potential may not be able to handle 




In most force fields, only the van der Waals parameters for interactions between the 
same atom types (the diagonal terms) are provided. The parameters for interactions 
between different atom types (the off-diagonal terms) are determined by the choices 
of combination rules in the force fields. These combination rules are often the 
arithmetic means or geometric means of the diagonal terms. Different combination 
rules can be applied to different off-diagonal terms in the same potential function. 
For example, if the exponential-6 potential is selected in the Dreiding force field,  
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geometric means are used to calculate the off-diagonal A and B parameters, whilst 




II. Electrostatic interaction 
The electron density may not be uniform around the molecule. The variations in net 
charge density at different parts of the molecule result in a specific non-bonded 
interaction. However, it would be complicated to calculate the electrostatic potential 
if the charge density is a continuous function in space. To simplify the problem, a 
point charge is assigned to each atom in a molecule so that such a model can 
approximately reproduce the actual electrostatic potential contours around the 
molecule. Several methods have been developed to assign atomic charges. One of 
these is commonly known as the Gasteiger charge method, which was developed by 
Johann Gasteiger and Mario Marsili.
111
 The orbital electronegativity of each atom is 
expressed as a quadratic polynomial of the atomic charge. The coefficients in the 
polynomial are related to the ionisation potential and the electron affinity of an atom. 
Initially, all atoms in a molecule have zero charge and the difference in orbital 
electronegativity between any pair of bonded atoms is the driving force for charge 
transfers. Charges are transferred from one atom to another via a series of iterations. 
To avoid convergence issues, in each iteration, a damping factor of 0.5
α
 is applied to 
the amount of transferable charge, where α is the number of the iteration step. Note 
that the Gasteiger charges only depend on the connectivity of atoms in a molecule 
and are not affected by conformational changes in a molecule. 
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Another commonly used method is the charge equilibrium approach (Qeq).
112
 The 
atomic energy is expressed as a quadratic polynomial of its own charge. In addition, 
the electrostatic energy between any two charges is included. The optimal charge 
distribution can be achieved when the first derivatives of energy with respect to 
every point charge are equal. A shielding correction is applied to avoid infinite 
energy at short distances. The resulting energy value is related to the idempotentials 
of the atoms involved (idempotential is the difference between the ionisation 
potential and electron affinity). Since the distance between point charges have been 
taken into account, the charges will vary with a change in molecular configuration. 
 
Quantum mechanical or semi-empirical methods can be used to calculate the 
electrostatic potentials at various points around an isolated molecule in gas phase. 
The deviation in electrostatic potential of the assigned point charges from the 
quantum mechanical or semi-empirical calculation is minimised by the least-square 
method, resulting in a set of ESP (electrostatic potential) derived atomic charges.
113
 
A constraint can be applied to ensure that the net charge of the molecule will remain 
zero.  
 
Since the electrostatic potential, Eelectrostatic = ke · ( qi · qj )/rij, where ke is the Coulomb 
constant, qi and qj are the point charges on atoms i and j respectively and rij is the 
distance between the two point charges, it decays much more slowly than the van der 
Waals potential in real space. The Ewald summation method,
114
 named after Paul 
Peter Ewald, is a mathematical treatment which speeds up the convergence. Each  
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point charge is screened by a charge cloud of opposite sign. Meanwhile the screening 
charge cloud is compensated by another charge cloud which has the same sign as the 
point charge (Figure 1.20a&b).
115 , 116
 These charge clouds are represented by a 
Gaussian function. At long distances, the point charge is very much cancelled out by 
the screening charge cloud, and therefore the compensating charge cloud makes 
more contribution and behaves like a point charge. At short distances, the 
compensating charge cloud has little contribution, and the point charge together with 
the screening charge cloud dominate (Figure 1.20c). Splitting long range and short 
range electrostatic interactions is at the heart of this method. The charge density at 
long distances is expressed in Fourier space, and by selecting an appropriate width of 
the Gaussian function, the long range electrostatic potential converges quickly in 
reciprocal space. Meanwhile, the short range electrostatic potential between the point 
charge and the screening potential converges quickly in real space. Note that the use 
of Fourier space assumes the system of interest is periodic in nature which is valid 
for crystal systems. 
 
Figure 1.20 (a) A set of point charges along a one-dimensional axis. (b) Each point 
charge is ‘screened’ by a charge cloud (top), which is compensated by a charge cloud 
of opposite sign (bottom). (c) At long distances, the compensating charge cloud 
dominates. At short distances, the point charge and the screening charge cloud 
dominate. (Adapted from ref 116)  
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III. Hydrogen bond 
Some force fields may include an energy function for hydrogen bond interactions. In 
the Dreiding force field,
92
 a 12-10 potential is used: 


























 ( )θDHA  
where Dhb and Rhb determine the depth of the potential well and depend on the 
convention of assigning charges, θDHA is the angle between the hydrogen donor (D), 
the hydrogen (H) and the hydrogen acceptor (A), whilst RDA is the distance between 
the hydrogen donor and acceptor. 
 
1.6.2 Quantum mechanics 
In the early twentieth century, some physical phenomena at atomic or sub-atomic 
level could not be explained by Newtonian physics. There was evidence that an 
electron in an atom occupies discrete and quantised energy levels. The classical 
atomic model, which assumed that an electron moved around the nucleus on discrete 
orbits, led to paradoxical conclusions. Firstly, the orbiting electron would emit 
electromagnetic waves and would eventually collapse into the nucleus due to the loss 
in energy. Secondly, the position and the momentum of the electron could be 
determined simultaneously. The former never happens, whilst the latter is found 
impossible because an accurate measurement of electron position would 
simultaneously and inevitably lead to a less accurate measurement of its momentum, 
and vice versa.
117
 After the discovery of the laws of photoelectric effect by Albert 
Einstein,
118
 Louis de Broglie proposed the wave-particle duality of electrons.
119
 This  
  
 39 
hypothesis was confirmed by Clinton Davisson and Lester Germer’s electron 
diffraction experiments on nickel crystals
120 , 121
 and was generalised by Erwin 
Schrödinger’s wave function.122 The non-relativistic time-independent Schrödinger’s 
equation describes the quantisation phenomenon as an eigenvalue problem:  
Ĥψ = Eψ 
where ψ is the wave function of the particles, Ĥ is the Hamiltonian operator and E is 
the energy of a quantum state. The Hamiltonian operator consists of a Laplace 
operator which describes the kinetic energy of the particles, and a potential energy 
function which accounts for interactions between particles in the system. For a 
simple system like the hydrogen atom, the Schrödinger’s equation can be solved 
analytically. For more complicated systems, approximations are needed in order to 
solve the equation computationally. According to the Born-Oppenheimer 
approximation,
90
 the motions of electrons and nuclei can be treated separately. 
Consequently, only the electron motions, nucleus-electron attractions and electron-
electron repulsion terms are considered in the Hamiltonian. 
 
1.6.2.1 The Hartree-Fock approximation  
In multi-electron atoms, the orbital approximation is adopted to reduce the 
complexity of Schrödinger’s equation. Each electron is described separately by its 
own wave function (orbital) with an additional Hartree potential, which accounts for 
the coulombic interaction of the electron with an average electron density.
123,124
 
According to the Pauli Exclusion Principle,
125
 the wave function changes sign under 
the interchange of any two electrons. Therefore, the approximate atomic wave  
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function is expressed as a Slater determinant of all one-electron orbitals, such that the 
anti-symmetric property is preserved.
126,127
 The wave function of a molecule can be 
handled in a similar way, where each unknown one-electron wave function is 
expanded as a linear combination of the known atomic orbital functions, resulting in 
a set of secular equations. With the advent of computational technology, the 
coefficients in each expression can be solved by the ‘self-consistent field’ (SCF) 
method.
124
 After calculating the matrix elements in the secular determinant, sensible 
estimates of the coefficients are used to compute the energy terms, which are then 
substituted into the secular equations to generate new coefficients. This step is 
repeated until the value of each coefficient converges. Note that the energy 
calculated by the Hartree-Fock approximation is always greater than the true 
energy.
128
 Errors are due to ignoring relativistic effects for the core electrons of 
heavy elements and the fact that electron-electron correlation effects are ignored. The 
former has less impact on the calculation accuracy because only the valence 
electrons are involved in a chemical reaction.
128
 The latter may cause more serious 
problems in calculating dissociation energies or in estimating the ionisation 




1.6.2.2 Semi-empirical methods 
Most of the computational effort in Hartree-Fock calculations is spent calculating the 
two electron integrals. The number of integrals increases approximately as the fourth 
power of the number of basis functions in the molecule.
128
 Semi-empirical methods 
were developed to provide a better balance between the calculation speed and the 
accuracy of the results. The core approximation used in these methods treats all inner  
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electrons and the nucleus as a core. Only valence electrons are handled quantum 
mechanically.
89,128
 Different methods approximate the molecular integrals to various 
extents. In the complete neglect of differential overlap (CNDO) approach,
129
 a 
majority of two-electrons integrals are ignored, and the remaining integrals are 
parameterised using an ab initio method.
89
 The intermediate neglect of differential 
overlap (INDO) model
130
 includes two electron integrals containing basis functions 
on the same atom. Therefore, the interaction between two electrons on the same atom 
with parallel spins has a lower energy, compared with that between two electrons 
with a paired spin.
89
 The neglect of diatomic differential overlap (NDDO) 
approach
129
 only neglects all the integrals involving atomic orbitals on two different 
atoms. These models demonstrate the development of semi-empirical methods. 
However, they often agree poorly with the experimental results because relatively 
low-level ab initio data was used in their parameterisation.
89
 The modified 
intermediate neglect of differential overlap (MINDO)
131
 and the modified neglect of 
diatomic differential overlap (MNDO) methods
132
 were introduced later and can be 
applied to many different research areas. MINDO and MNDO are based on the 
theories in INDO and NDDO respectively, except that much more experimental data 
are used in their parameterisation. Austin Model 1 (AM1)
133
 and Parameterized 
Model number 3 (PM3)
134
 are improved MNDO models and implemented in 
software packages such as Molecular Orbital PACkage (MOPAC)
135
and General 





1.6.2.3 The Density Functional Theory 
The wave function used in the Hartree-Fock approximation is a complicated entity. 
Physicists devised a different approach in solving the multi-electron Schrödinger’s 
equation. Electron density attains a maximum and forms a cusp at the nucleus. 
Information such as the number of electrons and the nuclear charge can be retrieved 
from the electron density in a system.
137
 The idea of taking electron density as the 
basic quantity in a quantum mechanical problem dates back to the Thomas-Fermi 
model in the 1920s.
138,139
 The foundation of the density functional theory (DFT) was 
laid by Hohenberg and Kohn in 1964. According to the Hohenberg-Kohn theorem, 
the full many-particle ground state energy is a unique functional of particle density, 
and the functional for total energy will attain its minimum if and only if the input 
density equals the true ground state density.
140
 The energy functional can be split into 
four functionals for the kinetic energy, the Hartree potential, the exchange-
correlation energy and the nuclear potential. Kohn and Sham proposed using a set of 
fictitious orbitals (known as Kohn-Sham orbitals) for non-interacting electrons in 
1965.
141
 The difference in kinetic energies between the fictitious and the actual 
systems is incorporated in the exchange-correlation functional. Unfortunately, this 
functional is not exactly known. Otherwise, DFT would be an exact theory. Much 
effort has been spent on working out an appropriate form of this functional. Since the 
electronic exchange and correlation have a small contribution to the total energy, a 
sensible approximation is sufficient. The local density approximation (LDA) 
assumes that the electron density is uniform at any point in the system.
141
 The 
exchange-correlation functional can be obtained from the Monte-Carlo simulation of 
electron gas. In the generalized gradient approximation (GGA), the local gradient of  
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density is considered in the functional.
142,143
 PW91 (Perdew-Wang 91)
144,145
 and PBE 
(Perdew-Burke-Ernzerhof)
146
 are examples of GGA functionals. An alternative way 
is to combine the exchange-correlation data from pure DFT with part of the exact 
exchange from Hartree-Fock theory, resulting in a hybrid DFT functional like 
B3LYP (Becke, three-parameter, Lee-Yang-Parr).
147
 For simulating crystalline 
materials, the Kohn-Sham orbitals can be placed in a periodic potential according to 
the Bloch’s theorem.148 A plane-wave basis set, being periodic in nature, is used to 
calculate the electron density.
149
 One of the drawbacks of a plane-wave basis set is 
that a large number of plane waves are needed to simulate dramatic change in 
electron density near the nucleus. This problem can be alleviated by introducing 
pseudo-potentials like the Projector Augmented Wave (PAW) method
150
 to describe 
the strong coulombic interactions between the nucleus and the inner electrons. 
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This chapter gives an overview of the development of crystal structure prediction 
(CSP) methodologies and a series of ‘blind tests’ organised by the University of 
Cambridge and hosted by the Cambridge Crystallographic Data Centre which 
investigate the reliability of these methodologies in predicting a number of 
unpublished experimental crystal structures. The CSP methodology used in this work 
(the GRACE software package) and its implementation details are given in this 
chapter. 
 
2.2 Crystal structure prediction (CSP) 
Polymorphism
17
 can cause problems but also offers exploitation opportunities 
because of the variation in physical properties among polymorphs. The ability to 
predict the crystal structures of a compound would make a significant contribution to 
crystal engineering. In 1988, John Maddox commented that the general failure in 
CSP remained ‘one of the continuing scandals in physical sciences’.151 Six years later, 
Angelo Gavezzotti addressed the difficulties in a landmark review paper entitled 
‘Are crystal structures predictable?’, and the answer given was ‘no’.152  The two 
major technical challenges in CSP are the problem of searching for all potential 
crystal structures within a given energy window and the problem of calculating their 





2.2.1 Structure generation algorithms 
For molecular crystals, the degrees of freedom in the unit cell parameters, the 
molecular positions, orientations and flexibilities form an enormous search space.
153
 
Some software simplifies the problem by packing rigid molecules into the unit cell 
and carries out systematic grid scans over the search space. In PROMET,
154
 a 
molecular nuclei concept is applied. Two to four rigid molecules in a cluster are 
related to each other by the most common symmetry elements such as the inversion 
centre, the screw axis and the glide plane. Trial crystal structures are generated by 
translating the clusters in three directions. MOLPAK (MOLecular PAcKing)
155
 
makes use of Kitaigorodskii’s assumption that rigid molecules are closely packed 
with minimum void space. The orientations of a central molecule and the 
coordination patterns of its surrounding molecules are investigated. Five to ten small-
volume crystal structures are selected for lattice energy minimisation by the WMIN 
program.
156
 On the other hand, CRYSCA (the CRYstal Structure Calculation 
program)
157,158
 and MPA (Molecular Packing Analysis)
159
 generate trial structures by 
assigning random values to each dimension in the search space. UPACK (Utrecht 
Crystal Packer)
160 ,161
 was originally designed to predict the crystal structures of 
carbohydrate molecules. The positions and orientations of a rigid molecule together 
with the unit cell parameters are probed by either using a systematic grid scan or 
randomly assigned values. Trial structures with up to two independent molecules in 
the asymmetric unit can be generated. The estimated density of the trial structure 
helps eliminate one of the cell parameters. In order to filter unreasonable trial 
structures more quickly, the geometric details of the hydroxyl group is omitted 
initially but re-introduced at a later stage. 
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The search problem can be further simplified by restricting the search to some 





 samples trial structures in 13 space groups which account 
for more than 90 % of crystals in the database: P1, P1¯, P21, P21/c, C2, Cc, P212121, 
P21212, Pna21, Pca21, Pbcn and Pbca (Table 2.1). Using space group symmetry 
reduces the complexity of the search problem. For triclinic crystal system, six 
degrees of freedom are attributed to the three unit cell axes and the three angles 
between the axes. In addition, six degrees of freedom arise from the three positional 
and three orientational coordinates of each rigid molecule in the asymmetric unit. 
Instead of considering four independent molecules in a P1 asymmetric unit (which is 
identical to a P1 unit cell), a search in the P21/c space group reduces the number of 
degrees of freedom from 27 to 10.
162
 Structure generation can also be made more 
efficient by weighting the space group occurrence in the search according to the 
probability of the occurrence of that space group in nature. This approach is 
sometimes taken a step further by only searching in the 13 most common space 






Table 2.1 Frequency distribution of the most common space groups and their 
degrees of freedom. [Reproduced by permission of The Royal Society of Chemistry 
from the work of Leusen and Kendrick in ref 162] 
    Degrees of freedom 
Space group Occurrence % Crystal system Z Cell Trans. Rot. Total 
P21/c 35.1 Monoclinic 4 4 3 3 10 










C2/c   8.1 Monoclinic 8 4 3 3 10 
P212121   7.8 Orthorhombic 4 3 3 3 9 
P21   5.4 Monoclinic 2 4 2 3 9 
Pbca   3.5 Orthorhombic 8 3 3 3 9 
Pna21   1.4 Orthorhombic 4 3 3 3 9 
Pnma   1.2 Orthorhombic 8 3 3 3 9 
Cc   1.1 Monoclinic 4 4 1 3 8 















Pbcn   0.9 Orthorhombic 8 3 3 3 9 
C2   0.8 Monoclinic 4 4 2 3 9 
Pca21   0.7 Orthorhombic 4 3 2 3 8 
 
The grid scan search is a demanding task for systems with many degrees of freedom. 
If S equally spaced values are considered for each degree of freedom, the size of the 
grid scan becomes S
N
, where N is the number of degrees of freedom.
153,162
 For 
hydrate/solvate, co-crystal and salt structures, the number of independent molecules 
in the asymmetric unit is always larger than one. The size of the grid scan increases 
exponentially for each additional molecule and quickly becomes unmanageable. A 
random searching method is a slightly better alternative, but it becomes inefficient 
for very complicated problems. For systems with a small increase in the degrees of 
freedom, a vast number of trial structures are generated and there is not much 
information whether all low-energy structures have been included.
153
 Therefore, 
modified random search methods such as the Monte Carlo simulation and the genetic 
algorithm were developed in order to improve the efficiency. 
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In the Monte Carlo search method, a random move in the search space is accepted or 
rejected, based on the associated change in energy and the predefined energy barrier. 
Polymorph Predictor (PP)
163
, marketed by Accelrys Limited, applies a modified 
Monte Carlo simulated annealing method which consists of a heating and a cooling 
(annealing) phase. A random number ζ ranging from 0 to 1 governs the extent of 
changes allowed in each move. The Metropolis algorithm
164
 is used to determine 
whether a change is accepted or rejected. If a new trial structure is more stable, it will 
be accepted as the current structure. Otherwise, it will only be accepted when exp(-
ΔE/kT) > ζ, where ΔE is the lattice energy difference between the new and old trial 
structures, k is the Boltzmann constant and T is the temperature. During the heating 
phase, the temperature is increased so that more moves will be accepted and large 
energy barriers in the search space are overcome. This ensures a complete search 
throughout the search space. During the cooling phase, a high energy move is less 
likely. The search then focuses on various low-energy local minima. A key 
advantage of this method is that a search can be performed in all 230 space groups 
separately. The conformation-family Monte Carlo global optimisation scheme, 
performed in the CRYSTALG program,
165
 makes steps between families rather than 
between individual structures at a constant temperature. The Modified Genetic 
Algorithm for Crystals and cluster structures (MGAC) minimises the lattice energy 
of a structure and allows ‘crossover’, ‘mutation’ and ‘selection’ of the unit cell 





 program also implements a genetic algorithm, 
except that no lattice energy calculation is performed. It retrieves structural data, for 
instance the intermolecular atom-pair distance frequencies, in structures which  
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contain molecules chemically similar to the target molecule, and derives a scoring 
function. During the search, structures which fit well to the scoring function are 
probed. However, this method did not make any successful predictions in the ‘blind 
tests’ of crystal structure prediction (see section 2.3). 
 
2.2.2 Lattice energy minimisation 
Since nature has a tendency to adopt a thermodynamically stable structure at the end 
of the crystallisation process, many CSP methodologies are based on the assumption 
that the low energy predicted structures are likely to be observed experimentally. The 
relative stability of two polymorphs is determined by their free energy difference, 
ΔG, at constant temperature and pressure:  
ΔG = PΔV + ΔU – TΔS 
where P is the pressure, ΔV is the volume difference, ΔU is the internal energy 
difference, T is the temperature and ΔS is the entropy difference. The PΔV term is 
negligible, since the difference in unit cell volumes is usually small. The entropy 
term, on the other hand, may not be negligible at room temperature but is usually 
ignored, because reliable calculation is not straightforward. Hence, in CSP, the ΔU 
term, expressed as the lattice energy difference between polymorphs at a nominal 0 
K, is taken as an approximation to the actual ΔG. All kinetic factors, solvent effects, 
nucleation processes and crystal growth factors etc., are ignored in CSP, except that 






Many CSP methodologies calculate lattice energy by molecular mechanical methods, 
for example Cerius
2





Atomic point charge or distributed multipole models can be used to represent the 
quantum mechanical electrostatic potential of the gas phase molecule calculated by 
programs like GAUSSIAN
176
 or CampCASP (Cambridge package for Calculation of 
Anisotropic Site Properties).
177
 To compare the performance of atomic point charge 
and distributed multipole models, an extensive CSP study of 50 rigid molecules 
investigated the number of the unobserved structures having lower energies than the 
experimental structures and the associated energy differences. It was found that the 
multipole model is more capable of discriminating small energy difference between 
the low energy predicted structures.
178
 Therefore, an advanced energy model is 
important for improving the CSP success rate. DMAREL
179
 and its revised version 
DMACRYS
180
 use distributed multipole analysis to model the anisotropic 
electrostatic and van der Waals interactions, and minimise the energies of structures 
generated by another program like MOLPAK
155
 or Polymorph Predictor.
163
 For 
flexible molecules, minimisation of lattice energy based on the intermolecular 
potential alone is insufficient because the molecular conformations generated by 
simple force field methods often lead to unphysical results. In DMAflex 
calculation,
181
 the lattice energy is split into the energy penalty due to any 
conformational changes from the in vacuo geometry of the molecule and the 
intermolecular energy inside the crystal. The conformational energy and charge 
density of an isolated molecule are calculated using GAUSSIAN.
176
 During the 
minimisation, atomic multipoles are calculated by DMAREL
179
 whenever any 
conformational changes have been introduced. CrystalOptimizer
182
 performs similar  
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calculations, except that the atomic multipoles are updated when necessary. The 
conformational energy, its first and second derivatives and the atomic multipoles are 
stored for re-use, in case that the same conformational changes are encountered. A 
simpler energy model is adopted in CrystalPredictor.
183,184
 Atomic point charges are 
used for calculating the electrostatic energy. The molecule is kept fully rigid or 
partially rigid with a number of flexible torsions. The torsional energies are 
expressed using the interpolation of pre-computed QM energies. 
 
Instead of using an atom-atom energy model, PIXEL
185,186,187,188
 applies a semi-
classical density sums (SCDS) method. The electron density of an isolated molecule 
calculated by GAUSSIAN
176
 consists of millions of pixels. These pixels are 
agglomerated into larger pixels for calculating molecule-electron interactions to yield 
the electrostatic, exchange-repulsion, dispersion and polarisation energies. 
 
2.3 The ‘blind tests’ of crystal structure prediction 
To assess the technological advances in CSP, a series of blind tests was organised by 









 and 2010 (CSP2010).
193
 
Before each blind test, requests for unpublished organic crystal structures were 
circulated to a number of crystallography laboratories. A set of three to six structures 
were selected by an independent referee. The molecular structures were sent to the 
participants, who were invited to make a maximum of three predictions for each 
compound with reasons and degree of confidence for their choices. The root-mean- 
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square-deviation in atomic positions was calculated by programs which overlaid 




By estimating the state-of-the-art capabilities before each blind test, the selection 
criteria of candidate molecules and crystal structures has been modified throughout 
the years.  In CSP1999, the maximum size of the molecule was no more than 30 
atoms, including hydrogen atoms. The small and rigid molecules either comprised C, 
H, N, O atoms with less than 20 atoms or contained some less common elements. A 
small amount of conformational freedom was allowed. The candidate crystals were 
restricted to only one molecule in the asymmetric unit and in some commonly seen 
space groups.
189
 These criteria remained the same in CSP2001, except that the 
maximum molecular size was increased to 40 atoms and a flexible molecule having 
two degrees of acyclic torsional freedom was included.
190
 In CSP2004, the flexible 
molecules had several torsional degrees of freedom. Candidate crystals in all space 
groups with no more than two molecules in the asymmetric unit were allowed.
191
 In 
CSP2007, a two-component crystal of rigid molecules was added,
192
 whilst in 
CSP2010, a molecular salt, a hydrate of a flexible molecule and a much larger and 
more flexible molecule were included (Figure 2.1).
193
 These changes reflect the 




Figure 2.1 Molecular diagrams of the target compounds in the blind tests and the 
numbering scheme in Roman numbers. 
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In CSP1999, CSP2001 and CSP2004, no single methodology could consistently 
predict the experimental crystal structures (Table 2.2), leading to scepticism of CSP 
in the crystallographic community. In particular, molecule VI (6-amino-2-phenyl-
sulfonyl-imino-1,2-dihydropyridine, see Figure 2.1) in CSP2001 has been the subject 
of extensive discussions in the literature. None of the blind-test participants had 
predicted the then only known experimental structure (form I, a Z'=1 structure) of 
molecule VI.
190
 Two additional polymorphs, forms II
195
 (a Z'=2 structure) and III
196
 
(a Z'=1 structure), were discovered after the 2001 blind test. Neither of these new 
structures had been reported by the blind-test participants. It was concluded that CSP 
had failed because the observed polymorphs were kinetically favoured and the 
methods used in CSP are designed to locate thermodynamically favoured forms.
195-
197
 These findings led to comments on the state of CSP
197,198
 and it was suggested 
that “structure prediction, which would be most valuable for process chemistry, has 
still a way to go”.199 In the 2007 blind test a new approach (the GRACE software 
package) correctly predicted, for the first time, all four target structures.
200
 Recently, 
the same methodology was used to re-evaluate the lattice energies and energy 
rankings of the experimental structures and all submitted predictions in the 1999, 
2001, and 2004 blind tests, with very encouraging results.
201
 Other results obtained 
with the DFT(d) approach also suggest that a sufficiently accurate thermodynamic 
approach can predict the likely crystal structures of small organic molecules.
202,203,204
 
































CSP1999 Molecule I 
Polymorph I (metastable) - Pbca   5.31 12.65 14.54   90.00 - 
Polymorph II (stable) - P21/c   4.95   9.85   9.68   90.57 - 
MPA 1 Pbca   5.13 12.50 14.10   90.00 0.28 
PP 1 Pbca   5.37 12.57 15.13   90.00 0.23 
Zip-Promet 1 Pbca   5.19 12.56 14.34   90.00 0.20 
UPACK 3 Pbca   5.28 12.47 14.39   90.00 0.53 
        
CSP1999 Molecule II 
Experimental - P21/n   7.52   8.33   9.06 100.19 - 
PP 2 P21/n   7.24   8.30   9.21 104.53 0.43 
        
CSP1999 Molecule III 
Experimental - P21/c   6.84   7.63 21.42   96.45 - 
UPACK 1 P21/c   6.77   7.76 20.94   98.32 0.21 
        
CSP1999 Molecule VII 
Experimental - P21/n   4.15 12.61   6.98   94.28 - 
UPACK+ab initio 1 P21/c   6.78 12.57   7.80   31.35 0.16 
        
CSP2001 Molecule IV 
Experimental - P21/a   7.70 10.61   9.34   95.00 - 
PP+ab initio 2 P21/c   9.23 10.41   7.96   83.90 0.20 
PP 3 P21/a   8.02 10.51   9.18   83.00 0.26 
        
CSP2001 Molecule V 
Experimental - P212121   7.26 10.64 15.63   90.00 - 
MOLPAK 1 P212121 10.39 16.35   7.13   90.00 0.36 
MOLPAK+ DMAREL 1 P212121 16.22 10.41   7.18   90.00 0.35 
UPACK 1 P212121   9.99 15.89   7.12   90.00 0.78 
MPA 3 P212121 10.66   6.93 15.58   90.00 0.26 
        
CSP2001 Molecule VI 
Polymorph I - P21/c   8.25   8.96 15.09   91.21 - 
No successful prediction 
        
CSP2004 Molecule VIII 
Experimental - C2/c   9.35 12.18   7.23 104.59 - 
Crystal Predictor 1 C2/c   8.97 12.09   7.75 102.55 0.53 
PP+DMAREL 1 C2/c   8.96 12.29   7.86 102.96 0.62 
UPACK+XTINKER 1 C2/c   8.75 12.22   7.72 103.29 0.60 
MGAC 2 C2/c   8.77 12.09   7.60 101.27 0.61 
PP 3 C2/c   8.21 12.07   8.56 103.28 1.70 
        
CSP2004 Molecule IX 
Experimental - P21/c   9.51   9.12   9.79 117.47 - 
PP+DMAREL 1 P21/c   4.22 20.925   9.31 101.05 0.19 
        
CSP2004 Molecule X 
Experimental - P21/n 12.57   4.85 17.27   99.16 - 
No successful prediction 
        
CSP2004 Molecule XI 
Experimental - P21/c   9.51   9.12   9.79 117.47 - 
No successful prediction 
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CSP2007 Molecule XII 
Experimental - Pbca   6.97   9.51   9.75   90.00 - 
GRACE 1.0+VASP 1 Pbca   6.97   9.50   9.98   90.00 0.127 
PP 1 Pbca   6.88   9.70   9.99   90.00 0.156 
MOLPAK+DMAREL 2 Pbca   7.04   9.75 10.15   90.00 0.174 
Zip-Promet+PIXEL 2 Pbca   6.81   9.62   9.58   90.00 0.183 
        
CSP2007 Molecule XIII 
Experimental - P21/c   3.89 13.51 14.43   93.64 - 
GRACE 1.0+VASP 1 P21/c   3.88 13.46 14.47   94.97 0.082 
Crystal Predictor+ 
Cerius 2 OFF+DMAREL 
1 P21/c   3.88 13.68 14.40   92.01 0.159 




1 P21/c   3.80 13.79 14.53   93.78 0.152 
        
CSP2007 Molecule XIV 
Experimental - P21/c 13.06   9.74   9.34 105.80 - 




1 P21/c 12.88   9.77   9.61 107.62 0.222 
UPACK+XTINKER 1 P21/c 12.85   9.80   9.34 106.52 0.147 
        
CSP2007 Molecule XV 
Experimental - P21/n   7.28 13.67 12.67   96.65 - 
GRACE 1.0+VASP 1 P21/n   7.26 13.82 12.52   97.44 0.075 
UPACK+XTINKER 3 P21/n   7.34 13.56 12.67   97.34 0.294 
        
CSP2010 Molecule XVI 
Experimental - Pbca   9.65   7.38 16.19   90.00 - 
GRACE 1.5-1.6+VASP 1 Pbca 16.30   7.51   9.49   90.00 0.157 
UPACK+XTINKER+ 
GAMESS-UK+MOLDEN 
2 Pbca 10.16   7.34 16.05   90.00 0.247 
        
CSP2010 Molecule XVII 
Experimental - P21/c 12.64   5.98 11.42   96.81 - 




2 P21/c 12.66   5.86 11.67   96.44 0.130 
        
CSP2010 Molecule XVIII 
Experimental - Pbca   9.89   8.89 24.97   90.00 - 
GRACE 1.5-1.6+VASP 1 Pbca   9.93   8.79 25.44   90.00 0.122 
        
CSP2010 Molecule XIX 
Experimental - Pca21 23.50 3.71 12.65   90.00 - 
UPACK+XTINKER+ 
GAMESS-UK+MOLDEN 
2 Pca21 23.94   3.70 12.75   90.00 0.220 
GRACE 1.5-1.6+VASP 3 Pca21 23.63   3.76 12.37   90.00 0.151 
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CSP2010 Molecule XX 
Experimental - P21/n 14.08   6.36 25.31   96.06 - 
Crystal Predictor+ 
DMAREL+DMACRYS 




1 P21/n 14.26   6.32 25.36   82.72 0.178 
        
 
CSP2010 Molecule XXI 
Experimental - P21/c   9.79   3.61 21.58   91.46 - 
No successful prediction 
a root-mean-square-deviation in atomic positions between the experimental and predicted structures. 
 
2.4 GRACE software 
The GRACE software (Generation, Ranking And Characterization Engine) was 
developed by Marcus Neumann for CSP.
205
 The heart of this software is a DFT(d) 
method which combines density functional theory simulations and an empirical 
correction for dispersive forces (section 2.4.1). To speed up the structure generation, 
the parameterisation of a tailor-made force field (TMFF) against reference data sets 
generated by the DFT(d) method is implemented in GRACE. The mathematical 
framework of the TMFF and the detailed CSP strategy are given in section 2.4.2 and 
2.4.3 respectively. 
 
2.4.1 DFT(d) method 
Density functional theory (DFT) calculations are performed by the Vienna ab initio 
simulation package (VASP)
206,207,208,209
 which is used as a black box in the GRACE 
software. Projector augmented wave (PAW) potentials
150
 and the PW91 exchange-
correlation functional
144,145
 with the Vosko, Wilk, and Nusair interpolation formula  
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are used with the plane-wave cut-off energy set at 520 eV. The k-point spacing in the 
Brillouin zone is approximately 0.7 Å
−1





 per atom. Minimisations are complete when the change in lattice 




 per atom, atomic displacements are no 
more than 3 × 10
−3





 per atom. Pure DFT calculations tend to underestimate the densities of organic 
crystal systems in which van der Waals interactions make significant 
contributions.
210
 Dispersive corrections to DFT had been proposed to overcome the 
shortcomings in the DFT method. Initially, many efforts focused on system size
211,212
 
or good quality of C6 coefficients with high-level DFT calculations.
213
 A damping 
function, dAB(r), was originally applied to avoid the divergence of the dispersive C6 






























where r is the distance between atoms A and B, C6,AB is the coefficient for the 
dispersive potential between atoms A and B, RAB is the cross-over distance and cdamp 
is a coefficient. Neumann introduced a form factor n into the damping function so 
































During the parameterisation of the DFT(d) method, the form factor and the crossover 
distances were refined so that the DFT(d) calculations reproduced a range of 
experimental structures obtained from X-ray diffraction and neutron diffraction 
measurements at temperatures between 0 and 50 K.
205
 The C6 coefficients were  
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refined based on the Dipole Oscillator Strengths Distributions results by Meath and 
co-workers.
215,216,217,218,219,220,221
 This DFT(d) method has been parameterised for 
elements H, C, N, O, F, Cl, Br, and S. Preliminary tests showed that the DFT(d) 
method is successful in predicting the crystal structures of a wide variety of organic 
molecules. 
 
2.4.2 Tailor-made force field (TMFF) 
It is infeasible to apply the accurate but computationally expensive DFT(d) method 
to sample a large number of plausible crystal structures. Neumann devised an 
algorithm in the GRACE software which enables the parameterisation of a tailor-
made force field (TMFF) against some crucial DFT(d) reference data sets.
222
 Unlike 
other conventional force fields, a TMFF can only work for one particular molecule, 
and loses its transferability. In order to avoid the problem of overfitting, the number 
of variables in the energy functions is reduced to a minimum. For bonded 
interactions, bond stretching and angle bending energies are described by simple 
harmonic functions (section 1.6.1.1). The torsion energy is treated differently. Figure 
2.2 (left) shows the torsion rotation around a covalent bond formed between atoms j 

















A a − 
360˚
B b − φi0jkl0  + φi0 jkl0   
where A and B are the numbers of neighbouring atoms covalently bonded to atom j 
and k respectively, P]−180,180] is an operator which maps its argument within the 
interval ]−180˚, 180˚]. The torsion energy is then expressed as a Fourier series of the 
overall torsion angle:  
 60 
Eoverall_torsion = E0 + 
n=1
 cn cos[pn(φoverall − φn)] 
where E0 is a constant energy term (usually set to zero), cn are constants for  
parameterisation, p is the periodicity of the torsion rotation and φn are phase angles.  
The advantage of this definition is that only one function is needed for each torsion 
rotation. If the cosine function mentioned in section 1.6.1.1 is used, nine energy 
functions would be needed for the system in Figure 2.2. However, the cosine 
function remains as an alternative option in the TMFF implementation in GRACE.  
   
Figure 2.2 Atom indices for overall torsions (left) and for overall inversions (right). 
 
The inversion energy is treated with a Taylor series of the out-of-plane distance (or 






where cn are constants for parameterisation and dijkl is the inversion distance of a 
central atom i from the plane formed by atoms j, k and l. Note that dijkl is a vector. Its 
sign indicates the inversion direction of the central atom i and depends on the order 
of surrounding atoms j, k and l. A Taylor series would be sufficient for treating both  
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planar and non-planar equilibrium geometries. It also provides additional flexibility 
in case that one inversion direction is more favourable than the other. Harmonic 
angle bend terms can be coupled to the inversion energy (Figure 2.2 (right)). α1, α2 
and α3 are obtained by projection of the bonds i-j, i-k and i-l onto the plane formed 
by atoms j, k and l. 
 
Nevertheless, the cosine function remains as an alternative option 
in the TMFF implementation in GRACE.  
 
For non-bonded interactions, exponential-6 functions are used to treat van der Waals 
interactions by default. Off-diagonal A and B parameters are calculated using 
geometric and arithmetic means of the diagonal terms respectively. The combination 
rule for C6 coefficients is the same as that used in the DFT(d) method: 
C6,ti,tj = 
2(C
2    
 6,ti,ti C
2    




   )
1/3
 + (C6,tj,tj N eff,ti
2 
   )
1/3 
where Neff are the effective electron numbers.
223
 The Lennard-Jones potential and 
other combination rules are available as alternatives in GRACE. Hydrogen atoms 
involved in hydrogen bonds are dealt with separately. Hence, hydrogen bond 
potentials are often switched off to avoid redundancy in TMFF fitting. Atomic point 
charges fitted to the calculated QM electrostatic potential are used to account for the 
electrostatic interactions and are assigned via bond increments. The bond increment 
method is an alternative way to preserve charge-neutrality of a molecule. For 
covalently bonded atoms i and j of different atom types, a bond increment δij is 
defined as the contribution of charge + δij and − δij to atoms i and j respectively. For 
atoms which are not covalently bonded, the charges Δqt1 and Δqt2 transferred to each  
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atom of atom types t1 and t2 respectively due to the charge-transfer increment δij' are 
defined as: 
Δqt1 = + 
Nt1 + Nt2
2Nt1




where Nt1 and Nt2 are the number of atoms with atom types t1 and t2 in the unit cell. 
Consequently, the overall charge in the unit cell remains neutral. Gasteiger charges 
and Qeq charges are available as alternatives. Once the TMFF has been 
parameterised, it is assumed that it can mimic the DFT(d) method in structure 
generation, structure optimisation, and CSP, thereby reducing the required CPU 
resources. 
 
2.4.3 The computational strategy in crystal structure prediction 
The CSP procedure implemented in the GRACE software
222
 is summarised in Figure 
2.3.  
 




Step 1: TMFF parameterisation 
The TMFF requires data to describe bonded interactions (bond stretching, bending, 
torsion and inversion changes) and non-bonded interactions (Coulomb and van der 
Waals interactions). Some important DFT(d) reference data sets are presented here. 
The full details of the data sets and their method of calculation can be found in ref 
222. 
 
A. Electrostatic data 
Only important conformers are considered. Each conformer is first densely packed 
into a P1 crystal, so that there is hardly any empty space within 1.5 vdw radii from 
the atomic positions. After a slight expansion, the electrostatic potential in the space 
beyond 1.5 vdw radii is calculated. This data is used for fitting the bond increments 
of the force field. 
 
B. Rigid molecule packing, minimisation data and expansion data  
Data generated from rigid molecule packing is used for the refinement of non-
bonded interactions. Each conformer is considered as a rigid body. Crystals in some 
common space groups with a small number of molecules in the unit cell (P1, P1¯, P2, 
P21, Pm, Pc, Cm and Cc) are sampled. At this stage, any internal degrees of freedom 
are ignored, whilst lattice deformations, molecular rotations and translations are 
allowed. Minimisation data provides lattice energy differences between optimised 
rigid-packing structures and the energy derivative of each structure. Expansion data 
is used to calibrate the strength of the non-bonded interactions in the TMFF. 
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C. Conformation data and wide amplitude data  
Conformation data is used for deriving bonded interaction data. The molecule is 
packed in a unit cell with P1 space group symmetry. The cell size is large enough to 
allow some empty space around the molecule. Changes in energy and forces due to 
bond stretching, bond bending and torsional angle are investigated around each 
conformational minimum. Wide amplitude data explores the energy barriers between 
molecular conformations. Restraint potentials are imposed on torsions and inversions, 
such that they can evolve from one conformation to another.  
 
D. Reverse minimisation data  
Some energy minima located by the TMFF are re-optimised by the DFT(d) method. 
Any false energy minima generated by the TMFF need to be eliminated by 
incorporating DFT(d) results concerning the false minima into the fitting procedure. 
 
Step 2: Structure generation 
A Monte Carlo parallel tempering algorithm is used in crystal structure generation. 
One or more molecules in the asymmetric unit can be sampled in all 230 space 
groups. The lattice energy of each structure is optimised by the TMFF. The search 
takes place within a predefined energy window, and stops when the low energy 
structures have been located several times and when no new structures are being 
found. The TMFF structures are ranked according to their lattice energies.  
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Step 3: Final energy ranking 
A number of the most stable TMFF structures are then optimised by the DFT(d) 
method. The average energy shift between the TMFF and DFT(d) methods and its 
standard deviation are used to determine the probability that the DFT(d) optimised 
structures have covered the most stable structure. As explained by Neumann,
222
 each 
structure will undergo an energy shift. If a list of m TMFF structures is generated and 
only the most stable n structures are further optimised by the DFT(d) method (m > n), 
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 i          are the TMFF lattice energies which increase with the index i, and E i          
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are the DFT(d) lattice energies after re-ranking. If the individual energy shift follows 
a Gaussian distribution, the probability that the remaining structures will have their 
DFT(d) lattice energies beyond an energy limit, Elim, will be: 
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i        + ΔE¯ − Elim
2σΔE
 
Elim is a user-defined value. For instance, it corresponds to the DFT(d) energy of the 
most stable structure if one expects a high probability that the most stable DFT(d) 
structure has been included. When p(E i        
DFT(d)
 > Elim ∀ i > n) is bigger or equal to a 
desired probability, no more TMFF crystal structures require DFT(d) optimisation. 
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2.5 Applications of crystal structure prediction 
2.5.1 Rational design of experiments for polymorph discovery 
One of the main purposes of CSP is to identify new polymorphs which have not been 
observed experimentally. The catastrophe of ritonavir discussed in section 1.4 
highlights the importance of successful CSP in drug development. In CSP or lattice 
energy calculation, structures with lattice energies lower than the experimentally 
observed structures may be the yet undiscovered ones. The lattice energy 
calculations in many CSP methodologies are useful in rational experimental design. 
In the work of Asmadi et al, the DFT(d) method was used to optimise the 
experimental structure of molecule V (7-endo-bromocamphorylsulfonylimine, see 
Figure 2.1) in the 2001 blind test as well as the predicted structures from the 
participants.
201
 The experimental structure was the fourth most stable structure. The 
lowest-energy structure was 0.36 kcal mol
−1
 more stable than the experimental 
structure, and had a significantly higher density than other low-energy structures. 
The energy minimisations were repeated at pressures up to 5 GPa. At high pressure, 
the most stable DFT(d) structure became even more stable and the energy gap 
between the rank 1 structure and the rank 4 structure (which corresponds to 
experiment) becomes larger than any likely inaccuracy in the energy calculations. 
This result suggested that the rank 1 structure might be a new polymorph which 





Figure 2.4 Relative enthalpy changes of the eight most stable crystal structures of 
molecule V as a function of pressure, obtained by lattice enthalpy minimisation with 
the DFT(d) method. The rank refers to that found at 0 GPa. The energy differences at 
each pressure are taken from the energy of the most stable structure at that pressure. 
(Adapted from ref 201) 
 
To determine an appropriate crystal template for seeding experiments, the target 
molecule A can be ‘virtually seeded’ into the crystal lattice of a chemically similar 
compound B, and the lattice energies of all hypothetical structures of A and its 
known experimental structures minimised. If the energy of a hypothetical structure of 
A is more stable than any of its known polymorphs, this hypothetical structure may 
be obtained using the isostructural crystal of compound B as a seed. This approach 
has recently led to the discovery of the fifth polymorph of carbamazepine (CBZ).
36
 
The CBZ molecules were substituted into the crystal lattices of the known 
polymorphs of dihydrocarbamazepine (DHC) (Figure 2.5). These structures together 





 Only the three torsions angles defining the two amide 
hydrogen positions, the rotation of the amide group with respect to the 7-membered 
ring and the angle of the amide to the phenyl ring were optimised within the crystal 
structure explicitly (Figure 2.5). All other intramolecular variables were defined by a 
constrained isolated molecule ab initio optimisation. The energy penalty for any 
conformational changes from the ab initio optimised structures was calculated using 
GAUSSIAN03.
176
 The intermolecular energy was calculated by DMACRYS
180
 using 
an isotropic exponential-6 potential for the van der Waals interactions and atomic 
multipoles up to hexadecapole for the electrostatic energy. The hypothetical structure 
of CBZ which was isostructural to form II of DHC had the lowest energy of those 
considered. This structure was also found to be more stable than the experimental 
forms II and III of CBZ. In a crystallisation experiment, a tiny crystal of the form II 
DHC was suspended in the vapour phase of CBZ and induced the growth of a new 
polymorph of CBZ (form V). Unlike other CBZ polymorphs, the amide group in the 





Figure 2.5 The molecular structures of (left) carbamazepine (CBZ) and (right) 




2.5.2 Predicting spontaneous resolution from a racemic mixture 
Different enantiomers of the same molecule may have different biological activities. 
Resolving the racemic mixture of a chiral molecule is therefore important to the 
pharmaceutical industry.
162
 CSP can be useful for predicting the lowest-energy 
racemic and enantiopure crystals, and thereby predicting the spontaneous resolution 
from a racemic mixture. Note that structurally similar chiral molecules may exhibit 
different crystallisation behaviour. For instance, 4-hydroxymethyl-2-oxazolidinone 
(4HMO) and 2-(3-hydroxyphenyl)-2,5,5-trimethylpyrrolidine-1-oxy (2-3-HTP) are 
known to crystallise as racemic crystals, whilst their structural isomers, 5-
hydroxymethyl-2-oxazolidinone (5HMO) and 2-(4-hydroxyphenyl)-2,5,5-
trimethylpyrrolidine-1-oxy (2-4-HTP), are known to form a conglomerate which is a 
mixture of enantiopure crystals of one enantiomer and its stereoisomer (Figure 2.6). 
Gourlay et al carried out conformational analyses of these molecules using ab initio 
methods.
224,225
 The crystal structure search for each molecule was restricted to the 13 
most common space groups in the CSD and was performed with the Material Studio 
Polymorph Predictor
163
 using the Dreiding force field
92
 and the atomic point charges 
derived from the calculated QM potentials. Low-energy force field structures were 
then optimised by the DFT(d) method. For 4HMO, the most stable DFT(d) predicted 
structure corresponded to the experimental racemic structure, whilst the rank 5 
prediction corresponded to another enantiopure experimental structure. For 2-3-HTP, 
the experimental racemic structure corresponded to the rank 2 prediction which had 
lower energy than the most stable predicted enantiopure structure. For 5HMO and 2-
4-HTP, the experimental enantiopure structures were found to be more stable than 
the lowest-energy predicted racemic structures. Therefore, the DFT(d) method 





Figure 2.6 Molecular structures of (top left) 4-hydroxymethyl-2-oxazolidinone 
(4HMO), (top right) 2-(4-hydroxyphenyl)-2,5,5-trimethylpyrrolidine-1-oxy (2-4-
HTP), (bottom left) 5-hydroxymethyl-2-oxazolidinone (5HMO) and (bottom right) 2-
(3-hydroxyphenyl)-2,5,5-trimethylpyrrolidine-1-oxy (2-3-HTP). 
 
2.5.3 Crystal structure determination 
The size and quality of a crystal are important for a successful single X-ray analysis. 
In some cases, a metastable crystal cannot be isolated for such an analysis. CSP can 
complement structure determination by providing a set of possible structures. The 
structure of the metastable crystal can be deduced if its experimental powder pattern 
is highly similar to the simulated powder X-ray diffraction pattern of a predicted 
structure. In the experiment conducted by ter Horst et al, the metastable form II co-
crystal of carbamazepine and isonicotinamide first emerged in the solution and later 
transformed into the stable form I (Figure 2.7).
226
 The crystal structure of the latter 
was solved successfully using single crystal X-ray analysis, whilst only the powder 
X-ray diffraction pattern was available for the former.
226
 A CSP study was carried 





 Structures were generated in the 15 most common space groups P1, P1¯, 
P21, P21/c, P21212, P212121, Pna21, Pca21, Pbca, Pbcn, C2/c, Cc, Pc and P2/c. At 
this stage, the lattice energy was calculated by CrystalPredictor
183,184
 using an 
isotropic atom-atom model. The sampled structures were refined using 
DMACRYS
180
 which provides a more realistic electrostatic model. Finally, the 
intramolecular flexibilities and unit cell parameters of these structures were further 
refined using DMAflex.
181
 The most stable predicted co-crystal corresponded to the 
form I co-crystal. The rank 2 prediction, which was isostructural to the co-crystal of 
carbamazepine and nicotinamide (Figure 2.7), corresponded to the form II structure 
solved from the powder pattern.
227
 Therefore, the CSP result confirmed the crystal 
structure of the metastable form II of carbamzepine:isonicotinamide co-crystal.  
 
 
Figure 2.7 Molecular structures of (left) carbamazepine, (middle) isonicotinamide 
and (right) nicotinamide. 
 
2.6 CSP of multi-component molecular crystals 
CSP of solvates, co-crystals and salts remain challenging. The first issue is whether 
the current CSP methodologies can reliably predict the formation of multi-
component crystals from their pure components. For solvates and co-crystals, the 
stoichiometric ratios of their components may also affect their relative stabilities. 
Organic salts are considered even more difficult for modelling due to the presence of  
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long-range ionic interactions, charge transfer and strong polarisation effects. The 
second issue is the shear increase in the degrees of freedom related to the increased 
number of independent molecules in the asymmetric unit. This section discusses 




To investigate the thermodynamic driving force behind co-crystal formation, the 
lattice energies of 26 known co-crystals of caffeine, succinic acid and 4-
aminobenzoic acid were compared with their pure co-formers by Issa et al (Figure 
2.8).
228
 If thermodynamics determines the formation of the co-crystal, its lattice 
energy should be lower than the combined energies of its crystalline co-formers. The 
potential problem associated with the disordered atoms in the experimental structure 
of caffeine was avoided by using the CSP results for caffeine and taking the lattice 
energy of the most stable predicted structure as the reference. High level QM 
calculations was carried out to calculate atomic multipole moments and to determine 
the energy penalty for conformational changes in the packings. Four out of six 
caffeine co-crystals and six out of eight succinic acid co-crystals were found to be 
more stable than their pure components. However, only two out of twelve 4-
aminobenzoic acid co-crystals had lower lattice energies if the comparison was made 
with the α form of 4-aminobenzoic acid of which the stability was overestimated by 
the energy model. Overall, only 12 out of 26 co-crystals were predicted to be more 
stable than their pure components.
228
 This work highlighted that calculating the 
polymorph stability of a co-former accurately is a prerequisite for a reliable 
prediction of co-crystal formation, and the lattice energy calculations performed in 




Figure 2.8 Molecular structures of (left) caffeine, (middle) succinic acid and (right) 
4-aminobenzoic acid.  
 
Full CSP studies for the co-crystals of 4-aminobenzoic acid with 2,2'-bipyridine and 
4-nitrophenylacetic acid were later conducted by Karamertzanis et al to address the 
question whether these experimentally observed structures could be predicted (Figure 
2.9).
229
 The parameters for the non-bonded interactions of 4-aminobenzoic acid were 
modified, and the β polymorph then became more stable which was more consistent 
with the experimental data.
229
 The repulsion potential between the acid proton and 
the pyridine nitrogen was also modified for the co-crystal prediction. The CSP was 
performed in a similar fashion as discussed in section 2.5.3.
229
 To ensure that the 
structure searches were complete, the lattice energies of around 50,000 structures for 
each single-component crystal and up to 565,000 structures for a co-crystal were 
minimised.
229
 The experimental structure of 2:1 4-aminobenzoic acid:2,2'-bipyridine 
corresponded to the most stable predicted structures with 2:1 stoichiometry and had a 
lower energy than its pure components. However, this structure was less stable than a 
predicted structure with 1:1 stoichiometry. For co-crystal with 4-nitrophenylacetic 
acid, a number of predicted structures were more stable than the experimental 
structure. The structure most similar to the experimental structure as well as other 
predicted 1:1 co-crystals were higher in energy than the pure components.
229
 The 
result showed that the inclusion of additional independent molecules in the  
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asymmetric unit significantly increased the number of structures for considerations. 
Although the search algorithm successfully located all experimental structures, the 
lattice energy calculations failed to reliably predict the co-crystal stoichiometry and 
its stability relative to the pure components.  
 
 
Figure 2.9 Molecular structures of (left) 2,2'-bipyridine and (right) 4-
nitrophenylacetic acid. 
 
CSP regarding the stoichiometries of theobromine solvates with acetic acid was 
carried out by Cruz-Cabeza et al (Figure 2.10).
230
Structures of 1:1 and 1:2 
theobromine:acetic acid were searched in space groups P21/c and P 1¯  using 
Polymorph Predictor.
163
 Conformational energies and the atomic multipoles were 
derived from QM calculations. A predicted 1:1 solvate was found to be more stable 
than all other 1:2 solvates and its pure components. The simulated powder X-ray 
diffraction pattern of this structure agreed very well with the experimental powder 
pattern of a sample after liquid assisted grinding.
230
 The solvates of urea with acetic 
acid were also investigated using similar methodology.
231
 Structures of 1:1, 1:2 and 
1:3 urea:acetic acid were sampled in five, two and one space groups respectively. For 
1:3 solvate structures, the search was restricted to P1¯  space group only and the 
urea−acetic acid dimer moiety commonly seen in the other two stoichiometries was 
kept rigid.
231
 These measures reflected the fact that generating structures with more 
independent molecules in the asymmetric unit is a very demanding task in CSP. The  
  
 75 
most stable predicted structure was in 1:2 stoichiometry which was consistent with 
the experimental results. The experimental structure ranked number 2 which was 0.3 
kcal mol
−1
 less stable than the global minimum. The relative stabilities of different 
stoichiometries at 0 K were compared by considering all possible combinations of 1 
mole of urea and 3 moles of acetic acid. In accord with experiment, the 1:2 
urea:acetic acid solvate with one mole of acetic acid crystal yielded the lowest 
energy combination.
231
 Nevertheless, this encouraging result was achieved by 
introducing conformational constraints on the molecules and by restricting the space 
group in the search. A reliable prediction of solvate stoichiometry from first 
principles remains challenging. 
 
 
Figure 2.10 Molecular structures of (left) theobromine, (middle) urea and (right) 
acetic acid. 
 
The work by Karamertzanis et al illustrates recent progress in the CSP of 
diasteromeric salts. Two salt pairs of (R)-1-phenylethylammonium with (R/S)-2-
phenylbutyrate were studied (Figure 2.11). Each molecular ion was kept rigid 
throughout the simulation, except for a number of flexible torsions. A conformational 
analysis for each isolated ion in the gas phase was carried out using QM methods. 
The cation had one possible conformation, whilst the anions had three. During the 
structure search, conformational changes from the calculated in vacuo geometries  
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were limited to certain ranges. Structures were generated in six chiral space groups 
P1, P21, P21212, P212121 and C2, which accounts for more than 93% of the chiral 
molecular crystals in the CSD. The electrostatic energy was modelled using a 
distributed multipole analysis.
184
 The search algorithm successfully located the three 
polymorphs of (R)-1-phenyl-ethylammonium (R)-2-phenylbutyrate and the 
experimental structure of (R)-1-phenyl-ethylammonium (S)-2-phenylbutyrate. Their 
predicted stability order of was consistent with the experimental results. However, 
many other predicted structures were energetically competitive to those observed 
experimentally, indicating that the prediction of racemate resolution from first 
principles is still constrained by the accuracy of the energy model and the limitations 
in computational resources. 
 
 
Figure 2.11 Molecular structures of (left) (R)-1-phenyl-ethylammonium and (right) 
(R/S)-2-phenylbutyrate. 
 
To conclude this section, many contemporary CSP methodologies experience 
difficulties in predicting the formation, the stoichiometry and the relative stability of 
a multi-component molecular crystal. The work in this thesis focuses on the 
prediction of co-crystal formation. The lattice energy calculations and CSP studies 
were carried out using the GRACE software and the results are presented in chapters 
5 and 6 respectively. 
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Chapter 3: Revisiting the crystal structure 
predictions of four ‘blind test’ molecules 
 
3.1 Introduction 
The failure of CSP for 6-amino-2-phenylsulfonylimino-1,2-dihydropyridine 
(molecule VI in the 2001 blind test),
190
 together with the discoveries of two 
additional polymorphs,
195,196
 led to negative comments on the state of crystal 
structure prediction.
198,199
 The prevailing view was that the calculations based purely 
on thermodynamics would be unable to predict kinetically-favoured experimental 
structures. Desiraju et al postulated that the more stable synthon or polymorph of this 
molecule is kinetically-unfavoured and therefore more difficult to be observed 
experimentally.
195
 The molecular mechanical method applied was shown to be 
inadequate for successful CSP.
192
 In the 2007 blind test, the results obtained through 
the use of quantum mechanical lattice energy calculations (the DFT(d) method) 
marked a significant advance in CSP technology.
192,200
 As part of a validation study, 
the experimental structures as well as the predicted structures submitted by each 
participant in CSP1999 (molecules I–III and VII), CSP2001 (molecules IV–VI) and 
CSP2004 (molecules VIII and X–XI) were later optimised using the DFT(d) method. 
The analysis of the final DFT(d) energies and structures indicated that the sets of 
predicted structures, submitted by the blind test participants, did not capture all 
possible low-energy crystal packing alternatives.
201
 This observation was particularly 
relevant for 5-cyano-3-hydroxy-thiophene and propane (molecules II & VII in 
CSP1999),
189
 6-amino-2-phenylsulfonylimino-1,2-dihydro-pyridine (molecule VI in 
CSP2001)
190
 and azetidine (molecule XI in CSP2004) (Figure 3.1).
191
  To address  
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these problems, it is necessary to get a complete overview of the possible low-energy 
crystal structures for these four compounds. Hence, full CSP studies are carried out 
with the GRACE software in the present study. 
 
 
Figure 3.1 Molecular structures of 5-cyano-3-hydroxythiophene (molecule II from 
CSP1999), 6-amino-2-phenylsulfonylimino-1,2-dihydropyridine (molecule VI from 
CSP2001), propane (molecule VII from CSP1999), and azetidine (molecule XI from 
CSP2004). [Reproduced by permission of the PCCP Owner Societies from ref 235] 
 
3.2 Methods 
In order to explore the possible conformers of molecule VI, a detailed 
conformational analysis was conducted using molecular mechanical, semi-empirical 
and ab initio quantum mechanical methods. The torsion angles studied are defined as 






























Figure 3.2 The three torsion angles used in this study. 
 
All semi-empirical calculations were performed by MOPAC93.
135
 The molecular 
structure was defined by its internal coordinates. The starting geometries were 
defined by 30º increments in torsion 1 and torsion 2, which ranged from −60º to 90º 
and from −150º to 180º respectively. A total of 72 starting geometries of either cis or 
trans configuration were then optimised using the PM3 Hamiltonian. No restraint 
was imposed on any part of the molecule, except that the amino group (-NH2) 
located on the pyridine ring was constrained to be planar. Representatives of the 
lowest-energy clusters were selected for re-optimisation by ab initio methods. 
Hartree-Fock (HF) calculations with the 6-31G* basis set and density functional 
theory (DFT) calculations with the B3LYP functional were performed by GAMESS-
UK.
136
 The geometries of four conformers obtained from the semi-empirical 
calculations were re-optimised. Electron density contours at 0.0050, 0.0010, 0.0005 
and 0.0001 atomic units (au) around the molecule were established. An atomic unit 
of electron density is defined as Ne/Bohr
3
, where Ne is the number of electrons and 1 
Bohr = 0.52917 Å . For each conformer, a set of atomic point charges was then 
derived by a least-squares fitting procedure, which minimised the difference in 
electrostatic potentials calculated by GAMESS-UK and the Coulomb’s law.113 The 
sum of atomic point charges was always constrained to zero. Atoms which were 
symmetrical considering the skeleton of the molecule were constrained to have the  
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same charges. The standard deviations were about 0.007 au. An equal-weighted 
average was taken from the four sets of atomic point charges to avoid bias. This 
averaged set of atomic point charges was used with the Dreiding force field
92
 for 
calculating the potential energy surfaces. Apart from electron density contours, the 
heat of formation of each conformer was also calculated by GAMESS-UK. The 
distribution of each conformer in the gas phase at room temperature (298K) was 
deduced from a Boltzmann distribution. All molecular mechanical calculations were 
carried out with Material Studio version 4.1.
232
 CVFF has its own charge set,
233
 
whilst the Dreiding force field was first used with Gasteiger charges
111
 and later with 
atomic point charges derived from ab initio calculations. The van der Waals and 
electrostatic cut-off distances were set at 99 Å  to ensure that all interactions were 
considered. The systematic grid scan allowed iterating a fixed increment on each pre-
defined torsion angle of the molecule, optimise the geometry and calculate the 
potential energy at each restrained conformation. Since the phenyl ring and the amine 
group had been assumed symmetrical about the rotating bonds, torsion 1 and 3 were 
varied from 0º to 180º, whilst torsion 2 was varied from 0º to 360º. All torsions were 
varied at 5º increments and, for each configuration, a total of 93,312 conformers 
were studied. 
 
The GRACE software (version 1.0)
234
 was used in the CSP studies of all four 
molecules.
235 , 236
 Conformational analysis using the Dreiding force field with 
Gasteiger charges yielded sensible conformers, which were used to generate DFT(d) 
reference data sets. After fitting a TMFF for each of the four molecules, the Monte 
Carlo parallel tempering algorithm in GRACE was used to generate crystal structures.  
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Torsional degrees of freedom were explored as part of the crystal packing process. 
For molecules II, VI and VII, the packing of a single molecule in the asymmetric unit 
was considered for all 230 space groups. For molecule XI, the packing of one (Z' = 1) 
and two (Z' = 2) independent molecules in the asymmetric unit was considered for all 
230 space groups. Each generated crystal structure was optimised with the TMFF. 
The searches found all structures within a predefined energy window, and were 
stopped when all structures in the energy window had been located several times and 
no new structures were being found. For molecule VI, the packing of two 
independent molecules in the asymmetric unit was considered for the five most 
common space groups (P21/c, P 1¯ , P21, P212121 and P1).
237
 After ranking the 
structures for each molecule according to their TMFF lattice energies, the most stable 
TMFF structures were re-optimised using the DFT(d) method. Statistical correlations 
between the TMFF and DFT(d) energies were used to determine the probability that 
the lists of DFT(d) optimised structures included the most stable crystal packing 
alternatives. Crystal structure similarity was studied using the Mercury software 
(version 2.2),
194
 which overlaid clusters of molecules from the two crystal structures 
under comparison and calculated the root-mean-square (RMS) of the atomic 
deviations between the two clusters. Hydrogen atoms were excluded from these 
similarity calculations, and the number of molecules in the clusters was either 16 for 
Z' = 1 structures or 30 for Z' = 2 structures. After optimising a number of TMFF 
structures with the DFT(d) method, the standard deviation (σ) between the energies 
of the two methods was obtained. For each molecule, all low-energy TMFF 
structures up to at least 3σ from the lowest energy TMFF structure were re-optimised 
by the DFT(d) method (Table 3.1). This ensured greater than 99% confidence that  
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the selected TMFF structures included the global minimum according to the DFT(d) 
method. Note that some TMFF structures converged to the same structure after 
optimisation with the DFT(d) method. 
 
Table 3.1 Important parameters for crystal structure generation of molecules II, VI, 
VII, XI. [Reproduced by permission of the PCCP Owner Societies from ref 235]  
Molecule II VI VI VII XI 
Number of molecules in the asymmetric unit (Z') 1 1 2 1 1 & 2 
Number of space groups considered in the search 230 230 5 230 230 
Number of structures optimised by the DFT(d) 
method 80 125 186 50 430 
Number of unique structures after optimisation 78 118 173 50 365 
σ (kcal mol−1)a 0.31 0.89 0.62 0.06 0.16 
Energy window of TMFF structures optimised by the 
DFT(d) method, in terms of σ 
4.94 4.03 3.06 3.78 3.42 
a
 σ stands for the standard deviation in energy comparing TMFF and DFT(d) results. 
 
The DFT(d) optimisation results of the experimental structures and the blind test 
predictions were taken from the work of Asmadi et al.
201
 and were compared against 
the CSP results obtained in the present study. To identify previous blind test 
predictions, a ‘‘xyz_number’’ nomenclature is adopted in Tables 3.9–3.12, where 
‘‘xyz’’ represents the name of the blind test participant(s) and ‘‘number’’ represents 
the rank of the prediction submitted by the participant(s) in the blind test. In a few 
cases, the rankings of structures with similar lattice energies have altered slightly 
when compared to Asmadi’s work,201 because the structures were obtained from a 
different starting point. The energy differences between such structures are very 
small (<0.01 kcal mol
−1
). The clustering patterns of the DFT(d) optimised 
participants’ structures are also slightly different from Asmadi’s work,201 because a 




3.3.1 Conformational analysis of 6-amino-2-phenylsulfonylimino-
1,2-dihydropyridine (molecule VI) 
 
Besides the molecular flexibilities, the imine bond can lead to either a cis or trans 
configuration (Figure 3.3). All reported polymorphs contain molecules in the trans 
configuration, and crystallise in space groups with inversion symmetry. Unlike forms 
I and III, form II has two, rather than one, independent molecules in the asymmetric 
unit. Table 3.2 summarises the crystallographic and conformational information of 















Figure 3.3 (a) The cis configuration and (b) the trans configuration of molecule VI. 
 
Table 3.2 The crystallographic and conformational information of the three 
polymorphs. A positive sign is assigned to an anti-clockwise rotation of the plane 
closer to the observer. The value in brackets corresponds to the second independent 
molecule. 
 Form I Form II Form III 
CSD code UJIRIO01 UJIRIO02 UJIRIO05 
cis / trans configuration trans trans trans 
Space group P21/c P21/c Pbca 
Number of molecule in the asymmetric unit (Z') 1 2 1 
Torsion 1 (º) +25.0 +43.0 (+61.1) +35.77 
Torsion 2 (º) +68.6 +72.6 (+69.5) +61.56 
-S-N=C- bond angle (º) 120.9 119.4 (119.4) 119.6 
-S-N- bond length (Å ) 1.578 1.584 (1.583) 1.578 
-C=N- bond length (Å ) 1.363 1.379 (1.373) 1.364 
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3.3.1.1 Semi-empirical method 
A. Test runs 
Attempts to perform an automated systematic grid scan of molecule VI were made 
using MOPAC93. The geometry of molecule VI was first defined by its internal 
coordinates, and the AM1 and PM3 Hamiltonians were used separately for 
comparison purposes. Unfortunately, the calculations led to an unphysical -S-N=C- 
angle close to 180º.  Insertion of a dummy atom onto the sulphonamide nitrogen 
atom failed to overcome this problem entirely, and therefore grid scans could not be 
carried out. Geometry optimisations worked well using the PM3 Hamiltonian only, 
or otherwise the molecular geometry had to be defined by Cartesian coordinates 
(Table 3.3). Note that the optimised conformers failed to form clusters because the 
amine group underwent a random inversion, which caused fluctuations in energy and 
intervened with the convergence process. To avoid this problem, a planar constraint 
was applied to the amine group during the geometry optimisation. 
 
Table 3.3 Geometry optimisation and systematic grid scan test runs by MOPAC93 
software. Internal coordinates were used for defining starting geometries. 
Hamiltonian Input 
Geometry 
optimisation Systematic grid scan 
AM1 cis Done Failed 
 cis     + dummy atom Done Failed 
 trans Failed - 
 trans + dummy atom Done Done 
PM3 cis Done Failed 
 cis     + dummy atom - Failed 
 trans Done Done 




B. Geometry optimisations 
Conformers obtained from different starting geometries were clustered after the 
geometry optimisation (Table 3.4). Note that the calculated -S-N=C- angle and -S-N- 
bond length are 8º to 10º larger and 0.15 Å  longer than the experimental values 
respectively. The imine bond length, on the other hand, agrees with the experimental 
data. On average, the cis conformers are 0.86 kcal mol
−1
 more stable than the trans 
conformers. The two lowest-energy clusters in each of the cis and trans 
configurations are inversion-related. The most stable conformer in each of these four 
clusters (2 cis and 2 trans configurations) was later re-optimised by ab initio methods. 
 
Table 3.4 Geometry optimisation results by MOPAC93 using the PM3 Hamiltonian. 
The amino group was constrained to be planar by means of internal coordinates. The 
two clusters formed are indicated with grey and white backgrounds. 
 
(a) the 20 lowest-energy trans conformers 





Torsion 1 Torsion 2  Torsion 1 Torsion 2 bond angle (º) bond length (Å ) 
(º) (º)  (º) (°) -S-N=C- -S-N- -N=C- 
−30 +180  −88.2 −167.9 130.53 1.732 1.317 0.00000 
−60 +120    87.8   165.0 130.56 1.733 1.318 0.00017 
+60 +150    87.3   166.0 130.51 1.732 1.318 0.00082 
−60 −150  −87.6 −165.5 130.61 1.732 1.317 0.00121 
+30 +150    87.7   167.2 130.57 1.733 1.318 0.00172 
+30   −60  −88.2 −164.7 130.72 1.732 1.317 0.00172 
−60 +180  −88.1 −166.8 130.56 1.732 1.318 0.00172 
−60 −120  −87.5 −163.6 130.71 1.732 1.317 0.00175 
+30 −120  −88.0 −167.5 130.55 1.732 1.318 0.00177 
−60 +150    88.8   168.7 130.58 1.732 1.317 0.00220 
+90 −120  −87.0 −163.1 130.68 1.732 1.318 0.00230 
+30 +120    87.3   163.5 130.72 1.732 1.317 0.00237 
+60 +120    87.4   163.2 130.69 1.732 1.317 0.00240 
+90 +120    87.5   163.5 130.68 1.732 1.318 0.00245 
+90 +180  −88.8 −172.4 130.48 1.733 1.317 0.00254 
−30 −120  −89.1 −170.2 130.56 1.732 1.318 0.00264 
+60 −150  −88.5 −168.2 130.57 1.732 1.317 0.00292 
+90 −150  −87.1 −162.3 130.65 1.732 1.318 0.00372 
0 +180  −85.7 −165.9 130.56 1.732 1.318 0.00388 




Table 3.4 (Cont’d) 
 
(b) the 20 lowest-energy cis conformers 





Torsion 1 Torsion 2  Torsion 1 Torsion 2 bond angle (º) bond length (Å ) 
(º) (º)  (º) (°) -S-N=C- -S-N- -N=C- 
+90 +120    78.0   124.1 128.03 1.728 1.333 0.00000 
+60   +60    77.3   123.9 128.07 1.728 1.332 0.00034 
−60 −150  −78.2 −124.0 128.02 1.728 1.333 0.00066 
+30 +150    78.0   124.1 128.01 1.728 1.332 0.00095 
+90   +90    77.9   124.0 128.15 1.727 1.332 0.00107 
+30 +120    78.1   123.7 128.11 1.728 1.332 0.00117 
+30   +60    77.5   124.0 128.05 1.728 1.333 0.00119 
−60   +60    77.5   124.3 128.07 1.728 1.332 0.00123 
0 −120  −75.8 −123.9 128.06 1.728 1.333 0.00124 
+60   +90    78.0   124.3 128.09 1.728 1.332 0.00127 
+90 +150    77.5   124.1 128.01 1.728 1.332 0.00134 
+60 −120  −77.4 −123.6 128.10 1.727 1.333 0.00137 
+30 −150  −79.1 −124.3 128.03 1.728 1.332 0.00142 
−60 +120    77.7   123.6 128.07 1.727 1.333 0.00152 
−30   −60  −78.6 −124.0 128.05 1.728 1.333 0.00157 
−30 −150  −77.7 −124.2 128.04 1.728 1.333 0.00163 
+60 +150    77.9   124.0 128.03 1.728 1.333 0.00167 
−60   −90  −77.8 −124.5 128.08 1.728 1.332 0.00168 
−30   +90    78.5   124.2 128.06 1.728 1.332 0.00171 
+30   −60  −78.4 −123.7 128.05 1.728 1.333 0.00177 
 
3.3.1.2 ab initio method 
The optimisation results of the four conformers by GAMESS-UK are summarised in 
Table 3.6. The torsion angles do not vary greatly from the input values. The 
calculated -S-N=C- bond angle and -S-N- bond length are much closer to the 
experimental values, whilst the -N=C- bond length did not have significant changes. 
According to the Boltzmann distribution, the distribution of each conformer at a 









where Ni is the number of conformer i having a relative energy Ei, k is the Boltzmann 
constant and T is the temperature. The energy difference between the cis and trans  
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conformers is about 6.0 kcal mol
−1
, which is similar to the hydrogen bond enthalpy 
(Table 3.5). This result suggests that the cis configuration is stabilised by an 
intramolecular hydrogen bond and has a higher probability to be observed in the gas 
phase at 298 K. Interestingly, the experimental data shows that the molecule adopts 
the trans configuration which facilitates intermolecular hydrogen bonding in the 
solid state. 
 
Table 3.5 Geometry optimisation results by GAMESS-UK and the predicted 
distribution of each conformer at 298 K. The cis and trans conformers are 
highlighted in grey and white backgrounds respectively. 



















 (Å ) 
(º) (º)  (º) (°) -S-N=C- -S-N- -N=C- 
101.8 236.0  102.5 221.8 122.69 1.645 1.326 0.000 50.110 
  78.0 124.1    77.4 138.3 122.73 1.644 1.326 0.003 49.886 
  87.8 165.0    87.1 163.8 119.62 1.661 1.319 5.949   0.002 
  91.8 192.1    91.5 193.4 119.28 1.662 1.319 5.975   0.002 
 
Each atom in the molecule was indexed as in Figure 3.4. The overall sum of charges 
was constrained to zero. Symmetry constraints were imposed on two pairs of carbons 
(C6&7 and C9&11) and three pairs of hydrogens (H10&12, H16&17 and H27&28). 
A set of atomic charges was calculated for each conformer. An average set of point 
charges was calculated by fitting the four calculated electrostatic potentials 
simultaneously (with equal weighting) and this was used with the Dreiding force 
















































Figure 3.4 Atom indices by GAMESS-UK. 
 
Table 3.6 Atomic point charges derived from GAMESS-UK calculations.  
Atom index Atom 
Atomic charge 
Conformer Equally weighted 
average 1 2 3 4 
1 S  1.12781  1.12925  1.15691  1.14687  1.16167 
2 C -0.04741 -0.04893 -0.01527 -0.00680 -0.04526 
3 N -0.69116 -0.69088 -0.79528 -0.79867 -0.74904 
4 O -0.57915 -0.57951 -0.58631 -0.58452 -0.58622 
5 O -0.57915 -0.57951 -0.58631 -0.58452 -0.58622 
6 C -0.10584 -0.10479 -0.11900 -0.12266 -0.10769 
7 C -0.10584 -0.10479 -0.11900 -0.12266 -0.10769 
8 C  0.62885  0.62686  0.75340  0.76784  0.69435 
9 C -0.09654 -0.09627 -0.10365 -0.10082 -0.10051 
10 H  0.13468  0.13424  0.14135  0.14192  0.13685 
11 C -0.09654 -0.09627 -0.10365 -0.10082 -0.10051 
12 H  0.13468  0.13424  0.14135  0.14192  0.13685 
13 C -0.40377 -0.39943 -0.46627 -0.48169 -0.42809 
14 N -0.49397 -0.49360 -0.59285 -0.60125 -0.55071 
15 C -0.08279 -0.08348 -0.08784 -0.09162 -0.08279 
16 H  0.10381  0.10356  0.10389  0.10386  0.10336 
17 H  0.10381  0.10356  0.10389  0.10386  0.10336 
18 C  0.06911  0.06642  0.08608  0.09968  0.07198 
19 H  0.18162  0.17972  0.21527  0.21961  0.19886 
20 C  0.61840  0.61819  0.72041  0.72367  0.66095 
21 H  0.35559  0.35553  0.38601  0.38829  0.36995 
22 H  0.10076  0.10124  0.10117  0.10137  0.10000 
23 C -0.47025 -0.46928 -0.51138 -0.51724 -0.48604 
24 H  0.11391  0.11454  0.11893  0.11547  0.11696 
25 N -0.87244 -0.87279 -0.97212 -0.97111 -0.90099 
26 H  0.18179  0.18171  0.18912  0.18973  0.18450 
27 H  0.38501  0.38524  0.42056  0.42016  0.39606 
28 H  0.38501  0.38524  0.42056  0.42016  0.39606 
 
3.3.1.3 Molecular mechanical method 
Some bugs were noticed in the CVFF implementation in Material Studio version 4.1. 
The starting value of the torsion angle affects the systematic grid scan results: If it is 
negative, unphysical conformers would be generated. If it is close to +0º, the 
software fails to restrain the torsion at desired values, and the optimised conformers  
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would converge into the closest local energy minimum. The grid scan function 
gradually resumes when the torsion angle increases from +0º. Besides, an additional 
restraint is imposed on the imine double bond in order to prevent switching from the 
trans to the cis configuration. The software also failed to allow the rotation of the 
amino group if only one of the N-H bonds is used in defining torsion 3.  Hence, the 
CVFF results are not presented here. 
 
A. Study on the cis configuration 
A.1 Dreiding force field with Gasteiger charges 
The 2D energy plot shows a prominent energy hill for values of torsion 2 between 
+60º and −60º for any value of torsion 1 except about +90º (Figure 3.5a). The 
unfavourable energy is ascribed to the close contact between the pyridine ring and 
the phenyl ring in those conformations. The two high-energy bands at torsion 2 = 
+120º or −120º are much less prominent, indicating that the rotation of torsion 2 
experiences less resistance. It is probably related to the formation of an 
intramolecular hydrogen bond between the dihydropyridine ring and the sulfonyl 
oxygen atoms. The repulsion between the pyridine ring and the oxygen atoms is 
therefore reduced. For similar reasons, the local energy minima (points A and A’) 
show that the pyridine ring can stay closer to the oxygen atoms. The variations in 
torsion 3 do not alter the contour profiles very much (Figure 3.5b). 
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A.2 Dreiding force field with fitted charges derived from ab initio calculations 
The 2D energy plots vary significantly with fitting the ab initio atomic charges 
(Figure 3.6a). The energy hills at torsion 2 = +120º or −120º disappear. As a result, 
the two energy minima, points A and A’ in Figure 3.5, are no longer present. The 
energy surface gently descends into a minimum as torsion 2 varies from 60º to 180º. 
It is likely that the calculation has taken into account the intramolecular hydrogen 
bond between the dihydropyridine ring and the sulfonyl oxygen atoms. Torsion 3 
only shifted the potential energy in the whole system without altering the contour 






Figure 3.5 2D energy plots of cis molecule VI using the Dreiding force field with 
Gasteiger charges: (a) torsion 3 = 0º and (b) torsion 3 = 90º. Points A, A’ and B 







Figure 3.6 2D energy plots of cis molecule VI using the Dreiding force field with ab 
initio fitted charges: (a) torsion 3 = 0º and (b) torsion 3 = 90º. The energy contours 
are expressed in terms of kcal per mole. 
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B. Study on the trans configuration  
B.1 Dreiding force field with Gasteiger charges 
The 2D energy plot of torsion 1 versus torsion 2 (Figure 3.7a) resembles Figure 3.5a. 
Two significant high-energy bands are observed at torsion 2 = +120º or −120º, 
indicating that the rotation of torsion 2 is hampered by the repulsion between the 
pyridine ring and either oxygen atom of the sulfonyl group. Three energy minima are 
observed and labelled as points A, A’ and B. Their coordinates and relative energies 
with respect to the lowest energy conformer are tabulated in Table 3.7. The 
conformations found in all three experimental polymorphs of molecule VI appear to 
fall into the same well as A or A’. Points C, D, E and F are the calculated values 
closest to the experimental data, where C’, D’, E’ and F’ represent their inversion-
related conformations respectively (Figure 3.7a). Torsion 3 only shifted the potential 
energy in the whole system without altering the contour profiles (Figure 3.7b). 
 
Table 3.7 Comparison of conformational data between experimental and Dreiding 
force field with Gasteiger charges results. A positive sign is assigned to an anti-






Relative energy with respect to the 




A +45.0 +64.9 0.000  
A’ −45.0 −64.9 0.000  
B +90.0 +180.0 0.021  
C +35.4 +60.75 0.053 Form III 
C’ −35.4 −60.75 0.053 Form III 
D +59.6 +69.5 0.070 Form II 
D’ −59.6 −69.5 0.070 Form II 
E +25.6 +69.2 0.126 Form I 
E’ −25.6 −69.2 0.126 Form I 
F +45.2 +73.5 0.156 Form II 







Figure 3.7 2D energy plots of trans molecule VI using the Dreiding force field with 
Gasteiger charges: (a) torsion 3 = 0º and (b) torsion 3 = 90º. Points A, A’ and B 
indicate the energy minima and points C (C’), D (D’), E (E’) and F (F’) are the 
calculated values closest to the conformations in the three polymorphs. The energy 
contours are expressed in terms of kcal per mole.  
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B.2 Dreiding force field with fitted charges derived from ab initio calculations 
The 2D energy plot after charge fitting (Figure 3.8a) resembles that using Gasteiger 
charges (Figure 3.7a). The positions of two energy minima (Points A and A’) varies 
slightly but their relative energies increase by more than 2.0 kcal mol
−1
 and point B 
becomes the global energy minimum (Table 3.8). Points C, D, E and F are the 
calculated values closest to the experimental values, where C’, D’, E’ and F’ 
represent their inversion-related conformations respectively (Figure 3.8a). Torsion 3 
only shifted the potential energy in the whole system without altering the contour 
profiles (Figures 3.8b). 
 
Table 3.8 Comparison of conformational data between experimental results and 
results obtained with the Dreiding force field with fitted ab initio charges. Points A, 
A’ and B indicate the energy minima and points C (C’), D (D’), E (E’) and F (F’) are 
the calculated values closest to the conformations in the three polymorphs. A positive 






Relative energy with respect to the 




B +90.0 +180.0 0.000  
A +50.0   +70.1 2.324  
A’ −50.0   −70.1 2.324  
F +45.2   +74.7 2.362 Form II 
F’ −45.2   −74.7 2.362 Form II 
E +59.6   +70.2 2.367 Form II 
E’ −59.6   −70.2 2.367 Form II 
D +25.7   +70.2 2.572 Form I 
D’ −25.7   −70.2 2.572 Form I 
C +35.5   +60.9 2.679 Form III 







Figure 3.8 2D energy plots of trans molecule VI using the Dreiding force field with 
fitted ab initio charges: (a) torsion 3 = 0º and (b) torsion 3 = 90º. Points A, B and C 
indicate the energy minima and points D (D’), E (E’) and F (F’) are the calculated 
values closest to the conformations in the three polymorphs. The energy contours are 
expressed in terms of kcal per mole.  
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3.3.2 Crystal structure prediction results and structure 
comparisons 
 
In this section, the important findings in the CSP studies are highlighted, and the 
DFT(d) predicted structures are compared against the experimental structures as well 
as the predictions made by the blind test participants. The TMFFs of these four 
molecules are provided in the Appendix 3. The cif files of all the predicted structures 
are available on a supplementary disk provided with this thesis. 
 
3.3.2.1 5-cyano-3-hydroxythiophene (molecule II) 
The experimental structure of molecule II
238
 (see Figure 3.1) corresponded to the 
rank four DFT(d) predicted structure. 11 out of 23 blind test prediction results 
matched one of the 78 DFT(d) predicted structures. Among these 11 structures, the 
rank 2 prediction by Verwer and Leusen matched the experimental structure in the 
blind test, and therefore ranked fourth among the DFT(d) results (Table 3.9). After 
optimisation with the DFT(d) method, four of the CSP1999 predictions were found 
to be more stable than the experimental structure: three of these ranked second while 
one ranked third. The other six were found at DFT(d) ranks 6, 11, 20, 36, 42 and 74. 
The TMFF energies of the remaining 12 blind test predictions were found to be 
outside the 3σ energy window and these structures were therefore not considered for 
optimisation with the DFT(d) method. A new structure was found as the DFT(d) 
global minimum, which would not have been identified without a full CSP study. 
Both the new structure and the experimental structure have an one-dimensional (1D) 
hydrogen bonding pattern, which propagates perpendicular to the plane of projection 
in Figure 3.9a & b. However, the 1D hydrogen bonded chains in the new structure  
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are packed in a zigzag manner, whilst those in the experimental structure stack in a 
parallel way (Figure 3.9c & d). 
 
Table 3.9 The ten most stable DFT(d) predicted structures and those corresponding 
to the experimental polymorph as well as the CSP1999 prediction results for 























Rank a (Å ) b (Å ) c (Å ) β (˚) 
1 14 0.000 1.501 P21/c 7.49 9.10 10.15 53.14 - 
2 1 0.177 1.493 P212121 7.24 8.31 9.25 90.00 pri_1, smd_1, wil_2 
3 7 0.190 1.501 P21 4.00 7.28 9.51 89.53 v-L_3 
4 2 0.190 1.483 P21/c 7.58 8.33 10.45 58.14 exp, v-L_2 
5 4 0.214 1.488 C2/c 13.27 8.32 14.85 137.02 - 
6 3 0.220 1.488 P21/c 6.85 8.28 10.50 110.27 v-L_1 
7 9 0.331 1.482 C2/c 14.02 8.27 10.42 111.67 - 
8 17 0.374 1.460 Pnma 10.78 6.35 8.32 90.00 - 
9 6 0.393 1.495 P212121 3.94 7.29 19.38 90.00 - 
10 75 0.395 1.418 C2/c 15.64 5.23 14.34 87.33 - 
11 22 0.441 1.492 Pna21 17.05 3.90 8.37 90.00 pri_2 
20 26 0.661 1.450 P21/c 7.83 9.85 7.48 83.43 wil_1 




42 41 0.924 1.427 C2/c 13.09 8.30 10.83 81.64 mot_1 
74 76 1.573 1.436 P21/c 3.98 10.12 14.52 81.69 pri_3 
a Relative DFT(d) lattice energy. b Unless otherwise shown, angles α and γ are 90˚ due to symmetry 
constraints. For structures in the P1¯ space group, angles α, β and γ are shown respectively. c The three 
letter shorthand represents one of the following: exp = experimental (CSD reference GUFJOG), hof = 





Figure 3.9 Crystal structures of molecule II; (a) the rank 1 predicted structure, (b) 
the experimental structure,
238
 (c) the hydrogen bonding pattern in the rank 1 
predicted structure and (d) the hydrogen bonding pattern in the experimental 
structure.
238
 [Reproduced by permission of the PCCP Owner Societies from ref 235] 
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The effect of pressure on the relative stabilities of the rank 1 to 7 (ranking at 0 GPa) 
predicted structures of molecule II was studied. These seven structures were re-
optimised with the DFT(d) method at pressures of 1, 2, 3, 4 and 5 GPa. Figure 3.10 
shows the lattice energies relative to the most stable structure at each pressure. The 
rank 1 predicted structure becomes increasingly more stable with respect to the other 
structures as the pressure increases. This result is consistent with the high density of 
the rank 1 structure. The increase in energy difference between the two lowest-
energy structures at high pressure outweighs any error in the energy calculations. 
Thus, if the crystallisation process took place at high pressure, the rank 1 structure 
would be even more likely to occur. 
 
 
Figure 3.10 The changes in relative lattice energies of the seven most stable 
predicted crystal structures of molecule II as a function of pressure. The ranks refer 
to stability rankings at 0 GPa. The lattice energies are relative to the lowest energy 
structures at each pressure. [Reproduced by permission of the PCCP Owner Societies 
from ref 235] 
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3.3.2.2 Azetidine (Molecule XI) 
The experimental structure of molecule XI corresponded to the rank 2 DFT(d) 
predicted structure. 36 out of 54 blind test predictions matched one of the 365 DFT(d) 
predicted structures. Among these 36 structures, seven clusters were found: four 
structures at rank 4, two at rank 11, three at rank 26, seven at rank 37, seven at rank 
42, three at rank 179 and another three at rank 214. The remaining seven structures 
were found at ranks 5, 9, 13, 14, 19, 114 and 186 (Table 3.10). The global minimum 
identified in the present study has neither been found experimentally nor was it 
predicted in CSP2004. The hydrogen bonded molecules in the new structure form a 
1D helix structure, whereas those in the experimental structure form a 1D catemer 
(Figure 3.11).  
 
Table 3.10 The ten most stable DFT(d) predicted structures and those corresponding 
to the experimental polymorph as well as the CSP2004 prediction results for 























Rank a (Å ) b (Å ) c (Å ) β (˚) 
1 5 0.000 1.022 I41/a 1 16.55 16.55 5.42 90.00 - 
2 30 0.090 1.024 P21/c 2 9.61 8.92 9.88 118.95 exp 
3 293 0.187 1.023 I41/a 2 16.13 16.13 11.39 90.00 - 
4 1 0.205 1.039 P21/c 1 8.57 4.27 9.99 87.92 pan_1, smd_2, srg_2, 
ver_2 
5 83 0.208 1.011 P21/c 1 9.80 4.41 10.46 123.96 pan_2 
6 89 0.209 1.013 P21/c 2 5.41 17.98 7.73 94.86 - 
7 3 0.232 1.035 C2/c 2 35.41 4.26 10.01 104.24 - 
8 88 0.232 1.024 P21/c 2 17.28 4.38 10.37 70.69 - 
9 2 0.233 1.038 C2/c 2 19.55 4.27 19.98 61.22 day_3* 
10 49 0.242 1.016 Pc 2 5.36 9.22 7.57 93.79 - 
11 94 0.247 1.020 P21/c 1 8.17 4.39 10.39 88.22 swz_1, van_2 
13 10 0.254 1.037 C2/c 1 9.98 4.28 17.14 88.46 cli_1 
14 6 0.259 1.033 C2/c 1 19.57 4.26 10.02 61.47 cli_2 
19 77 0.283 1.024 P21212 2 8.14 16.75 5.43 90.00 pan_3* 
26 27 0.291 1.029 C2 1 10.00 4.29 8.60 87.63 cli_3, mot_2, srg_3* 
37 117 0.334 0.988 P21/c 1 5.34 4.53 15.88 89.05 amm_1, day_1, 
erk_1, leu_1, p-t_1, 
smd_1, van_1 































Rank a (Å ) b (Å ) c (Å ) β (˚) 
114 260 0.442 1.009 C2/c 1 17.44 4.32 9.99 91.96 amm_3 
179 345 0.530 1.023 Cc 1 5.21 14.63 5.83 123.36 del_3, dzy_1, p-t_2 
186 7 0.539 1.043 Pbca 1 4.35 9.67 17.27 90.00 mot_3 
214 402 0.580 1.000 P21/c 1 5.23 15.21 5.14 111.94 dzy_2, p-t_3, ver_1 
a Relative DFT(d) lattice energy. b Number of independent molecules in the asymmetric unit. c Angles 
α and γ are 90˚ due to space group symmetry constraints. d The three letter shorthand represents one of 
the following: exp = experimental (CSD reference XATMOV), amm = Ammon, boe = boerrigter, day 
= Day, del = Della Valle, dzy = Dzyabchenko, erk = Erk, leu = Leusen, cli = Liang, mot = Motherwell, 
pan = Pantelides, p-t = Price and Torrisi, smd = Schmidt, srg = Scheraga, swz = Schweizer, ver = 
Verwer, and van = van Eijck. Any entry with an asterisk has two independent molecules in the 
asymmetric unit (Z' = 2), while entries without an asterisk have just one independent molecule in the 
asymmetric unit (Z' = 1). 
 
 
Figure 3.11 Crystal structures of molecule XI; (a) a new structure predicted to be 
more stable than the known experimental polymorph, (b) the experimental structures, 
(c) the hydrogen bonding pattern in the new predicted structure and (d) the hydrogen 
bonding pattern in the experimental structure. Only hydrogen atoms involved in 
hydrogen bonding are shown. [Reproduced by permission of the PCCP Owner 
Societies from ref 235]  
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3.3.2.3 Propane (Molecule VII) 
The experimental structure of molecule VII
239
 corresponded to the rank 1 DFT(d) 
predicted structure. 10 out of 16 blind test predictions matched one of the 50 DFT(d) 
predicted structures. Among these 10 structures, the rank 1 prediction made by Mooij 
matched the experimental structure. Three CSP1999 predictions formed a cluster at 
rank 11. The other six were found at ranks 2, 6, 7, 8, 17, 22, by the DFT(d) method 
(Table 3.11). 
 
Table 3.11 The ten most stable DFT(d) predicted structures and those corresponding 
to the experimental polymorph as well as the CSP1999 prediction results for 
























Rank a (Å ) b (Å ) c (Å ) β (˚) 
1 1 0.000 0.780 P21/c 4.19 12.77 8.11 59.90 exp, moo_1 
2 8 0.027 0.778 P212121 4.16 8.42 10.73 90.00 wil_1 
3 4 0.037 0.778 P21/c 4.16 10.74 9.26 114.70 - 
4 22 0.042 0.779 P21/c 4.64 7.69 11.20 109.69 - 
5 2 0.048 0.778 Pna21 12.77 7.01 4.20 90.00 - 
6 14 0.048 0.777 P21/c 4.16 8.44 10.74 89.07 wil_2 
7 9 0.054 0.775 P21/c 4.20 7.03 12.80 91.43 van_2 
8 7 0.068 0.775 P21/c 7.01 4.19 13.20 77.39 moo_2 
9 12 0.073 0.778 Pna21 10.74 8.40 4.17 90.00 - 
10 5 0.084 0.770 P212121 4.21 7.06 12.80 90.00 - 
11 23 0.093 0.772 P1¯ 4.17 5.91 7.95 99.15 
95.45 
99.15 
mot_3, van_1, v-L_1 
17 11 0.112 0.767 P21/c 6.62 4.19 14.11 102.77 moo_3 




a Relative DFT(d) lattice energy. b Unless otherwise given, angles α and γ are 90˚ due to symmetry 
constraints. For structures in the P1¯ space group, angles α, β and γ are shown respectively. c The three 
letter shorthand represents one of the following: exp = experimental (CSD reference JAYDUI), moo = 
Mooij, mot = Motherwell, van = van Eijck, v-L = Verwer and Leusen, and wil = Williams. 
 
3.3.2.4 6-amino-2-phenylsulfonylimino-1,2-dihydropyridine (Molecule VI) 
The experimental structure of molecule VI in CSP2001 (form I)
195
 ranked number 1 
in the list of DFT(d) predicted structures. Two additional polymorphs were 
discovered in 2003 (form II)
195
 and in 2009 (form III),
196
 and these additional  
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polymorphs ranked third and second, respectively, among the predicted structures in 
the present study. The calculated stability order of these three polymorphs agrees 
well with experimental differential scanning calorimetry results.
196
 Note that the 
neighbouring molecules in form II adopt a dimer structure which is embedded in a 
two-dimensional hydrogen-bonding network, consistent with the so-called 
‘thermodynamically favoured’ synthon A discussed elsewhere.195,196 Forms I and III 
exhibit a one-dimensional hydrogen-bonding network, which corresponds to the so-
called ‘kinetically favoured’ synthon B.195,196  Figure 3.12 shows a plot of lattice 
energies versus densities of the predicted structures, mapping the dimensionalities of 
the hydrogen bonding patterns across the energy spectrum. One-dimensional 
hydrogen-bonding patterns are prevalent among the low-energy structures, whilst 
two-dimensional networks occur infrequently. Zero- and three-dimensional motifs do 




Figure 3.12 Plot of relative lattice energies versus densities of the predicted 
structures, showing the distribution of hydrogen-bond dimensionalities. (Adapted 
from ref 236) 
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No successful prediction was made in CSP2001 and none of the CSP2001 
predictions match any of the ten lowest-energy structures in Table 3.12. Only 6 out 
of the 32 blind test prediction results matched any of the 291 DFT(d) predicted 
structures. The rank 1 prediction by Mooij and the rank 2 prediction by van Eijck 
formed a cluster ranking 148
th
 on the DFT(d) prediction list. The remaining four 
structures were found at ranks 47, 140, 173 and 262. 
 
Table 3.12 The ten most stable DFT(d) predicted structures and those corresponding 
to the experimental polymorph as well as the CSP2001 prediction results for 

























Rank a (Å ) b (Å ) c (Å ) β (˚) 
1 1 0.000 1.452 P21/c 1 8.54 9.00 14.84 92.10 exp_form_I
e
 
2 20 0.212 1.428 Pbca 1 10.59 9.32 23.50 90.00 exp_form_IIIf 
3 140 0.218 1.471 P21/c 2 12.11 10.78 17.41 97.96 exp_form_II
g
 
4 18 0.273 1.417 P21/c 2 23.84 10.61 9.30 83.50 - 
5 21 0.324 1.438 Pbca 2 10.60 9.31 46.72 90.00 - 
6 2 0.325 1.445 P21/c 1 11.70 10.61 9.24 87.45 - 
7 5 0.364 1.425 Pbca 2 10.62 9.26 47.26 90.00 - 
8 16 0.401 1.408 Pbca 1 10.62 9.28 23.85 90.00 - 
9 17 0.413 1.428 Pbca 2 10.60 9.33 46.88 90.00 - 
10 111 0.435 1.436 P21/c 2 14.17 10.98 17.79 56.45 - 
47 258 1.537 1.525 Pbca 1 9.12 10.59 22.47 90.00 moo_3 
140 79 2.698 1.469 P21/c 1 13.69 7.33 12.59 63.09 van_3 








262 256 4.132 1.384 P21/c 1 5.61 9.66 22.31 81.88 smd_3 
a Relative DFT(d) lattice energy. b Number of independent molecules in the asymmetric unit. c Unless 
otherwise shown, angles α and γ are 90˚ due to symmetry constraints. For structures in the P1¯ space 
group, angles α, β and γ are shown respectively. d The three letter shorthand represents one of the 
following: exp = experimental, moo = Mooij, smd = Schmidt and van = van Eijck. e CSD reference 
UJIRIO. f CSD reference UJIRIO05. g CSD reference UJIRIO02. 
 
3.3.3.5 Geometric deviations between experimental and predicted structures 
The crystal packing similarities between the experimental structures and their 
corresponding DFT(d) predicted structures were studied. With the exception of 
molecule II, the predicted structures are in good geometric agreements with the  
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experimental structures (Table 3.13). Figures 3.13–3.18 show the superpositions of 
the experimental and predicted structures, viewed along several directions. 
 
Table 3.13 Crystal structure comparisons between the experimental structures and 
the corresponding DFT(d) predicted structures for molecules II, VI, VII and XI. 

























































































































a exp = experimental structure; rank ‹n› = rank nth predicted structure; an asterisk indicates a Z' = 2 
structure. b CSD stands for Cambridge Structural Database. c The temperature at which the 
experimental structure was determined. d Angles α and γ are 90˚ due to space group symmetry 
constraints. e The root-mean-square deviations calculated by the crystal packing similarity tool in 
Mercury 2.2, with a 16 molecule overlay for Z' = 1 structures and a 30 molecule overlay for Z' = 2 




[Reproduced by permission of the PCCP Owner Societies from ref 235]
 
Figure 3.13 Superposition of the 
experimental structure of molecule II 
(blue) onto the rank 4 predicted 




Figure 3.14 Superposition of the form I 
experimental structure of molecule VI 
(blue) onto the rank 1 predicted 




Figure 3.15 Superposition of the form 
II experimental structure of molecule VI 
(blue) onto the rank 3 predicted 
structure (green), viewing along the b-
axis. 
 
Figure 3.16 Superposition of the form 
III experimental structure of molecule 
VI (blue) onto the rank 2 predicted 




Figure 3.17 Superposition of the 
experimental structure of molecule VII 
(blue) onto the rank 1 predicted 
structure (green), viewing along the c-
axis of the experimental structure. 
 
 
Figure 3.18 Superposition of the 
experimental structure of molecule XI 
(blue) onto the rank 2 predicted 




The conformational analysis of molecule VI shows that the molecular mechanical 
method, being able to locate possible conformers observed in the experimental 
crystal structures, can be taken as the first step towards CSP. Its simple mathematical 
framework allows straightforward modifications based on the more sophisticated 
semi-empirical and ab initio calculations. Extra caution is needed when applying the 
energetics of a molecule in gas phase to solid-state simulation. For instance, ignoring 
the high energy trans configuration may lead to an incomplete search of possible 
crystal packings and eventually a failure in CSP.  
 
In the CSP studies of the four molecules, the DFT(d) method successfully predicts all 
the experimental structures among the low-energy crystal packing alternatives. It is 
noteworthy to observe the re-ranking of TMFF structures after DFT(d) optimisation. 
Many low-energy TMFF structures are found around the DFT(d) global minimum, as 
is to be expected. However, some high-energy TMFF structures are also found. For 
instance, the DFT(d) rank 3 structure of molecule VI ranks 140 according to the 
TMFF, whilst the DFT(d) rank 3 structure of molecule XI ranks 293 according to the 
TMFF. This finding shows that the simple mathematical framework in molecular 
mechanics is not accurate enough to reproduce the finer details of a quantum 
mechanical based approach. Therefore, statistical analysis of the energy differences 
between the two methods is essential, correlating the probability of locating the 
global minimum according to the DFT(d) method to the number of low-energy 
TMFF structures to be considered. 
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Another interesting feature is that, apart from molecule VI, the rank 1 TMFF 
structure corresponds to at least one of the participants’ predictions, demonstrating 
the commonality among these molecular mechanics approaches. Nevertheless, the 
TMFFs would have predicted correctly (under the rules of the blind test) the crystal 
structures of three out of the four compounds studied here, whilst all the predictions 
of all the participants in the blind tests taken together produced only two correct 
predictions for the four molecules out of 43 attempts. 
 
The CSP results show that using the three lowest energy structures from each 
participant is not sufficient to capture all relevant low-energy structures. Many 
participants only considered a selection of common space groups based on the 
statistical distribution of space groups recorded for crystal structures in the 
Cambridge Structural Database (CSD), and experienced difficulties in searching for 
structures with two independent molecules in the asymmetric unit. For molecules II 
and VII, only one cluster of participants’ predictions is found near the global 
minimum, due to the small numbers of submitted structures. For molecule VI, the 
blind test participants only considered structures with Z' = 1. Only six predictions 
match structures found in the full CSP study reported here; the other crystal 
structures predicted by the participants fall outside the energy window considered in 
this study. The most stable DFT(d) optimised participants’ structure corresponds to 
the rank 47 structure in the combined Z' = 1 and Z' = 2 list of DFT(d) optimised 
structures, and rank 15 in the Z' = 1 list. Moreover, this structure is 1.5 kcal mol
−1
 
above the CSP global minimum, showing that the accuracy of the molecular 
mechanics methods used by the blind test participants was insufficient to handle this 
flexible molecule.  
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The inclusion of an additional independent molecule in the asymmetric unit increases 
the number of predicted structures within the same energy window. For molecule VI, 
despite restricting the number of space groups being searched in the Z' =2 case, the 
number of low-energy structures (up to rank 47) more than doubled going from Z' = 
1 (searching 230 space groups) to Z' = 2 (searching 5 space groups). The structures 
with Z' = 2 in the remaining 225 space groups are yet to be explored. 
 
For molecules II and XI, some additional structures are found to be more stable than 
the experimentally observed structures. The global minima are 0.2 and 0.1 kcal mol
−1
 
more stable than the DFT(d) optimised experimental structures of molecule II and XI 
respectively. They are structurally unrelated to the experimental structures, and may 
be potential new polymorphs if appropriate kinetic pathways are found to access 
each of them. High pressure crystallisation may lead to a new polymorph of 
molecule II, as the predicted global minimum becomes relatively more stable under 
increasing pressure. Note that the rank 1 predicted structure of molecule XI is in a 
high-symmetry space group, I41/a, which is not unusual for many hydroxy and a few 
amino compounds.
240
 Other structurally related compounds that are known to 
crystallise in high-symmetry space groups include 1-amino-cyclopropane
241
 (space 
group R3c) and 1-amino-1-methyl-cyclopropane
242
 which crystallises in the same 
space group (I41/a) and has the same hydrogen-bond helix as the rank 1 predicted 
crystal structure of molecule XI. 
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For molecule XI, the DFT(d) optimised participants’ structures are found in two 
separate regions in the final list of DFT(d) optimised structures; 29 are found below 
the rank 42 structure, while the rest are higher in energy than the structure ranked 
114. It is likely that the potential energy surface of this crystal is relatively flat and 
many unique structures can be found within a narrow energy range. This issue was 
pointed out after the third blind test.
191
 In the present work, the most stable 42 
structures are found within 1.5 kcal mol
−1
 of the global minimum and the energy 
difference between the rank 42 and 114 structures is only 0.1 kcal mol
−1
. Therefore, 
accurate lattice energy calculations are essential in order to differentiate between 
crystal packing alternatives and to determine their relative stabilities. 
 
Due to the small size of molecule VII (propane) and lack of any strong 
intermolecular interactions, the lattice energy hypersurface is very flat with many 
different crystal packing alternatives found within a narrow energy window. 
Therefore, this simple compound is a good test for the accuracy of lattice energy 
calculation methods used in CSP. Note that in CSP1999 Mooij predicted the crystal 
structure of propane as his rank 1 outcome by using a sophisticated molecular 
mechanics approach with ab initio derived intermolecular potentials, including 
atomic multipole moments, atomic dipole polarisabilities, a damped dispersion term 
and an exponential repulsion term with anisotropic features.
189
 In the present study, 
the TMFF also predicts the propane solid state structure correctly, probably due to its 
accurate parameterisation although its potentials are less sophisticated than the 
functional form of the molecular mechanics methodology applied by Mooij. The 
global minimum crystal structure of molecule VII as calculated by the DFT(d) 
method also corresponds to the experimental structure.  
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Finally, correct prediction of the three experimental polymorphs of molecule VI, 
both in terms of stability and geometry, falsifies the speculation that the crystal 
structures of small organic molecules cannot be predicted reliably. Crystallisation is 
a kinetic process, which explains the phenomenon of polymorphism. On the other 
hand, nature strives towards structures with the lowest possible energy, which 
explains why it is feasible to predict crystal structures by only considering lattice 
energy. All three polymorphs are shown to be thermodynamically favourable, and 
they can only be obtained experimentally if crystallisation conditions can be chosen 
such that a kinetic pathway exists to each of these structures. The failure of previous 
CSP studies to predict correctly the polymorphs of molecule VI was not due to the 
kinetic nature of the crystallisation process, but due to the inaccuracy of the force 
fields used. Even the TMFF developed specifically for molecule VI as part of this 
study is not capable of correctly ranking the three known polymorphs according to 
their relative stability. 
 
3.5 Conclusions 
The crystal structure generation algorithm in GRACE using a tailor-made force field 
has successfully located all the six known experimental structures of the four 
molecules considered. In addition, accurate lattice energy calculations using the 
DFT(d) method have been shown to predict a low ranking for all of the optimised 
experimental structures, with excellent agreement (except for molecule II) between 
the predicted and experimental crystal geometries. The observation that the 
experimental polymorphs of these four molecules are amongst the lowest-energy  
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DFT(d) structures provides further justification for the use of a thermodynamic based 
approach as the basis for the prediction of crystal structures from first principles. 
 
The results show that the selection of only three structures from each blind test 
participant as a method for structure generation is inadequate. The sheer number of 
low energy structures and the size of the energy window, which reflects the accuracy 
of the force field, mean that many more structures need to be considered as potential 
candidates. This problem is particularly profound for molecule VI, which is more 
flexible than the other molecules in this study and which has other structural features 
that are more difficult to capture with a force field. These considerations demonstrate 
the importance of understanding the relative accuracies of the force fields with 
respect to the DFT(d) method. Given the limitations of molecular mechanics 
potentials it is clearly difficult, if not impossible, to improve the accuracy of force 
field lattice energy calculations beyond a certain point. It is therefore unlikely that 
simple force fields will ever be a reliable source of lattice energies in CSP. The 
statistical analysis of the discrepancies between the TMFF predicted energies and 
those obtained with the DFT(d) method provides a controlled and systematic 
approach to this problem. A quantum mechanical calculation of the lattice energy is 
clearly necessary for reliable CSP. But the computational resources required for such 
calculations are much greater than for molecular mechanics calculations and there 
must therefore be a trade-off between the accuracy of the calculations and the number 
of structures which can be considered. Nevertheless, as computational power 
increases there will be a shift towards more reliance on quantum mechanical 
calculations of the lattice energy. 
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For molecules II and XI, the CSP studies found crystal structures which have lower 
lattice energies than the optimised experimental structures, indicating that these may 
be new polymorphs waiting to be found under the right crystallisation conditions. 
Polymer-induced heteronucleation may be a useful technique, which has been proven 
successful in preparing new polymorphs of molecule VI
196
 and other 
compounds.
243,244
 In the case of molecule XI, the global minimum structure has the 
same space group and hydrogen bonding pattern as found in the experimental 
structure of a similar compound, indicating that a kinetic pathway to this as yet 
unobserved polymorph may exist. For molecule II, the global minimum structure is 
shown to become even more stable relative to the experimental polymorph as the 
pressure is increased. It is likely therefore that this crystal structure will be found by 








The study of the structural changes brought about by substituting different groups in 
a molecule can be used as a probe of the intermolecular interactions. In a systematic, 
experimental investigation of the structural relationships and similarities between a 
number of aspirin derivatives, carried out in the group led by Professor Hursthouse at 
the University of Southampton,
245 , 246
 it was shown that the conformation of the 
aspirin core is very similar in all derivatives except for those with substitution at the 
6 position. In all but one structure, carboxylate dimers are observed and adopt either 
a syn or anti conformation (Figure 4.1). However, this phenomenon could not be 
explained in previous experimental studies. Unlike other derivatives, 5-chloroaspirin 
(5-Cl) demonstrates polymorphism and crystallises in two different forms α and β. 
 
 
Figure 4.1 The general structure of the substituted aspirins, showing atomic 
numbering, and the syn/anti carboxylate conformations. [Reproduced by permission 
of The Royal Society of Chemistry from ref 252] 
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CSP provides an ideal opportunity to make an incisive examination of the structural 
systematics landscape of this compound. This chapter describes a CSP study on 5-
chloroaspirin along with the identification of the structures of the two experimental 
polymorphs and their stability order. Secondly, low-energy predicted structures are 
compared against other members of the substituted aspirin family, notably other 5-
substituted molecules. The similarities between the predicted structures and the 
experimental structures of other aspirin derivatives help identify appropriate seeding 
templates for polymorph discovery.  
 
4.2 Methods 
CSP was performed using the GRACE software package version 1.0.
234
 Quantum 
mechanical density functional theory (DFT) calculations of the lattice energy were 
performed by the VASP program,
206-209
 with a correction for the dispersive 
interactions (the DFT(d) method).
205
 Initial conformer analysis was done in GRACE 
using the Dreiding force field
92
 with Gasteiger charges
111
 and the resulting low-
energy conformers were optimised with a semi-empirical quantum mechanical 
method (ORCA).
247
 The conformers obtained were further geometry optimised in the 
process of generating reference data sets by the DFT(d) method.
205
 These data sets 
were then used to derive a tailor-made force field (TMFF)
222
 specific to 5-
chloroaspirin (5-Cl). The variables in the TMFF, including force constants, bond 
lengths, bond angle values and torsion angle values as well as the parameters of the 
non-bonded interactions (Coulomb and van der Waals interactions) were fitted to the 
reference data. Crystal structure generation was performed for a single molecule in  
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the asymmetric unit sampling all 230 space groups. The lattice energy of each 
structure was optimised by the TMFF. The search took place within a predefined 
energy window, and stopped when all structures in the window had been located 
several times and when no new structures were being found. The TMFF structures 
were ranked according to their lattice energies. A number of the most stable TMFF 
structures were then optimised by the DFT(d) method. The statistical correlation 
between the TMFF energies and those obtained with the DFT(d) method was used to 
determine the probability that the most stable DFT(d) structure was amongst the list 
of optimised structures. The two experimental polymorphs were optimised by the 
TMFF and the DFT(d) method separately, and the results were compared with the 
TMFF generated structures and those optimised by the DFT(d) method. 
 
Detailed structural comparisons between the 12 lowest-energy predicted structures 
and the experimental structures of all reported aspirin derivatives
245,246
 were 
conducted by Dr Montis at the University of Southampton using the XPac 
program.
248
 All non-hydrogen atoms of the basic aspirin core structure were selected 
as the ‘‘Corresponding Ordered Set of Points’’ (COSP). The results of these 
calculations allow identification of molecular motifs which occur in more than one 
structure, which are referred to as Supramolecular Constructs (SCs), and which can 
have 0, 1, 2 or 3-D similarity. For these calculations, the settings of the ‘‘filter 
parameters’’ were fine tuned – these are the limits of angular and distance variations 
in the similarity comparison, below which a particular similarity feature is returned, 
along with a ‘‘dissimilarity’’ parameter. Generous filter parameters enabled the 
identification of more approximate similarities.
246
 These findings give understanding  
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as to any differences in such features as weak intermolecular interactions, directed 
and undirected, and the competition of these with shape effects, which affect the 
level of the similarities. 
 
4.3 Crystal structure prediction results 
As can be seen in Table 4.1, optimisation of the two experimentally known 
polymorphs using the DFT(d) method results in crystal structures that are very close 
to the experimentally determined structures. 5-Cl α shows deviations of less than 
0.4% in the lattice parameters and 5-Cl β shows deviations of less than 2%. The root 
mean squared deviations in atomic positions between the experimental structures and 
their optimised counterparts calculated using a 15 molecule cluster (ignoring 
hydrogen atoms) by the Compack method
194
 as implemented in Mercury 2.3 
249
 are 
also small; 0.112 and 0.134 Å for the α and β polymorphs respectively. The DFT(d) 
method is demonstrating excellent performance for the prediction of the structural 
features of this compound (Figure 4.2−4.3), which is in line with previous results 







Figure 4.2 Superposition of the experimental structure of 5-Cl α (blue) onto the rank 
2 predicted structure (green), viewing along the b-axis. 
 
 
Figure 4.3 Superposition of the experimental structure of 5-Cl β (blue) onto the rank 
5 predicted structure (green), viewing along the c-axis. 
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Table 4.1 Comparison of the experimental crystal structures of 5-chloroaspirin (5-Cl) 
with their DFT(d) optimised counterparts. [Reproduced by permission of The Royal 
Society of Chemistry from ref 252] 
Polymorph Method Space group a (Å ) b (Å ) c (Å ) β (°) RMSDa (Å ) 
5-Cl α Exp  10.122 4.736 19.445 96.2  
 DFT(d) opt P21/n 10.160 4.740 19.390 97.0 0.112 
 Δ (%)  0.4 0.1 0.0 −0.3  
        
5-Cl β Exp  5.085 17.895 10.447 98.3  
 DFT(d) opt P21/c 5.098 18.249 10.291 98.1 0.134 
 Δ (%)  0.2 2.0 −1.5 −0.2  
a RMSD is the root mean squared deviation of the non hydrogen atoms in a 15 molecule cluster 
comparing experimental and optimised structures calculated using the Compack algorithm194 as 
implemented in Mercury 2.3.249  
 
The TMFF of 5-Cl is provided in Appendix 4. Table 4.2 summarises the relative 
energies and structural features of the twelve most stable packings according to the 
DFT(d) method. Structures corresponding to the experimentally observed 
polymorphs are found at ranks 2 and 5 for 5-Cl α and 5-Cl β respectively. Note that 
the rank 2 structure is shown in Table 4.2 with the P21/c setting of space group 14. 
The crystal structure data predicted in this study is available on a supplementary disk, 
provided with this thesis. All the predicted structures, except for the rank 5 and 10 
structures, can be classed as isostructural pairs, differing only in the position of the 
carboxylate hydroxyl group with respect to the acetyl group (syn or anti) (Figure 
4.4−4.8). The majority of the predicted pairs are ranked closely together, having very 
similar lattice energies and geometries. Although the barrier for interconversion 
between each pair is not known accurately, previous work
251
 suggests that it would 
be a facile process and therefore only the lowest energy structure of each pair would 
be observed experimentally. Assuming this to be the case then by considering only 
the lowest energy structure of each pair, a new polymorph is predicted at rank 1 and 
the experimental polymorphs are found with effective ranks 2 and 3. The predicted 
structures in the pair 5-Cl 10 and 5-Cl 05 are sufficiently different that the XPac  
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analysis did not cluster them together within the scope of the filter parameters used 
and this is also reflected in the differences in their lattice parameters. In earlier, 
experimental studies on aspirin derivatives by Hursthouse et al,
245,246
 it was noted 
that the experimental structures of all the derivatives containing the carboxylate-
carboxylate dimer showed one or the other of the syn/anti arrangements, and at that 
time, it was not possible to identify any particular reason for a specific choice.  
 
Table 4.2 Structures and energies of the 12 most stable DFT(d) optimised crystal 
structures of 5-chloroaspirin (5-Cl)
a
. [Reproduced by permission of The Royal 









group a (Å ) b (Å ) c (Å ) α (°) β(°) γ (°) 
1 (3) 1 0.00 1.529 P1¯ 5.70 7.67 11.27 96.8 94.3 72.7 
2 (4) 2 0.08 1.531 P21/c 10.22 4.76 20.70 90.0 112.2 90.0 
3 (1) 1 0.26 1.528 P1¯ 5.64 7.57 11.50 96.7 94.3 73.3 
4 (2) 2 0.27 1.520 P21/c 10.39 4.74 20.50 90.0 111.8 90.0 
5 (10) 3 0.27 1.508 P21/c 5.09 18.23 10.29 90.0 98.0 90.0 
6 (7) 4 0.30 1.552 P21/c 10.31 4.79 19.86 90.0 69.3 90.0 
7 (6) 4 0.47 1.536 P21/c 10.21 4.81 20.19 90.0 69.3 90.0 
8 (12) 5 0.53 1.547 C2/c 14.20 5.68 23.00 90.0 96.7 90.0 
9 (11) 6 0.66 1.524 P1¯ 5.66 7.63 11.77 107.6 91.8 74.7 
10 (5) 3 0.74 1.507 P21/c 4.81 19.47 11.17 90.0 115.2 90.0 
11 (9) 6 0.76 1.520 P1¯ 5.62 7.53 12.04 107.9 91.6 75.7 
12 (8) 5 0.78 1.535 C2/c 14.03 5.67 23.55 90.0 97.0 90.0 
a The structures corresponding to the experimentally observed structures are shown in bold at ranks 2 
and 5 for 5-Cl α and 5-Cl β respectively. b The number in brackets indicates the DFT(d) rank of its 
isostructural counterpart differing only in the position of the carboxylate group hydrogen. The rank 5 
and 10 structures are 3-D similar, showing slight packing differences as well as being a syn/anti pair 
with respect to the position of the carboxylate group hydrogen. c The effective rank assumes that 
interconversion between isostructural pairs that differ only in their syn/anti conformation is facile and 




Figure 4.4 Superposition of the rank 1 (blue) and the rank 3 (green) predicted 
structures, viewing along the b-axis. 
 
 
Figure 4.5 Superposition of the rank2 (blue) and the rank 4 (green) predicted 
structures, viewing along the b-axis.  
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Figure 4.6 Superposition of the rank 6 (blue) and the rank 7 (green) predicted 
structures, viewing along the b-axis. 
 
 
Figure 4.7 Superposition of the rank 8 (blue) and the rank 12 (green) predicted 
structures, viewing along the b-axis.  
 124 
 
Figure 4.8 Superposition of the rank 9 (blue) and the rank 11 (green) predicted 
structures, viewing along the b-axis. 
 
In addition to the ‘‘isostructural pairs’’ result, and the 5-Cl 05 and 5-Cl 10 difference, 
three other outcomes of the CSP calculations are notable. The first of these is the 
successful prediction of the two experimental monoclinic polymorphs 5-Cl α and 5-
Cl β with their predicted relative stabilities in agreement with experiment. The 
energy ranking of the two experimental polymorphs also correctly identifies the 
observed syn/anti conformation. The second result of interest is the prediction of a 
triclinic structure (5-Cl 01), with an energy 0.08 kcal mol
−1
 lower than the 5-Cl α 
structure. Although this triclinic structure is basically of a new type, in space group 
P1¯, and thus with no glide or screw axis relationships between the molecules, the 
centrosymmetric dicarboxylate dimer is present, as is the almost equally ubiquitous 
Cl∙∙∙O chain. In addition, a number of weak hydrogen bonds, involving acetyl and  
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phenyl H∙∙∙O contacts, and of types found throughout the whole set of experimental 
structures, are present. 
 
The third noteworthy result involves the predicted 5-Cl 06, 5-Cl 07 pair (which are 
very close in energy). These structures are iso- or pseudo-isostructural with the 5-F, 
5-Me and 5-NO2 experimentally determined structures,
245
 indicating that there could 
be a kinetic pathway to crystallise 5-Cl 06 or 5-Cl 07. 
 
4.4 Isostructural analysis 
This section discusses the structural relationships between the predicted 5-Cl 
derivatives and all the observed aspirin derivatives reported by Montis and 
Hursthouse.
245,246
  Much of the analysis reported in this section, including the 




For the detailed XPac study, the 12 lowest-energy predicted structures were 
integrated with the full group of structurally characterised aspirin derivatives
245,246
 
and a comprehensive comparison was made. The results are summarised in the 
relationship diagram shown in Figure 4.9. In deriving the relationships shown, the 
default medium constraints for the calculation have been used as this better reflects 
some differences in ‘‘similar’’ structures which may be important. Of most 
significance in this respect is the separation of the two predicted forms 5-Cl 05 and 





Figure 4.9 Sub-structure relationships diagram obtained with XPac program. 
[Reproduced by permission of The Royal Society of Chemistry from ref 252]  
 
The structures are set out along the header row, with groupings to show occurrences 
of iso- or pseudo-isostructurality.
245
 There is no significance in the positioning of the 
structures in the row. All experimental structures are given in pale grey type, except 
for the two 5-Cl polymorphs, which are highlighted in orange. The predicted 
structures are given in black type. 
 
The main body of the diagram shows the Supramolecular Constructs (SC’s), as 
identified by the XPac program.
248
 New SC’s found as a result of including the 
predicted structures are represented as circles colored blue. The relationships found 
previously
246
 are indicated in grey, apart from the important 0-D constructs which are  
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in black. These three constructs are the carboxylate dimer (A1), the Cl∙∙∙O(carboxy) 
or MeO∙∙∙O(carboxy) dimer (B1) and the acetyl dimer (C1). The most interesting 
result concerns the involvement of the 1-D SC AB1 (= A1 + B1) which is the chain 
of carboxylate dimers connected via Cl∙∙∙O intermolecular interactions. This is the 
main relationship observed in the two experimental polymorphs 5-Cl α and 5-Cl β, 
and is also present in the majority of the predicted structures. This is a clear 
indication of the robustness of this intermolecular arrangement, which is not only a 
peculiarity of the 5-Cl derivative, but also the 5-I, 5-Br and 5-MeO derivatives. 
However, this arrangement is not found in the predictions 5-Cl 06 and 5-Cl 07, 
which adopt instead the structure of the 5-F, 5-Me and 5-NO2 set, where alternative 
associations are operative. The main interactions in these two isostructural predicted 
structures, in addition to the carboxylate dimer, is the acetyl-acetyl dimer, a further 
single acetyl C–H to acetyl O interaction and a further C–H∙∙∙O interaction between 
the acetyl carbonyl and the aromatic C–H(4). This collection of interactions results in 
the co-ordination of the acetyl methyl and the carbonyl being saturated, with obvious 
contributions to the lattice energy. 
 
SC AB1 is a precursor to three different 2-D SCs, AB21, AB22 and AB23, whose 
examination exposes some subtle features which separate the AB1-containing group 




Figure 4.10 Plans views of three Supramolecular Constructs AB21, AB22 and AB23. 
[Reproduced by permission of The Royal Society of Chemistry from ref 252] 
 
The AB21 construct comprises a ‘‘corrugated’’ layer of side-by-side tilted AB1 
chains related by glide symmetry. This construct is observed in structures 5-Cl β, 5-
Cl 05 and 5-Cl 10. The AB22 construct is a stack of tilted AB1 chains found in 5-Cl 
α and 5-Cl 10. Combining these two results provides a clear explanation of the 
dissimilarity between 5-Cl 05 and 5-Cl 10. 5-Cl 05 is isostructural to 5-Cl β, whilst 
5-Cl 10 possesses the stacking of 5-Cl α and the sewing symmetry of 5-Cl β. 
Conversion of 5-Cl 10 to 5-Cl β would simply require a change in the slippage of 
AB1 chains in the stacks and the intra-stack interactions between them and a change 
in carboxylate isomer conformation. This process may be feasible with a low 
activation energy, and thus represents a potential mechanism for phase change.  
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The third AB1-containing 2-D SC is AB23, which is a strongly slipped stack 
structure, and which relates three pairs of predicted structures - the low energy pair, 
5-Cl 01 and 5-Cl 03, and the two pairs 5-Cl 08 and 5-Cl 12, and 5-Cl 09 and 5-Cl 11. 
These have no 3-D relationship with any experimental structure. Detailed analysis of 




The TMFF successfully found the two experimental polymorphs, whilst the DFT(d) 
method accurately predicted their structures and correctly identified the order of 
stability between them; 5-Cl β is 0.2 kcal mol−1 less stable than 5-Cl α. Of equal 
importance and interest is the identification of pairs of structures showing the 
syn/anti differences, and successful identification of the more stable of the two for 
each polymorph. 
 
A third polymorph of 5-chloroaspirin is predicted to exist. This structure is calculated 
by the accurate DFT(d) method to be slightly more stable (by 0.08 kcal mol
−1
) than 
the observed α form. This as yet unobserved structure is predicted in the triclinic P1¯ 
space group, which is unusual in the series of aspirin derivatives. Despite this, the 
predicted polymorph has many intermolecular interaction motifs in common with the 
series of experimental structures. 
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The CSP study clearly identified significant relationships between the predicted 
structures and members of the extended family of experimental structures. Two 
notable results are the persistence of the Cl∙∙∙O interaction in all but two of the 12 
lowest energy structures, and also the identification of the exceptional 5-Cl 06 and 5-
Cl 07 pair of structures as members of the 5-F, 5-Me, 5-NO2 set, where the structures 
are supported only by C=O∙∙∙H–C interactions (in addition to the carboxylate dimer). 
Seeding the crystals of other aspirin derivatives to the solution of the 5-chloroaspirin 
may help induce the growth of undiscovered polymorphs. 
 
Regarding the choice of syn/anti configurations, there is no obvious correlation with 
any particular intermolecular interactions. However, no disorder of the proton 
positions occurs in any of the experimental structures, and there is consistency in the 
choice of configuration in the isostructural set consisting of 5-Cl α, 5-Br, 5-I and the 
isostructural set consisting of 5-Cl β, 5-MeO (and 5-Cl 05). It must be concluded 
therefore, that the choice of syn or anti configuration is really an integration of the 
whole set of inter- and intra-molecular interactions. Although this is speculation to 
some extent, it is likely that during crystallisation the carboxylate dimer forms and 
then interacts with neighbouring dimers to grow the crystal. In solution both syn and 
anti configurations appear to be equally likely, with the protons of the dimer able to 
move between their donor and acceptor atoms. Only when the growing crystal 
becomes large enough does the additional stability of one form drive the crystal to 
adopt the more stable configuration uniquely. 
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Chapter 5: Co-crystal and salt stability 
 
5.1 Introduction 
Co-crystallisation of a drug with another molecule to form a new crystalline material 
is an appealing approach to modify physical properties such as solubility, hardness or 
tabletting behaviour,
73,79, 253
and to address intellectual property issues and patent 
opportunities in pharmaceutical industry. Research in co-crystals has seen dramatic 
growth in recent years, mainly due to their potential pharmaceutical applications.  In 
the Cambridge Structural Database (CSD),
58
 for instance, the number of organic co-
crystals available in 2007 is 10 times higher than in 1988 and 2.5 times higher than in 
1997.
254
 Many experimental techniques can produce co-crystals
253,255,256,257,258
 and a 
major issue with co-crystals is their stability, which is often not sufficient for 
pharmaceutical formulations.
259
  Consider the following reaction, 
x A(solid) + y B(solid) → AxBy(solid) + ΔH 
where molecules A and B form a co-crystal in a stoichiometric ratio x:y and ΔH is 
the enthalpy change in the process.  Furthermore, 
ΔH ≈ EAB – (x EA + y EB) 
where EAB, EA and EB are the calculated lattice energies of AxBy(solid), A(solid) and 
B(solid) respectively.  ΔH is negative for an exothermic reaction, indicating that the co-
crystal (or salt) should be stable with respect to its components (ignoring entropic 
effects).  If ΔH is positive, the co-crystal (or salt) is not expected to form. 
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Attempts have been made to use lattice energy calculations to investigate whether a 
potential co-crystal is thermodynamically more stable than its pure co-former 
crystals.
181,228,231
 However, the results are inconclusive and there is still considerable 
uncertainty as to whether a given co-crystal will form (see section 2.6). In some 
occasions, the experimental crystal structures may not be available for the single 
component crystals or the co-crystal. The only way of calculating the appropriate 
lattice energies is to perform a crystal structure prediction study, which requires 
considerable effort. 
 
It is important to assess whether the DFT(d) method is sufficiently accurate for the 
purpose of predicting co-crystal stability.  This can be achieved by considering only 
co-crystals for which experimental crystal structures are available for both the co-
crystal itself and its pure constituent molecules. Nicotinamide (vitamin B6) and 
isonicotinamide (Figure 5.1) have attracted considerable interest in co-crystallisation 
research. The former is a ‘generally recognized as safe’ (GRAS) substance260 and has 
been used as a co-crystal former of pharmaceuticals such as carbamazepine, 
ibuprofen and celecoxib. The latter has been studied extensively for the effects of 
intermolecular interactions on the formation of co-crystals.
87,261,262 
The co-crystal and 
salts of picolinamide, a structural isomer of nicotinamide, are also included in the 




Figure 5.1 Molecular structures of nicotinamide (left), isonicotinamide (middle) and 
picolinamide (right) 
 
In the present study, the DFT(d) method is used to minimise the lattice energies of all 
known co-crystals and salts of nicotinamide, isonicotinamide and picolinamide, and 
their corresponding neutral co-formers, excluding any organometallic compounds.  
The stabilities of the resulting 102 co-crystals and salts are compared against their 
corresponding co-formers. The result will demonstrate whether a thermodynamic 
approach, which ignores temperature, pressure, solvent effects and other kinetic 
factors, can predict reliably the existence of a co-crystal.  
 
5.2 Methods 
All non-organometallic, anhydrous co-crystals and salts containing nicotinamide, 
isonicotinamide and picolinamide were selected for which full crystal structures of 
co-crystals and their co-formers are available, either from the Cambridge Structural 
Database (CSD)
58
 version 5.32 released in November 2011 or from the Inorganic 
Crystal Structure Database.
263
 The lattice energies of all reported polymorphs of 
these co-crystals and all reported polymorphs of their single component co-formers 
were minimised with respect to atomic coordinates and unit cell dimensions using 
the DFT(d) method. The details of the DFT(d) method have been discussed in  
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section 2.4.1. Regarding the types of structures considered in this study, the co-
formers form a total of 34 co-crystals and 10 salts with nicotinamide; 47 co-crystals, 
3 hybrid salt co-crystals and 6 salts with isonicotinamide; and 1 co-crystal and 2 salts 
with picolinamide. The stabilities of all 81 co-crystals (including a 1:1 
nicotinamide:isonicotinamide co-crystal), 18 salts and 3 hybrid salt co-crystals were 
determined from their calculated lattice energies relative to the sum of the co-former 
lattice energies. For polymorphic co-formers, the lattice energy of the most stable 
polymorph was used in the stability calculation. 
 
5.3 Results 
5.3.1 The DFT(d) optimisation of the pure co-formers 
The minimised lattice energies of the pure co-former structures and their geometric 
deviations after optimisation are summarised in Table 5.1. The predicted orders of 
polymorph stability is worthy of some discussions. The enantiotropic or monotropic 
relationships of some of the co-former polymorphs do not appear to be well studied 
experimentally. These co-formers include 3-nitrobenzoic acid, 4-nitrobenzoic acid, 
3,5-dinitrobenzoic acid, 4-(N,N-dimethylamino)-benzoic acid, orcinol, squaric acid, 
hydroquinone and diclofenac. 
 
For alkanedicarboxylic acids, the β polymorphs are the stable forms at room 
temperature, with phase transitions to α forms at high temperatures.264 The β form of 
malonic acid transforms into the γ form at 56 K which has two independent 
molecules in the asymmetric unit.
265
 However, the DFT(d) results suggest that the α  
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forms are more stable except for oxalic acid. The DFT(d) optimised γ form of 
malonic acid became a Z' = 1 structure and converged to the same minimum as the 
optimised β form. The atomic coordinates for the α form of glutaric acid are not 
known and only its unit cell parameters are available, hence it could not be 




For isonicotinamide, the order of polymorph stability from DSC results is form I > 
Iso3 > form II,
62
 whilst the DFT(d) results suggest a stability order of form II > form 
I  > Iso3. For tolfenamic acid, forms III and V transform into form I above 90 °C. 
The order of stability at 300 K based on the free energy estimations from solubility 
tests is form I > form II > form III > form V > form IV. The predicted order of 
stability is form II > form I > form III > form IV > form V. For monochloracetic acid 
and 2-chloro-4-nitrobenzoic acid, the calculated energy differences between their 
polymorphs are negligible (ca 0.1 kcal mol
−1
), and their stability orders are different 
from experimental results.
267,268
 For carbamazepine, the order of polymorph stability 
from DSC results is form III > form I > form IV > form II.
32
 In agreement with 
experiment, the DFT(d) results indicate that form III is the most stable phase, whilst 
form II is the least stable.  The calculated stability order for forms I and IV, however, 
is not in agreement with the DSC data, although the energy difference between these 
two forms is only 0.04 kcal mol
−1
.   
 
For long-chain fatty acids, the experimental findings are inconclusive, partly because 
the nomenclature of the polymorphs in the literature is confusing and because the  
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transition temperatures are very close to one other.
269
 However, transformation into 
form C prior to melting is always observed and the DFT(d) method predicts that all 
forms C are relatively less stable. 
 
Pressure-induced polymorphisms in acetic acid, propionic acid and nitric acid were 
reported. Except for nitric acid, the high-pressure polymorphs are predicted to be less 
stable by the DFT(d) method. It is also interesting to note that the crystals of racemic 
tartaric acid, ibuprofen (form I) and mandelic acid are found to be more stable than 
their pure enantiomers. 
 
The calculated relative stabilities of the polymorphs of nicotinamide, fumaric acid, 
adipic acid, rac-ibuprofen, DL-mandelic acid, 3-hydroxybenzoic acid, cinnamic acid, 
flufenamic acid and resorcinol are consistent with experiment. The P2/n polymorph 
of nicotinamide was confirmed to be metastable by Differential Scanning 
Calorimetry (DSC) and variable temperature powder X-ray diffraction.
62
 The α 
polymorph of fumaric acid was prepared by slow evaporation of an ethanol 
solution,
270
 whilst its β polymorph was prepared in a sublimation process at 403 K at 
reduced pressure.
271
  For adipic acid, form I is the stable phase above 136 K and it 
transforms into form II below 136 K.
272
 An additional form III was prepared by 
solvent evaporation at room temperature, but its structure was determined at 100 
K.
273
 The DFT(d) results suggest that form III is the most stable form, followed by 
forms II and I. The form II of rac-ibuprofen,
274
 the monoclinic polymorph of DL-
mandelic acid
275
 and the β form of cinnamic acid276 and resorcinol277 were reported  
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as metastable phases.  The monoclinic polymorph of 3-hydroxybenzoic acid was 
concluded to be the more stable form via a series of solubility tests and studies of 




The root mean squared deviation (RMSD) of the non-hydrogen atoms between the 
optimised and the experimental structure provides a quantitative measure of the 
similarity for each pair of structures.  Some crystals showed deviations larger than 
expected (>0.3 Å ), indicating either a problem with the DFT(d) method or a poor 
experimental structure.  Form II rac-ibuprofen has a poor experimental molecular 
geometry, resulting in a RMSD of 0.50 Å  after optimisation. The O-H bond of the 
carboxylic acid in the experimental structure of the orthorhombic form (Pcan) of 
diclofenac is exceptionally long (1.47 Å ), and was shortened prior to optimisation. The 
diclofenac molecules are significantly displaced on optimisation to facilitate the 
dimerisation of the carboxylic acid groups, resulting in a RMSD of 0.69 Å . The 
experimental, monoclinic form of norfloxacin contains zwitterions,
279
 but the reported 
structure has a proton missing from the piperidinium group. This proton was 
introduced prior to optimisation (VETVOG01). The possibility of an intramolecular 
hydrogen bond in the monoclinic form of norfloxacin was also considered 
(VETVOG01’). The optimised structures have RMSD of 1.32 and 2.11 Å  respectively. 
This structure was later confirmed to be a sesquihydrate form.
280
 For all other co-
formers, the RMSDs are smaller than 0.30 Å , which indicates that the geometric 




Table 5.1 Lattice energies of the pure co-formers in nicotinamide, isonicotinamide 
and picolinamide co-crystals and salts reported in the CSD version 5.32. The most 















nicotinamide C6H6N2O1 NICOAM01 P21/c -2333.09  0.071 
  NICOAM04 P2/n     (+0.25) 0.072 
isonicotimaide C6H6N2O1 EHOWIH02 Form II -2332.96  0.037 
  EHOWIH01 Form I     (+0.32) 0.044 
  EHOWIH03 Iso3     (+0.38) 0.035 
picolinamide C6H6N2O1 PICAMD - -2333.78 0.048 
oxalic acid C2H2O4 OXALAC04 Beta -1245.35 0.039 
  OXALAC06 Alpha     (+0.74) 0.047 
malonic acid C3D4O4 MALNAC03 Alpha -1639.61  0.059 
  MALNAC09 Beta     (+0.44) 0.080 
  MALNAC08 Gamma     (+0.45) 0.155 
fumaric acid C4H4O4 FUMAAC Alpha -1835.99  0.129 
  FUMAAC01 Beta     (+0.02) 0.045 
succinic acid C4H6O4 SUCACB07 Alpha -2029.31  0.050 
  SUCACB03 Beta     (+0.09) 0.034 
tartaric acid C4H6O6 ZZZDUI01 (racemic) -2337.92  0.069 
  TARTAL04 (+)-enantiomer     (+1.69) 0.199 
glutaric acid C5H8O4 GLURAC04 Beta -2413.33 0.100 
adipic acid C6H10O4 ADIPAC12 Form III -2799.70  0.058 
  ADIPAC05 Form II     (+0.52) 0.126 
  ADIPAC04 Form I     (+0.68) 0.032 
pimelic acid C7H12O4 PIMELA05 Alpha -3183.80  0.065 
  PIMELA06 Beta     (+0.02) 0.062 
suberic acid C8H14O4 SUBRAC01 - -3569.14  0.029 
azelaic acid C9H16O4 AZELAC10
d 
Alpha -3954.28  0.066 
  AZELAC03 Beta     (+0.05) 0.060 
sebacic acid C10H18O4 SEBAAC03 - -4339.22  0.069 
thiodiglycolic acid C4H6O4S1 TGLYCL01 - -2113.04 0.050 
acetic acid C2H4O2 ACETAC07 Low pressure -1102.56 0.063 
  ACETAC09 High pressure     (+0.05) 0.130 
trifluoroacetic acid C2H1F3O2 TFACET - -1117.30  0.050 
monochloroacetic acid C2H3Cl1O2 CLACET02 Beta -1066.29 0.063 
  CLACET01 Alpha     (+0.09) 0.079 
propionic acid C3H6O2 PRONAC Low pressure -1487.02  0.079 
  PRONAC02 High pressure     (+0.25) 0.082 
dodecanoic acid C12H24O2 LAURAC
d
 Form A1 -4953.01 0.126 
  LAURAC04 Form C     (+0.17)  0.090 
  LAURAC01 Super A     (+0.17) 0.117 
n-hexadecanoic acid C16H32O2 YEFWEM Form C -6493.86  0.150 
heptadecanoic acid C17H34O2 DARWAU
d
 Form B -6878.82 0.089 
  DARWAU01 Form C     (+0.29) 0.173 
octadecanoic acid C18H36O2 STARAC06 orthorhombic B -7264.88  0.156 
  STARAC02
d monoclinic B     (+0.01) 0.066 
  STARAC07 orthorhombic E     (+0.09) 0.083 
  STARAC05 monoclinic E     (+0.10) 0.081 
  STARAC01
d monoclinic C     (+0.97) 0.265 
ibuprofen C13H18O2 IBPRAC Form I (racemic) -4627.93  0.051 
  JEKNOC11 (S-enantiomer)     (+0.97) 0.073 
  IBPRAC04 Form II (racemic)     (+2.95) 0.495 
mandelic acid C8H8O3 DLMAND03 Orthorhombic 
(racemic) 
-2855.46 0.244 
  DLMAND02 Monoclinic 
(racemic) 
    (+1.48) 0.068 
  FEGHAA (S-enantiomer)     (+1.75) 0.082 
3-indolylacetic acid C10H9N1O2 INACET04 - -3405.48  0.046 
citric acid C6H8O7 CITRAC11 - -3103.01  0.091 
clofibric acid C10H11Cl1O3 BEFVAJ
d
 - -3584.42  0.066 
cinnamic acid C9H8O2 CINMAC07 Alpha -2900.24  0.029 
  CINMAC06 Beta     (+0.12) 0.279 
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C11H12O4 CEMJOT02 - -3965.30  0.066 
ferulic acid C10H10O4 GASVOL - -3595.70  0.073 
2-phenylpropionic acid C9H10O2 GOGPEY (R-enantiomer) -3084.47  0.040 
2-phenylbutyric acid C10H12O2 ROLFII (racemic) -3469.30  0.051 
diclofenac C14H11Cl2N1O2 SIKLIH07 C2/c -4519.74  0.060 
  SIKLIH08 P21/c     (+0.35) 0.101 
  SIKLIH04
e Pcan     (+1.54) 0.687 
benzoic acid C7H6O2 BENZAC01 - -2317.15 0.063 
4-fluorobenzoic acid C7H5F1O2 PFBZAD01 - -2325.03  0.070 
2-hydroxybenzoic acid C7H6O3 SALIAC16 - -2481.73  0.026 
3-hydroxybenzoic acid C7H6O3 BIDLOP
f 
Monoclinic -2480.47  0.042 
  BIDLOP01
d Orthorhombic     (+0.28) 0.053 
4-hydroxybenzoic acid C7H6O3 JOZZIH
g
 - -2481.36  0.186 
3-methylbenzoic acid C8H8O2 ZZZKWI01
g
 - -2705.00  0.048 
4-methylbenzoic acid C8H8O2 PTOLIC
d
  -2705.58  0.079 
3-nitrobenzoic acid C7H5N1O4 MNBZAC Form I -2678.38  0.051 
  MNBZAC01
d Form II     (+0.48) 0.090 
4-nitrobenzoic acid C7H5N1O4 NBZOAC04 A2/a -2679.46  0.045 
  NBZOAC02 P21/c     (+0.39) 0.073 
3,5-dinitrobenzoic acid C7H4N2O6 CUKCAM10 A2/a -3034.96  0.044 





 - -3360.47  0.081 
4-(N,N-dimethyl-
amino)-benzoic acid 
C9H11N1O2 PDABZA01 Form I -3363.91  0.068 
  PDABZA03
g Form III     (+0.50) 0.069 
  PDABZA02 Form II     (+0.87) 0.073 
2-chloro-4-nitro-
benzoic acid 
C7H4Cl1N1O4 VOLZEC Form I -2640.68  0.130 
  VOLZEC01 Form II     (+0.11) 0.075 
niflumic acid C13H9F3N2O3 NIFLUM10
d
 - -4515.08 0.065 
flufenamic acid C14H10F3N1O2 FPAMCA Form III -4618.15 0.088 
  FPAMCA11 Form I     (+0.62) 0.111 
tolfenamic acid C14H12Cl1N1O2 KAXXAI Form II -4559.62 0.072 
  KAXXAI01 Form I     (+1.12) 0.058 
  KAXXAI02 Form III     (+1.25) 0.100 
  KAXXAI03 Form IV     (+1.25) 0.054 
  KAXXAI04
g Form V     (+2.61) 0.063 
mefenamic acid C15H15N1O2 XYANAC - -4976.55 0.084 
iodine I2 icsd_67706 -     -83.63  0.080 
deuterium chloride D1Cl1 icsd_27037 -   -148.54  0.069 
deuterium iodide D1I1 icsd_40251 -   -118.92  0.189 
nitric acid H1N1O3 icsd_166941 High pressure   -677.05  0.147 
  icsd_166940
g Low temperature     (+0.89) 0.294 
hydrogen perchlorate H1Cl1O4 icsd_63679 -   -597.85  0.077 
phosphoric acid H3P1O4 icsd_15887 - -1113.13  0.111 
formamide C1H3N1O1 FORMAM02 -   -838.52  0.057 
squaric acid C4H2O4 KECYBU17 Triclinic -1629.38  0.173 
  KECYBU06 Monoclinic     (+0.04) 0.028 
resorcinol C6H6O2 RESORA03 Alpha -2099.89  0.051 
  RESORA09 Beta     (+0.45) 0.099 
hydroquinone C6H6O2 HYQUIN05 Beta -2098.62  0.035 
  HYQUIN06 Alpha     (+0.20) 0.069 
  HYQUIN Gamma     (+1.13) 0.086 
fumaric acid 
monoethyl ester 
C6H8O4 XUCQIV - -2590.89  0.040 
p-tetrafluoro-diiodo-
benzene 
C6F4I2 ZZZAVM01 High 
temperature 
-1666.54  0.060 
picric acid C6H3N3O7 PICRAC12 - -3011.59  0.113 
chloranilic acid C6H2Cl2O4 CLANAC11 - -2159.72  0.045 
orcinol C7H8O2 EWAMAR Form I -2486.23 0.049 
  EWAMAR01 Form II     (+0.32) 0.109 
saccharin C7H5N1O3S1 SCCHRN03 - -2651.83  0.039 
 140 












sulfamethazine C12H14N4O2S1 SLFNMD01 Form I -4914.68 0.125 
carbamazepine C15H12N2O1 CBMZPN01 Form III -4732.12  0.066 
  CBMZPN12 Form IV     (+0.77) 0.048 
  CBMZPN11 Form I     (+0.81) 0.062 
  CBMZPN16 Form V     (+1.18) 0.081 
  CBMZPN03
d Form II     (+1.66) 0.067 
norfloxacin C16H18F1N3O3 VETVOG Triclinic -6077.68  0.158 
  VETVOG01
d
 Monoclinic     (+7.78) 1.321 
  VETVOG01’
d Monoclinic     (+4.53) 2.109 
celecoxib C17H14F3N3O2S1 DIBBUL - -6031.44  0.084 
ethyl paraben C9H10O3 FEGLEI
d
 - -3239.75  0.102 
a CSD = Cambridge Structural Database. b EDFT(d) is the minimised lattice energy per mole of molecule, 
calculated by the DFT(d) method. Numbers in brackets refer to the energy differences relative to the 
most stable polymorph, which is given in bold face. c The root-mean-squared atomic displacement 
after optimisation, in comparison to the experimental structure, excluding hydrogen atoms.  d Missing 
hydrogen atoms in the experimental structures were added manually prior to DFT(d) optimisation. e 
The position of a COOH proton was edited prior to DFT(d) optimisation.  f The structure was 
converted from the P1121/c space group into P21/c prior to DFT(d) optimisation. 
g For structures with 
disordered atoms, every possible starting configuration was DFT(d) optimised and the most stable 
results are shown. 
 
5.3.2 Energy for re-ordering polymorph stability 
The disagreements in the orders of stabilities are likely to be due to errors associated 
with the DFT(d) method, experimental issues associated with determining the 
relative stabilities or the fact that the thermal energies, zero point energies and 
entropies are ignored in the calculations. Table 5.2 shows the energy required to re-
order the less stable predicted polymorph which is in fact more stable according to 
the experimental data. Except for tolfenamic acid and nitric acid, the re-ordering 
energies are less than 0.5 kcal mol
−1
. The free energy of form IV tolfenamic acid 
relative to the most stable form I polymorph may be overestimated in the experiment 
due to a slow phase conversion, whilst the form V polymorph of tolfenamic acid 
demonstrates 50% occupancy of the whole disordered molecule. The proton in the 
low temperature polymorph of nitric acid is also disordered, and the stabilising effect 
due to disorder is not considered in the DFT(d) calculations. 
  
 141 













Isonicotinamide Form I → Form II 0.32 
 Iso 3 → Form I 0.06 
Malonic acid gamma → alpha 0.45 
Succinic acid beta → alpha 0.09 
Pimelic acid beta → alpha 0.02 
Azelaic acid beta → alpha 0.05 
Monochloroacetic acid alpha → beta 0.09 
2-chloro-4-nitro-
benzoic acid 
Form II → Form I 0.11 
Tolfenamic acid Form I → Form II 1.12 
 Form V → Form IV 1.36 
Nitric acid Low temp. → High Pressure 0.89 
Carbamazepine Form I → Form IV 0.04 
 
5.3.3 The calculated co-crystal and salt stability 
The lattice energies of 102 co-crystals and salts are expressed in kcal mol
−1
 per mole 
of formula unit and their stabilities are calculated relative to the most stable (as 
determined by the DFT(d) method) polymorphs of their pure component co-formers. 
The results are reported in Table 5.3. For polymorphic co-formers, the lattice energy 
of the most stable polymorph was used in the stability calculation.  
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Table 5.3 DFT(d) lattice energies of nicotinamide, isonicotinamide and picolinamide 
co-crystals and salts, and their stabilities relative to the lattice energies of the pure 
co-former crystals. 
CSD reference 











CUYXUQe (citric acid)·(nicotinamide)2 -7778.18 -9.00 0.106 
RUYHEZ (4-hydroxybenzoic acid)·(nicotinamide) -4820.03 -5.59 0.041 
NUKXUN (malonic acid)·(nicotinamide)2 -6311.28 -5.49 0.051 
DUZPAQ (succinic acid)·(nicotinamide)2 -6700.03 -4.55 0.041 
SUTTUXe (2-chloro-4-nitrobenzoic acid)·(nicotinamide) -4977.97 -4.20 0.306 
NUKZOJ (sebacic acid)·(nicotinamide)2 -9009.48 -4.09 0.093 
NUKYOI (adipic acid)·(nicotinamide)2 -7469.96 -4.08 0.054 
XAQPUBe (3,5-dinitrobenzoic acid)·(3-(N,N-
dimethylamino)-benzoic acid)·(nicotinamide) 
-8732.35 -3.84 0.151 
XAQQIQ (3-hydroxybenzoic acid)·(nicotinamide) -4817.26 -3.70 0.097 
NUKZEZ (suberic acid)·(nicotinamide)2 -8238.98 -3.67 0.072 
NUKYEY (glutaric acid)·(nicotinamide) -4749.97 -3.56 0.046 
EWAQAV (orcinol)·(nicotinamide)4 -11822.02 -3.45 0.067 
NUKYAU (fumaric acid)·(nicotinamide) -4172.32 -3.24 0.067 
SODDOF (2-hydroxybenzoic acid)·(nicotinamide) -4818.03 -3.22 0.066 
NUKZAV (suberic acid)·(nicotinamide) -5905.06 -2.84 0.134 
EXAQIE (tolfenamic acid) ·(nicotinamide)2 -9228.40 -2.61 0.206 
IACNCA (3-indolylacetic acid)·(nicotinamide) -5740.96 -2.40 0.199 
FIFLAI (heptadecanoic acid)·(nicotinamide) -9213.92 -2.02 0.157 
NUKYUO (pimelic acid)·(nicotinamide) -5518.83 -1.94 0.057 
EXAQOK (mefenamic acid) ·(nicotinamide)2 -9644.56 -1.84 0.155 
EXAQEA (niflumic acid) ·(nicotinamide) -6849.78 -1.61 0.120 
GOGQID (ethyl paraben)·(nicotinamide) -5574.44 -1.61 0.045 
NUKZID (azelaic acid)·(nicotinamide) -6288.87 -1.50 0.492 
NUKYIC (adipic acid)·(nicotinamide) -5134.28 -1.50 0.072 
JILZOU (mandelic acid)·(nicotinamide) -5189.94 -1.40 0.092 
JEMDIP (N-hexadecanoic acid)·(nicotinamide) -8828.27 -1.32 0.179 
UCOTUC (dodecanoic acid)·(nicotinamide) -7286.09 -1.22 0.180 
EXAQAWe (flufenamic acid)·(nicotinamide) -6952.45 -1.22 0.128 
SODDIZ (ibuprofen)·(nicotinamide) -6962.08 -1.06 0.069 
PEQBES (octadecanoic acid)·(nicotinamide) -9598.75 -0.78 0.181 
UMUYOR (isonicotinamide)·(nicotinamide) -4666.65 -0.60 0.048 
SOGLAC (ibuprofen)·(nicotinamide) -6961.49 -0.48 0.180 
UNEZES (carbamazepine)·(nicotinamide) -7065.35 -0.15 0.069 
VIGDARf (celecoxib)·(nicotinamide) -8362.70 1.82 1.706 
ULAWAF02 (oxalic acid)·(isonicotinamide)2 -5925.54 -14.27 0.067 
ULAWAF (oxalic acid)·(isonicotinamide)2 -5924.92 -13.65 0.061 
ULAWEJ (malonic acid)·(isonicotinamide)2 -6315.42 -9.89 0.128 
LUNNOX (fumaric acid)·(isonicotinamide)2 -6508.80 -6.89 0.041 
ULAWUZ (adipic acid)·(isonicotinamide)2 -7472.13 -6.51 0.031 
LUNNAJ (monochloroacetic acid)·(isonicotinamide) -3405.39 -6.14 0.048 
LUNPEP (thiodiglycolic acid)·(isonicotinamide)2 -6785.05 -6.09 0.057 
LUNNUD01 (succinic acid)·(isonicotinamide)2 -6701.06 -5.83 0.029 
XAQPOV (3,5-dinitrobenzoic acid)·(3,4-dimethoxycinnamic 
acid)·(isonicotinamide) 
-9338.57 -5.35 0.103 
BUFBIP (3,5-dinitrobenzoic acid)·(4-(N,N-(dimethyl-
amino)-benzoic acid)·(isonicotinamide) 
-8737.14 -5.31 0.126 
YIPCIK (p-tetrafluoro-diiodobenzene)·(isonicotinamide)2 -6337.65 -5.19 0.126 
AJAKEB (4-nitrobenzoic acid)·(isonicotinamide) -5017.56 -5.14 0.047 
LUNMEM (3-hydroxybenzoic acid)·(isonicotinamide) -4818.27 -4.84 0.061 
ASAXOH (3-nitrobenzoic acid)·(isonicotinamide) -5015.89 -4.55 0.038 
ULAWOT (glutaric acid)·(isonicotinamide)2 -7083.73 -4.48 0.059 
MOVTOH (benzoic acid)2·(isonicotinamide) -6971.71 -4.45 0.085 
VAKTUX (resorcinol)·(isonicotinamide)2 -6769.99 -4.17 0.071 
BUFQAU (3,5-dinitrobenzoic acid)·(ferulic acid )· 
(isonicotinamide) 
-8967.68 -4.07 0.133 
BUDZUV (3,5-dinitrobenzoic acid)·(3-methylbenzoic acid)· 
(isonicotinamide) 
-8076.97 -4.05 0.094 
VAKVIN (hydroquinone)·(isonicotinamide)2 -6768.55 -4.01 0.081 
AJAKIF (3,5-dinitrobenzoic acid)·(4-methylbenzoic acid)· 
(isonicotinamide) 
-8077.43 -3.93 0.080 
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Table 5.3 (Cont’d). 
CSD reference 








VETVUM (norfloxacin)·(chloroform)·(isonicotinamide) -8871.59 -3.74 0.098 
BUDWEC (benzoic acid)·(isonicotinamide) -4653.67 -3.55 0.057 
VAKTOR (4-hydroxybenzoic acid)·(isonicotinamide) -4817.79 -3.48 0.401 
ASAXUN (4-fluorobenzoic acid)·(isonicotinamide) -4661.18 -3.19 0.061 
ISIJIE (suberic acid)·(isonicotinamide) -5905.04 -2.94 0.039 
HANBOO (propionic acid)2·(isonicotinamide) -5309.93 -2.93 0.114 
ISIJEA (pimelic acid)·(isonicotinamide) -5519.66 -2.89 0.092 
JAWWAG (acetic acid)·(isonicotinamide) -3438.40 -2.88 0.061 
ROLFOO (2-phenylpropionic acid)·(isonicotinamide) -5420.26 -2.84 0.119 
EWAQID (orcinol)·(isonicotinamide)2 -7154.87 -2.71 0.069 
LUNMAI (cinnamic acid)·(isonicotinamide) -5235.85 -2.65 0.049 
ULAXEK (adipic acid)·(isonicotinamide) -5135.18 -2.52 0.049 
ISIJAW (azelaic acid)·(isonicotinamide) -6289.75 -2.52 0.086 
ROLFUU (2-phenylbutyric acid)·(isonicotinamide) -5804.63 -2.37 0.035 
ULAXAG (glutaric acid)·(isonicotinamide) -4748.58 -2.29 0.080 
XAQQEM (2-hydroxybenzoic acid)·(isonicotinamide) -4816.73 -2.04 0.089 
RONDAA (2-phenylpropionic acid)·(isonicotinamide) -5419.32 -1.89 0.050 
LUNPAL (mandelic acid)·(isonicotinamide) -5190.16 -1.75 0.067 
LUNNEN (fumaric acid monoethyl ester)·(isonicotinamide) -4925.59 -1.74 0.082 
UMUYUX (clofibric acid)·(isonicotinamide) -5919.10 -1.73 0.061 
YIPCEG (iodine)·(isonicotinamide) -2418.18 -1.60 0.041 
UMUZAE (diclofenac)·(isonicotinamide) -6854.21 -1.51 0.088 
RONDEE (2-phenylbutyric acid)·(isonicotinamide) -5803.47 -1.20 0.044 
LUNMIQ (3-(N,N-dimethylamino)benzoic 
acid)·(isonicotinamide) 
-5694.27 -0.84 0.071 
GAVHER (formamide)·(isonicotinamide) -3172.08 -0.60 0.067 
LOFKIB (carbamazepine)·(isonicotinamide) -7064.75 0.32 0.041 
LOFKIB01 (carbamazepine)·(isonicotinamide) -7064.41 0.67 0.136 
EXAPEZ (sulfamethazine)·(picolinamide) -7252.06 -3.60 0.102 
XOZWAL (isonicotinamidium)·(perchlorate) -2959.36 -28.54 0.071 
LICLAL (nicotinamidium)·(perchlorate) -2959.35 -28.41 0.111 
VUFPIV (nicotinamidium)·(iodide) -2476.14 -24.13 0.155 
TAFBUX (nicotinamidium)·(chloride) -2503.01 -21.38 0.043 
VAXLIP (nicotinamidium)·(nitrate) -3026.71 -16.58 0.085 
EMINUJ (nicotinamidium)2·(squarate) -6312.11 -16.56 0.039 
DAYFEP (isonicotinamidium)2·(squarate) -6311.40 -16.09 0.041 
LACTEO (nicotinamidium)·(dihydrogen phosphate) -3459.23 -13.01 0.057 
HILLIY (isonicotinamidium)·(dihydrogen phosphate) -3457.70 -11.60 0.056 
LICLEP01 (nicotinamidium)·(hydrogen oxalate) -3589.92 -11.48 0.139 
YICJEAe (nicotinamidium)·(trifluoroacetate) -3461.06 -10.68 0.174 
GAHJABg (isonicotinamidium)·(picrate) -5354.86 -10.31 0.173 
POVZIK (nicotinamidium)·(hydrogen chloranilate) -4502.87 -10.06 0.075 
POVZOQ (isonicotinamidium)·(hydrogen chloranilate) -4502.20 -9.52 0.051 
IPOZAO (nicotinamidium)·(picrate) -5353.51 -8.84 0.141 
JAWVUZ (isonicotinamide)·(isonicotinamidium)·(hydrogen 
tartarate) 
-7010.96 -7.12 0.157 
POVZEG (picolinamidium)·(hydrogen chloranilate) -4499.91 -6.42 0.036 
EYIXAL (picolinamidium)·(squarate) -3969.42 -6.27 0.033 
VEQHIJ (isonicotinamidium)·(saccharinate) -4989.09 -4.31 0.069 
a CSD = Cambridge Structural Database. b EDFT(d) is the minimised lattice energy of a co-crystal (or a 
salt) calculated by the DFT(d) method and is expressed in kcal per mole of formula unit which consist 
of two or more co-former molecules in a fixed stoichiometric ratio. c ΔE is the calculated energy 
change in forming a co-crystal or salt from the most stable polymorphs of the pure co-formers. d The 
root-mean-square atomic displacement after optimisation, in comparison to the experimental structure, 
excluding hydrogen atoms. 
e 
For structures with disordered atoms, every possible starting 
configuration was DFT(d) optimised and the most stable result is shown.   f Disordered atoms labelled 
with “?” in the CSD cif file were ignored in the DFT(d) optimisation. g Missing hydrogen atoms in the 
experimental structures were added manually prior to DFT(d) optimisation. 
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Out of the 102 co-crystals and salts, the only co-crystals calculated to be less stable 
than their co-formers are the two polymorphs of carbamazepine:isonicotinamide and 
celecoxib:nicotinamide. The minimised lattice energies of the two polymorphs of 
carbamazepine:isonicotinamide, forms I and II, are respectively 0.32 and 0.67 kcal 
mol
−1
 higher than the total lattice energy of pure carbamazepine and isonicotinamide. 
The calculated stabilities of the co-crystal polymorphs are consistent with the 
observations in solvent crystallisation experiments that the less stable form II first 
appears in the liquor and later transforms into the more stable form I co-crystal.
226,227
 
It is unclear why the carbamazepine:isonicotinamide polymorphs are calculated to be 
less stable than their pure co-formers. Possible reasons include kinetic effects, 
although the experiments were conducted under standard conditions (co-
crystallisation took place from pure crystalline components in ethanol solution at 25 
˚C). 
 
The minimised lattice energy of the 1:1 celecoxib:nicotinamide co-crystal structure 
reported in the CSD is 1.82 kcal mol
−1
 higher than the energy of its components.  
This large, apparent instability may be caused in part by an incorrect experimental 
structure for the co-crystal as indicated by its exceptionally large RMSD (1.71 Å ).  A 
detailed investigation of the experimental structure revealed several irregularities. 
The reported crystal structure (CSD code: VIGDAR) possesses unoccupied hydrogen 
bonding sites and has S=O bond lengths of 1.596 and 1.405 Å .  In addition, the 
reported C=O bond of the nicotinamide amide group is longer than its C-N bond. 
Since the refinement of the co-crystal structure relied heavily on powder X-ray 
diffraction data,
281
 it is possible that some nitrogen and oxygen atoms were  
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interchanged, as they have similar atomic weight. 24 possible variations of the 
celecoxib:nicotinamide co-crystal packing were investigated by altering the 
molecular conformations, including; rotation of the pyridine ring by 180˚  (2 
conformations), rotation of the nicotinamide amide group by 180˚  (2 conformations), 
rotation of the sulfonamide group by 120˚  (3 conformations) and consideration of 
the disordered trifluoromethyl group (2 conformations) in celecoxib.  All 24 
(2x2x3x2) structures were optimised with the DFT(d) method and converged to 12 
distinct structures. Both starting conformations of the trifluoromethyl group, Pos_a 
and Pos_b, always led to the same optimised structure.  Rotating the pyridine ring by 
180˚, in general, led to less stable structures, except for those with conformer_10a 
and conformer_10b (Table 5.4), in which intermolecular hydrogen bonds were 
formed between the pyridine ring and the sulfonamide during the optimisations.  
Structures with conformer_5a and conformer_5b involve a rotation of the amide 
group by 180˚ in nicotinamide and an anti-clockwise rotation of the sulfonamide 
group by 120˚ in celecoxib (viewing along the S-C bond), which facilitates hydrogen 
bonding between the two molecules (Figure 5.2).  These two structures converged to 
the most stable structure of all.  Note that in both conformer_5a and conformer_5b, 
the nitrogen atom of the amide group of nicotinamide occupies a position which 
corresponds to the amide oxygen in the reported VIGDAR structure, whilst the 
nitrogen atom of the sulfonamide group of celecoxib occupies a position which 
corresponds to the sulfonyl oxygen with the longer S=O bond in the reported 
VIGDAR structure.  Hence, based on these geometric comparisons and lattice energy 
considerations, we are confident that the real co-crystal structure of celecoxib and 
nicotinamide corresponds to the optimised structure with conformer_5a or  
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conformer_5b, except that the trifluoromethyl group is disordered. Note that this 
most stable co-crystal structure is still 0.36 kcal mol
−1
 less stable than the separate 
nicotinamide and celecoxib structures. This small energy difference may be, at least 
in part, due to the stabilising effects of the disordered trifluoromethyl group, which 
are not taken into account in the lattice energy calculations. Kinetic effects may also 
play a role in the crystallisation of this co-crystal. The proposed crystal structure of 




Table 5.4 Effect of 24 variations in molecular conformations in the 
celecoxib:nicotinamide 1:1 co-crystal structure on the DFT(d) minimised lattice 
energy. The structure with conformer_1a corresponds to the VIGDAR structure 

























conformer_1a Pos_a +0° +0° +0° -8362.70 1.82 
conformer_1b Pos_b +0° +0° +0° 
conformer_2a Pos_a +0° +0° +120° -8357.00 7.52 
conformer_2b Pos_b +0° +0° +120° 
conformer_3a Pos_a +0° +0° +240° -8353.94 10.58 
conformer_3b Pos_b +0° +0° +240° 
conformer_4a Pos_a +0° +180° +0° -8353.24 11.28 
conformer_4b Pos_b +0° +180° +0° 
conformer_5a Pos_a +0° +180° +120° -8364.16 0.36 
conformer_5b Pos_b +0° +180° +120° 
conformer_6a Pos_a +0° +180° +240° -8360.65 3.87 
conformer_6b Pos_b +0° +180° +240° 
conformer_7a Pos_a +180° +0° +0° -8358.60 5.92 
conformer_7b Pos_b +180° +0° +0° 
conformer_8a Pos_a +180° +0° +120° -8351.03 13.49 
conformer_8b Pos_b +180° +0° +120° 
conformer_9a Pos_a +180° +0° +240° -8351.09 13.43 
conformer_9b Pos_b +180° +0° +240° 
conformer_10a Pos_a +180° +180° +0° -8358.04 6.48 
conformer_10b Pos_b +180° +180° +0° 
conformer_11a Pos_a +180° +180° +120° -8361.26 3.27 
conformer_11b Pos_b +180° +180° +120° 
conformer_12a Pos_a +180° +180° +240° -8357.22 7.30 
conformer_12b Pos_b +180° +180° +240° 
a “Pos_a” and “Pos_b” stand for the positions of the fluorine atoms without and with the label “?” in 
the cif file, respectively.  b “+0°” stands for the conformation of the pyridine ring in the original 
structure, whilst “+180°” represents a rotation by 180°.  c “+0°” stands for the conformation of the 
amide group in the original structure, whilst “+180°” represents a rotation by 180°.  d “+0°” stands for 
the conformation of the sulfonamide group in the original structure, whilst “+120°” and “+240°” 
represent rotations by 120° and 240° respectively in an anti-clockwise direction, viewing along the S-
C bond.  e EDFT(d) is the minimised lattice energy of the co-crystal calculated by the DFT(d) method 
and is expressed in kcal per mole of building blocks which consist of one nicotinamide molecule and 
one celecoxib molecule.  f ΔE is the difference in lattice energy between an optimised co-crystal 
structure and the sum of lattice energies of nicotinamide (EDFT(d) of NICOAM01 in Table 1) and 




Figure 5.2 The molecular conformations and intermolecular packing in the reported 
celecoxib:nicotinamide co-crystal (top) and the most stable optimised structure in 
this study (bottom). Dotted lines indicate hydrogen bonds. 
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The remaining 99 co-crystals and salts are found to be more stable than their 
corresponding pure crystal components, i.e., considering only the thermodynamic 
stability of these compounds, calculated by accurate quantum mechanics and 
ignoring kinetics and other effects, these calculations successfully predict the co-
crystal or salt to be more stable than their co-formers with a success rate of more 
than 97%. The results are graphically presented in Figure 5.3, where the stabilities of 





Figure 5.3 DFT(d) calculated stabilities of nicotinamide and picolinamide co-
crystals and salts (top) and isonicotinamide co-crystals and salts (bottom). The 
structures are identified by their CSD reference codes. Blue indicates an optimised 
co-crystal structure. Red indicates that the optimised structure is a salt. Green 
indicates a hybrid structure. *At least one of the experimental structures was 
modified prior to optimisation. 
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The stabilities in Figure 5.3 show an interesting distribution over co-crystals, salts 
and hybrid salt co-crystals structures. Note that optimisation of the experimental 
structures using the DFT(d) method can change the nature of the crystals.  Six (CSD 
codes AJAKEB, LUNNAJ, SUTTUX, ULAWAF, ULAWAF02, ULAWEJ) out of 
the 24 optimised salts were initially co-crystals or structures with proton bridges. 
Seven (BUFQAU, CUYXUQ, LUNNEN, LUNPEP, NUKXUN, UMUZAE, 
XAQPOV) out of the eight optimised ‘hybrid’ structures were co-crystals before 
optimisation. In all cases a proton from the acid moiety of the co-former migrates to 
the pyridine nitrogen of nicotinamide or isonicotinamide. The remaining 18 DFT(d) 
optimised salts show no tendency to form neutral co-crystals. The average stability of 
the 24 DFT(d) optimised salts relative to their co-formers is −12.81 kcal mol−1. For 
the remaining 70 co-crystals (excluding eight ‘hybrid’ structures), the average 
relative lattice energy difference is only −2.75 kcal mol−1. Hence, according to the 
DFT(d) method, when salts form, they are considerably more stable than a co-crystal.  
This can be rationalised by considering that the strength of the hydrogen bond in a 
co-crystal is at most about 8 kcal mol
−1
, but the potential strength of the salt bridge, 
if it can be formed, is significantly greater. 
 
5.4 Conclusions 
The thermodynamic stability of 102 co-crystals and salts of nicotinamide, 
isonicotinamide and picolinamide has been investigated by means of lattice energy 
calculations using the DFT(d) method. In 99 (over 97%) of the 102 cases the 
calculated stability is in accord with the fact that the compound can be crystallised.  
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Even though a 1 kcal mol
−1
 re-ordering energy may affect the relative stabilities of 
six more co-crystals (GAVHER, LUNMIQ, PEQBES, SOGLAC, UMUYOR, 
UNEZES), over 90% of co-crystals and salts investigated are still thermodynamically 
more stable than their pure components. This is the first study that provides 
conclusive evidence that the existence of salts and co-crystals and their stability 
relative to their co-formers can be predicted so reliably.  These results strengthen 
previous findings
200,236,250 
(see Chapter 3) that it is of paramount importance in 
computational studies to get the thermodynamics of crystallisation correct before 
invoking any kinetic arguments. This study provides confidence that, even when the 
crystal structures of co-crystals or their co-formers are not known, crystal structure 
prediction using accurate lattice energy calculations will be able to predict reliably 
the existence and stability of a co-crystal or salt relative to its single component 
crystals. 
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In chapter 5, it was shown that the majority of known co-crystals and salts of 
nicotinamide, isonicotinamide and picolinamide are thermodynamically favoured 
when compared with their pure components. However, as discussed in chapters 3 and 
4, a CSP using the DFT(d) method may predict more stable but as yet undiscovered 
polymorphs. In order to establish the existence and true stability of a co-crystal, full 
CSPs of the co-crystal and its pure components are needed. This chapter aims to 
address, from a thermodynamic perspective, why two paracetamol co-crystals are not 
observed experimentally. Paracetamol (Figure 6.1 (left)) is a widely used painkiller 







It forms co-crystals with three acid molecules (oxalic acid, citric acid and 2,4-
pyridine-dicarboxylic acid)
253,283,284
 and a number of basic co-formers.
253,285
 In all 
these structures, hydrogen bonds are formed between the carbonyl oxygen atoms of 
the acid molecules and the phenol or the amide proton of paracetamol (Table 6.1). 
According to the synthon approach, other acid molecules such as benzoic acid and 
anthranilic acid (Figure 6.1 (middle and right)) can form co-crystals with 
paracetamol via similar interactions. However, benzoic acid and anthranilic acid did 
not form any co-crystals in Kofler microscopy screening tests and in solvent co-
crystallisation experiments.
286
 In this study, the existence and stabilities of 1:1 
benzoic:paracetamol and 1:1 anthranilic acid:paracetamol co-crystals are investigated 
using a DFT(d) based CSP method. 
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Table 6.1 Hydrogen bond interactions between paracetamol and acid molecules in 
three reported experimental co-crystals. 
Citric acid R-OH ∙∙∙∙∙∙ OH-Ph Paracetamol 
 HOC=O ∙∙∙∙∙∙ HO-Ph  
Oxalic acid COOH ∙∙∙∙∙∙ O=C-CH3 Paracetamol 
 HOC=O ∙∙∙∙∙∙ H-N-COCH3  
2,4-pyridine-dicarboxylic acid HOC=O ∙∙∙∙∙∙ H-N-COCH3 Paracetamol 
 
 
Figure 6.1 The molecular structures of (left) paracetamol, (middle) benzoic acid and 
(right) anthranilic acid. 
 
6.2 Methods 
The GRACE software (version 1.6) was used in this study. 
250
 The CSP of 
paracetamol using the same methodology has been published elsewhere.
282
 All three 
polymorphs of paracetamol were found among the predicted structures, and the most 
stable polymorph corresponded to the rank 1 prediction. Hence, in this work, the 
experimental structures of the three polymorphs were optimised by the DFT(d) 
method, and the lowest-energy structure was selected for calculating the co-crystal 
stabilities. For benzoic acid and anthranilic acid, TMFFs were generated in a similar 
fashion to that already described in chapter 3. To prepare a TMFF for the benzoic 
acid:paracetamol and anthranilic acid:paracetamol co-crystals, the TMFF of 
paracetamol provided by Marcus Neumann and used in reference 282 was merged 
with those of benzoic acid and anthranilic acid. Additional rigid-molecule 
minimisation data sets containing paracetamol and each co-former were generated by 
the DFT(d) method, and were used to parameterise the van der Waals terms between  
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the two different molecules (see section 2.4.3). The TMFF enables efficient 
calculations of lattice energies and forces during the structure generation step. 
Plausible structures were sampled in all 230 space groups using the Monte Carlo 
parallel tempering algorithm, until the probability of finding a new structure in a pre-
defined energy window fell below 1%. For benzoic acid and anthranilic acid, only 
one independent molecule in the asymmetric unit was considered. For each co-
crystal, one molecule of paracetamol and one molecule of the co-former were 
considered in the asymmetric unit. Following structure generation for each co-former 
and both co-crystals, the energy re-ranking algorithm of GRACE was used to select 
structures within the required energy window based on lattice energies calculated 
with the DFT(d) method using the PW91 functional.
144,145
 For these calculations the 
geometry optimisations were converged to a relatively low level of accuracy. Such 
coarse calculations provided a limited set of low-energy structures, which were 
subsequently refined using stricter convergence criteria, using the DFT(d) method 
with the PBE functional.
146
 After optimising a number of TMFF structures with the 
DFT(d) method, the standard deviation (σ) between the energies of the two methods 
was obtained. In all cases, all low-energy TMFF structures up to at least 3σ from the 
lowest energy TMFF structure were selected for reranking by the DFT(d) method 
(Table 6.2). The TMFFs used in structure generations are provided in the Appendix. 
The DFT(d) optimised and predicted structures are included on the supplementary 
disk. The stability of each co-crystal was determined by the lattice energy of the most 
stable predicted structure relative to the sum of the lowest possible lattice energies of 
the co-formers. Note that the form I polymorph of anthranilic acid contains one 
neutral molecule and one zwitterion in the asymmetric unit.
287
 Although it is feasible  
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to parameterise independent TMFFs for both a neutral molecule and a zwitterion, a 
single TMFF cannot describe the change in ionisation state between neutral 
molecules and zwitterions. In the current study, the experimental structure of form I 
was optimised by the DFT(d) method and included in the lattice energy comparison. 
 
Table 6.2 Important parameters in crystal structure generations of benzoic acid, 
anthranilic acid, 1:1 anthranilic acid:paracetamol and 1:1 benzoic acid:paracetamol. 
Molecules σ (kcal mol−1)a Energy window 












Anthranilic acid 0.66 5.18 615 63 
Benzoic acid 0.59 5.12 768 48 
1:1 Anthranilic acid:paracetamol 1.67 3.00 1663 78 
1:1 Benzoic acid:paracetamol  1.02 4.13 2827 1254 
a
 σ is the standard deviation in energy comparing TMFF and DFT(d) results. 
 
Crystal structure similarity was studied using the Mercury software (version 2.3),
194
 
which overlaid clusters of molecules from the two crystal structures under 
comparison and calculated the root-mean-square (RMS) of the atomic deviations 
between the two clusters. Hydrogen atoms were excluded from these similarity 
calculations, and the number of molecules in the clusters was either 16 for the single-




6.3.1 Structure generation of anthranilic acid, benzoic acid and 
their co-crystals 
 
Figure 6.2 shows the numbers of structures generated within a certain TMFF energy 
window, expressed as the number of standard deviations (σ) between the TMFF and 
DFT(d) energies for anthranilic acid, benzoic acid, 1:1 anthranilic acid:paracetamol 
and 1:1 benzoic acid:paracetamol. σ is related to the probability that the most stable 
DFT(d) structure has been included among the TMFF structures considered. Within a 
2σ energy window, the numbers of structures for all cases are comparable. For a 3σ 
energy window, the number of 1:1 anthranilic acid:paracetamol structures is more 
than 10 times that of anthranilic acid, whilst the number of 1:1 benzoic 
acid:paracetamol structures is more than twice that of benzoic acid. For a 4σ energy 
window, the number of benzoic acid co-crystal structures is more than five times that 
of benzoic acid. Hence, the addition of one independent molecule in the structure 
search leads to a sharp increase in the number of structures for considerations, if the 




Figure 6.2 Plot of cumulative number of structures generated within the tailor-made 
force field energy window, expressed as the number of standard deviation (σ) 
between the TMFF and DFT(d) energies.  
 
6.3.2 Paracetamol 
The DFT(d) optimisation results of the three experimental polymorphs are 
summarised in Table 6.3. Small changes in unit cell parameters (<3%) and small 
RMSDs in atomic positions (<0.2 Å ) show that the optimised structures are in good 
geometric agreements with their experimental counterparts. Superpositions of the 
experimental and the optimised structures are shown in Figures 6.3−6.5. The 
predicted stability order of the polymorphs is consistent with the experimental results: 
form I is the most stable polymorph, whilst form III is the least stable form.
288
 
According to the CSP study of paracetamol using the same methodology,
282
 the form 
I polymorph corresponded to the rank 1 prediction. Hence, the minimised lattice 
energy of form I is used for determining the stabilities of the predicted co-crystals in 
this study.  
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Table 6.3 Comparison of the experimental crystal structures of paracetamol with 














Form I HXACAN01 P21/a 1 12.93 9.40 7.10 115.9   
 DFT(d)  P21/a 1 12.81 9.15 6.97 113.8 −2986.38 0.193 
 Δ (%)   −0.93 −2.66 −1.83 −1.81   
          
Form II HXACAN08 Pbca 1 17.17 11.78  7.21   90.0   
 DFT(d)  Pbca 1 17.22 11.59  7.31   90.0 (+0.17) 0.108 
 Δ (%)   +0.29 −1.61 +1.39 0.0   
          
Form III HXACAN29 Pca21 2 11.84 8.56 14.82   90.0   
 DFT(d)  Pca21 2 11.63 8.59 14.61   90.0 (+0.32) 0.182 
 Δ (%)   −1.77 +0.35 −1.42 0.0   
a The three experimental structures were taken from the Cambridge Structural Database. b Angles α 
and γ equal 90 degrees due to symmetry constraints. c The number in brackets is the relative energy 
from the most stable DFT(d) optimised structure. 
d
 RMSD is the root mean squared deviation of the 
non-hydrogen atoms in a 16 molecule cluster comparing experimental and optimised structures 
calculated using the Compack algorithm194 as implemented in Mercury 2.3. 249 
 
 
Figure 6.3 Superposition of the experimental structure of paracetamol form I (blue) 




Figure 6.4 Superposition of the experimental structure of paracetamol form II (blue) 
onto its DFT(d) optimised structure (green), viewing along the c-axis. 
 
 
Figure 6.5 Superposition of the experimental structure of paracetamol form III (blue) 
onto its DFT(d) optimised structure (green), viewing along the b-axis. 
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6.3.3 Anthranilic acid 
The DFT(d) optimisation and CSP results are summarised in Table 6.4. The DFT(d) 
optimised structures are in good structural agreements with the experimental 
polymorphs (Figures 6.6−6.8). The form I polymorph does not correspond to any 
predicted structure because structures containing a zwitterion and a neutral molecule 
in the asymmetric unit were not considered. The DFT(d) optimised form I structure 
is 0.74 kcal mol
−1
 more stable than the CSP rank 1 predicted structure, and therefore 
its minimised lattice energy is used for determining the co-crystal stability. The form 
II polymorph corresponds to the CSP rank 1 predicted structure, whilst the form III 
polymorph is not found among the 10 most stable predicted structures. The DFT(d) 
optimised form III structure is 0.35 kcal mol
−1
 less stable than the CSP rank 1 
structure and 0.17 kcal mol
−1
 more stable than the CSP rank 2 structure. The form III 
experimental structure undergoes significant changes in unit cell parameters after the 
optimisation with the TMFF. This indicates that the TMFF fails to predict this 
polymorph as an energy minimum of the DFT(d) method. One of the possible 
reasons for this is the inclusion of a high energy conformer in the DFT(d) reference 
data sets, which was not compatible with the TMFF being developed. Figure 6.9 
shows all the conformers considered. The bottom right conformer is more likely than 
the others to result in a zwitterion on optimisation by the DFT(d) method. As a 
suggestion for future work, the TMFF needs to be refitted before re-running the 




The thermodynamic relationships between the three experimental polymorphs are not 
clear in the literature. Selective phase transitions can be achieved by solid-state 
grinding with or without appropriate solvents.
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 When heated, form I transforms into 
a new phase which is probably form II or III prior to melting.
290
 This observation 
implies that form I might be the most stable form at low temperature.  
 
Table 6.4 Comparison of the experimental crystal structures of anthranilic acid with 
their DFT(d) optimised counterparts and the 10 most stable predicted structures. 
Polymorpha  
Space 






Form I AMBACO07 P21cn 2 12.86 10.79 9.31   90.0   
 DFT(d) opt P21cn 2 12.90 10.77 9.20   90.0 −2608.61 0.084 
 Δ (%)   +0.31 −0.19 −1.18     0.0   
          
Form II AMBACO05 Pbca 1 15.99 11.62 7.16   90.0   
 CSP rank 1 Pbca 1 15.94 11.52 7.09   90.0 (+0.74) 0.073 
 Δ (%)   −0.31 −0.86 −0.98 0.0   
          
Form III AMBACO08 P21/c 1 6.54 15.35 7.09 112.6   
 DFT(d) opt P21/c 1 6.45 15.36 6.95 112.1 (+1.09) 0.102 
 Δ (%)   −1.38 +0.07 −1.97 −0.44   
               
 CSP rank 2 P21/c 1 5.11 12.45 11.02 109.8 (+1.26)  
 CSP rank 3 P21/c 1 5.53 4.96 23.29 98.8 (+1.30)  
 CSP rank 4 Pccn 1 11.73 16.02 7.04 90.0 (+1.44)  
 





 CSP rank 6 P21/c 1 6.82 13.35 8.60 57.0 (+1.46)  
 CSP rank 7 P21/c 1 5.06 5.28 23.91 93.8 (+1.49)  
 CSP rank 8 C2/c 1 16.16 7.06 13.15 120.2 (+1.56)  
 CSP rank 9 P21/c 1 7.21 11.32 8.07 105.8 (+1.57)  
 CSP rank 10 P21/c 1 4.96 16.77 8.20 110.4 (+1.63)  
a The three experimental structures were taken from the Cambridge Structural Database. b Unless 
otherwise specified, angles α and γ equal 90 degrees due to symmetry constraints. c The number in 
brackets is the relative energy from the DFT(d) optimised form I structure. d RMSD is the root mean 
squared deviation of the non-hydrogen atoms comparing experimental and optimised structures. The 
Compack algorithm194 as implemented in Mercury 2.3 249 overlaid a 16 molecule cluster for Z' = 1 
structures and a 30 molecule cluster for Z' = 2 structures.  
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Figure 6.6 Superposition of the experimental structure of anthranilic acid form I 
(blue) onto its DFT(d) optimised structure (green), viewing along the c-axis. 
 
 
Figure 6.7 Superposition of the experimental structure of anthranilic acid form II 




Figure 6.8 Superposition of the experimental structure of anthranilic acid form III 
(blue) onto its DFT(d) optimised structure (green), viewing along the c-axis. 
 
 
Figure 6.9 The four conformers of anthranilic acid considered in the DFT(d) 
reference data sets for TMFF parameterisation. 
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6.3.4 Benzoic acid 
The 10 most stable predicted structures are summarised in Table 6.5. Only one 
polymorph of benzoic acid has been reported in the Cambridge Structural Database, 
and the disordered proton of the carboxylic acid has a higher probability (87% versus 
13%) of being bonded to the oxygen atom at site 1 than to that at site 2 at 20 K 
(Figures 6.10−6.11).291 The former corresponds to the rank 1 predicted structure of 
which the DFT(d) minimised lattice energy is taken for determining the predicted co-
crystal stability. The latter corresponds to the rank 2 structure which is 0.06 kcal 
mol
−1
 less stable than the rank 1 structure. The rank 1 and 2 structures are 
isostructural to each other, except that the proton of the acid moiety is located at a 
different position. It is interesting to note that 8 out of 10 most stable predicted 
structures form four such isostructural pairs. A similar result has been obtained in the 
CSP study of 5-chloroaspirin (see Chapter 4). However, no isostructural pair is 
observed among the 10 most stable predicted structures of anthranilic acid. 
 


















BENZAC07 (site 1) P21/c   5.39   5.00 21.69   98.5   
Rank 1 (2) P21/c   5.44   5.04 21.84   98.2 −2317.15 0.081 
BENZAC07 (site 2) P21/c   5.39   5.00 21.69   98.5   
Rank 2 (1) P21/c   5.50   5.06 21.63   98.3      (+0.06) 0.116 
Rank 3 (4) P21/c   5.20   5.35 21.26   87.2      (+0.08)  
Rank 4 (3) P21/c   5.22   5.41 21.11   87.0      (+0.15)  
Rank 5 (10) P21/c   6.34   3.89 25.03 105.1      (+0.36)  
Rank 6 P21/c   8.82   5.07 13.63   86.8 (+0.43)  
Rank 7 (8) P21/c   6.02 16.19   6.76 112.3      (+0.46)  
Rank 8 (7) P21/c   5.80 16.50   6.86 111.1      (+0.48)  
Rank 9 P21/c   7.89   6.38 12.77   73.4 (+0.50)  
Rank 10 (5) P21/c   6.38   3.92 24.83 104.9 (+0.50)  
a The experimental structure reported in the Cambridge Structural Database was determined at 20K. 
The disordered proton of the carboxylic acid has higher probability at site 1 than at site 2. b The 
number in brackets is the DFT(d) ranking of the isostructural partner. c Angles α and γ equal 90 
degrees due to symmetry constraints. d The number in brackets is the relative energy from the most 
stable DFT(d) predicted structure. e RMSD is the root mean squared deviation of the non-hydrogen 
atoms comparing experimental and optimised structures. The Compack algorithm194 as implemented 
in Mercury 2.3 overlaid clusters of 16 molecules.249  
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Figure 6.10 Superposition of the experimental structure of benzoic acid at 20 K 
(blue) onto the rank 1 DFT(d) predicted structure (green), viewing along the b-axis. 
In the experimental structure, the proton of the carboxylic acid group has 87% 
occupancy at this position and bonds to the oxygen at site 1. 
 
 
Figure 6.11 Superposition of the experimental structure of benzoic acid at 20 K 
(blue) onto the rank 2 DFT(d) predicted structure (green), viewing along the b-axis. 
In the experimental structure, the proton of the carboxylic acid group has 13% 
occupancy at this position and bonds to the oxygen at site 2.  
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6.3.5 1:1 Anthranilic acid:paracetamol co-crystal 
The 10 most stable 1:1 anthranilic acid:paracetamol co-crystals and their hydrogen 
bond dimensionalities are summarised in Table 6.6. Three-dimensional (3D) 
hydrogen-bond networks are observed in six predicted structures. For the remaining 
four structures, two of them consist of two-dimensional (2D) hydrogen-bonded 
stacks, whilst the other two show one-dimensional (1D) hydrogen-bonded chains. 
The anthranilic acid and paracetamol molecules interact through hydrogen bonds in 
all cases, except for one structure in which isolated dimers of anthranilic acid are 
embedded between the 2D stacks of paracetamol molecules. Despite the formation of 
extensive hydrogen bond networks (Figure 6.12), the most stable predicted 1:1 co-
crystal is 1.7 kcal mol
−1
 less stable than the DFT(d) optimised form I paracetamol 
and form I anthranilic acid crystals. If the CSP rank 1 structure of anthranilic acid 
(which corresponds to the form II polymorph) is used for comparison, the predicted 
co-crystal is still 0.9 kcal mol
−1
 less stable than its pure components.  
 
Table 6.6 Ten most stable predicted structures of 1:1 anthranilic acid:paracetamol. 





1 P21/c 10.64   9.54 17.15   56.3 −5593.30 3D 
2 C2/c 28.69   8.52 11.53   81.9      (+0.81) 0D + 2D 
3 P21/c 13.29   6.22 17.78 102.5      (+1.10) 3D 
4 P21/c   9.22 11.50 16.81 124.6      (+1.51) 3D 
5 P21/c 10.78   9.71 16.24 121.3      (+1.51) 3D 
6 P1¯   4.81 10.49 14.49 102.0 
  90.6 
  86.4 
     (+1.58) 1D 
7 Pbca 14.89 14.13 13.61   90.0      (+1.62) 3D 
8 P1¯   4.80   8.05 19.61   80.3 
  89.6 
  72.3 
     (+1.73) 1D 
9 P21/c 11.76   8.86 13.68   76.8      (+1.73) 2D 
10 P21/c 10.71 15.30   9.10   90.6      (+1.91) 3D 
a Unless otherwise specified, angles α and γ equal 90 degrees due to symmetry constraints. b The 
number in brackets is the relative energy from the most stable predicted 1:1 anthranilic 
acid:paracetamol co-crystal. c HB stands for the hydrogen-bond network dimensionality. 0D + 2D = 




Figure 6.12 Hydrogen bond network in the most stable predicted 1:1 anthranilic 
acid:paracetamol co-crystal. 
 
6.3.6 1:1 benzoic acid:paracetamol 
The 10 most stable 1:1 benzoic acid:paracetamol co-crystals and their hydrogen bond 
dimensionalities are summarised in Table 6.7. In seven out of ten predicted structures, 
benzoic acid forms isolated dimers between 2D hydrogen-bonded stacks of 
paracetamol. For the remaining three structures, two have 2D hydrogen-bonded 
stacks containing both molecules, whilst one has a 3D hydrogen-bonded network. 1D 
hydrogen-bonded chains are not observed in any of these structures. Figure 6.13 
shows the hydrogen bonding in the most stable predicted 1:1 benzoic 
acid:paracetamol co-crystal. Unlike anthranilic acid, benzoic acid in the absence of 
an amine group does not tend to form many hydrogen bonds with paracetamol. The 
most stable predicted 1:1 co-crystal is 1.7 kcal mol
−1
 less stable than the DFT(d) 
optimised form I of paracetamol and the most stable predicted benzoic acid structure. 
  
 169 
Table 6.7 Ten most stable predicted structures of 1:1 benzoic acid:paracetamol. 





1 P21/c   8.57   9.46 17.01 101.8 −5301.82 2D 
2 P21/c 14.26   8.35 11.75   79.1      (+0.21) 0D + 2D 
3 P21/c 14.33   8.38 11.73   79.0      (+0.22) 0D + 2D 
4 P212121   4.49 11.33 26.64   90.0      (+0.23) 3D 
5 Pbca 14.09 13.05 15.23   90.0      (+0.23) 0D + 2D 
6 Pbca   7.41 13.40 27.76   90.0      (+0.35) 0D + 2D 
7 P21/c   5.68 11.73 20.46 100.1      (+0.35) 2D 
8 Pbca 13.91 13.16 15.13   90.0      (+0.37) 0D + 2D 
9 Pbca   7.42 13.41 27.83   90.0      (+0.42) 0D + 2D 
10 P21/c 14.56   8.49 11.53   75.8      (+0.54) 0D + 2D 
a Angles α and γ equal 90 degrees due to symmetry constraints. b The number in brackets is the 
relative energy from the most stable predicted 1:1 benzoic acid:paracetamol co-crystal. c HB stands for 
the hydrogen-bond dimensionality. 0D + 2D = dimers of benzoic acid and 2D stacks of paracetamol. 
 
 




The failure in predicting the form III polymorph of anthranilic acid implies that some 
interesting polymorphs of both the anthranilic acid and its co-crystal with 
paracetamol may have not been found. The cause of the problem is due to a TMFF 
which was fitted to DFT(d) data sets including an incompatible conformer. In order 
to fully confirm the stability and the likely hydrogen bonding pattern of the 
anthranilic acid:paracetamol co-crystal, the CSP studies of these two systems need to  
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be rerun in the future. Nevertheless, the current CSP results show that both 1:1 co-
crystals of anthranilic acid:paracetamol and benzoic acid:paracetamol are 
thermodynamically unfavoured by 1.7 kcal mol
−1
 when compared to the lowest-
energy DFT(d) optimised or predicted structures of their co-formers. For the 1:1 
anthranilic acid:paracetamol co-crystal, the most stable predicted structure would 
still be 0.9 kcal mol
−1
 less stable than the co-formers, even if the form I experimental 
structure was ignored and only the Z'=1 CSP results of anthranilic acid were used in 
the calculations of stability. Such energy differences are significant in our experience. 
Hence, apart from any kinetic considerations, there appear to be thermodynamic 
reasons why these two co-crystals cannot be observed experimentally. 
 
The predicted anthranilic acid:paracetamol and benzoic acid:paracetamol co-crystals 
adopt very different hydrogen bonding patterns. The former favours three-
dimensional hydrogen-bonding networks, whilst the latter favours dimers of benzoic 
acid embedded between the two-dimensional stacks of paracetamol. The difference 
in hydrogen bonding pattern may be due to the absence of an amino group in benzoic 
acid as compared to anthranilic acid. Unlike other known acid:paracetamol co-
crystals, the carbonyl oxygen atom of anthranilic acid in the ten most stable predicted 
co-crystals does not form a hydrogen bonding with paracetamol. In the rank 1, 4 and 
7 benzoic acid:paracetamol co-crystals, the carbonyl oxygen atom of benzoic acid is 
involved in hydrogen bond with paracetamol. These findings indicate that these co-
formers, whilst sharing the same functional group, do not necessarily share similar 
intermolecular interaction patterns in their co-crystals with paracetamol. 
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The results presented here raise important issues which need to be addressed before 
the successful prediction of co-crystal formation can be regarded as routine.  Firstly 
there is still scope for improvement in the reliability of the DFT(d) method to predict 
relative energies, as might be indicated by the poor ranking of some of the co-former 
polymorph stabilities.  The otherwise good performance of the DFT(d) method is 
explained by the fact that polymorph ordering requires the DFT(d) method describe 
both salt and neutral, co-crystal systems with equal accuracy.  Secondly the present 
method of generating crystal structures relies heavily on a force field, which by its 
nature is not able to represent the interconversion between salt and co-crystal.  This 
means that it is either necessary to develop force fields which can describe both the 
energy and geometry of such systems well, or it is necessary to do crystal structure 
generation using two force fields; one developed for salts and one for co-crystals. 
Note that in the latter case any hybrid co-crystal salts would not be predicted unless 
such a system was searched for specifically. There is also the issue that at no point 
have thermal, entropic and zero-point terms been considered. Clearly these should 
only be considered once a sufficiently accurate potential energy is available. Finally, 
co-crystals with different stoichiometric ratios of the co-formers may have different 
stabilities. This possibility has not been considered in this study because no 
indication of co-crystal formations was observed in the screening experiments. 
However, this issue has to be addressed if the experimental information is 
insufficient. Note that having multiple independent molecules in the asymmetric unit 
leads to an exponential increase in the number of candidate structures for DFT(d) re-




Chapter 7: Final conclusions 
 
The crystalline state of a material is a distinct solid form which contain symmetry-
related motifs repeating themselves in three-dimensional space. Polymorphism − the 
phenomenon that a compound can crystallise in more than one crystal form − is a 
long standing problem in the chemical and pharmaceutical industries. Both the 
kinetic and thermodynamic factors play important roles in a crystallisation process: 
the former steers the reaction pathway towards a particular polymorphic structure, 
whilst the latter determines various equilibrium states of the system. Predicting 
polymorphic structures from a thermodynamic perspective is merely a first step to 
solving the whole problem. Provided that the search for all possible structures is 
complete and that the subtle free energy differences between them can be calculated 
accurately, the low-energy predicted structures of a given molecule are expected to 
be observed experimentally. Over the past one to two decades, significant advances 
in the CSP methodologies have been made to overcome these two hurdles. 
 
In this study, the TMFFs parameterised against the DFT(d) reference data sets 
provided a quick but fairly accurate calculation of lattice energy difference during 
the structure generation and (except for anthranilic acid) successfully located all 
experimental polymorphs of all molecules considered for CSP. Some experimental 
structures had high TMFF energies, suggesting that the simple mathematical 
framework in molecular mechanical methods is limited in its reproduction of the  
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quantum mechanical lattice energy hypersurface. The statistical correlations between 
TMFF and DFT(d) energies are therefore important to ensure a complete coverage of 
the low-energy minima of the DFT(d) method. The TMFF for a neutral anthranilic 
acid molecule is able to predict the form II polymorph but not the forms I and III 
experimental polymorphs. In future work, these issues with the TMFF need to be 
resolved. The current CSP results for anthranilic acid also raise some other important 
issues. When running CSP of a multi-component crystal without any experimental 
information, both salt and co-crystal structures should be considered and therefore 
the derivations of TMFFs for both ionic and neutral species are required. Various 
stoichiometric ratios of the co-formers should also be considered when running CSP 
of an unknown co-crystal. Note that the addition of an extra independent molecule 
leads to a significant increase in the number of candidate structures, which 
consequently costs much more CPU time in both the structure generation and the 
final DFT(d) re-ranking steps. 
 
The DFT(d) method shows an outstanding capability in accurately calculating the 
lattice energy differences between the polymorphs of small organic molecules. With 
the exception of systems involving anthranilic acid, all the CSP studies calculate 
energy differences between the predicted polymorphs of around 0.2 kcal mol
−1
 or 
less, and the experimental structures are always found among the lowest-energy 
structures. For benzoic acid (chapter 6), the more probable form of the two observed 
in the disordered, experimental structure is 0.06 kcal mol
−1
 more stable than the other. 
For propane (chapter 3), the experimental structure which corresponds to the rank 1 
prediction is only 0.02 kcal mol
−1
 more stable than the rank 2 predicted structure.  
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Hence, accurate calculations of lattice energy differences are essential for successful 
CSP, and the kinetic nature of the crystallisation process was not the real cause for 
the failures in previous CSP attempts. Note that, in chapter 5, the predicted stability 
orders of some polymorphs are not consistent with the experimental results. Atomic 
disorder has been reported in the low temperature form of nitric acid and form V of 
tolfenamic acid. The energy required for re-ordering the polymorph stability in each 
case is up to 0.9 and 1.4 kcal mol
−1
 respectively. In view of the expected accuracy of 
the DFT(d) method, these discrepancies are likely to be the result of experimental 
issues or neglecting the contribution of the disorder to the lattice energy.  
 
Lattice energy minimisations using the DFT(d) method show that the vast majority 
of co-crystals and salts of nicotinamide, isonicotinamide and picolinamide are more 
stable than the known structures of their pure co-formers, suggesting that there exists 
a thermodynamic driving force to co-crystal or salt formation, at least for 
nicotinamide and its structural isomers. Salts appear to have higher predicted 
stabilities over co-crystals, because the strength of the salt bridge can be much 
stronger than the hydrogen bond interaction in the co-crystal. However, it is still 
unclear why with the DFT(d) method some experimentally observed co-crystals 
transform into salts. In future work, the energy pathway for such a conversion can be 
probed by following the energy required for proton transfer using the DFT(d) method.   
 
The knowledge of possible crystal packings obtained from CSP is useful for 
designing experiments for discovering yet unobserved polymorphs. For 5-cyano-3- 
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hydroxy-thiophene (molecule II in chapter 3), the rank 1 structure may emerge under 
high pressure as it becomes substantially more stable with respect to other predicted 
structures at increased pressure. For azetadine (molecule XI in chapter 3), the rank 1 
structure is in a high-symmetry space group and has a similar packing pattern to 
another cyclic amino compound. A rigorous isostructural study carried out in 
Professor Hursthouse’s group shows that the rank 1 structure of 5-chloroaspirin 
possesses one-dimensional packing similarities to other aspirin derivatives. Hence, 
seeding experiments may be useful in preparing the predicted but as yet unobserved 
crystal structures of these two molecules.  
 
In most cases except for molecule II in chapter 3, the experimental structures 
optimised by the DFT(d) method are in good structural agreements with the 
unoptimised ones, indicating that the minima on the energy hypersurface of the 
DFT(d) method correspond to the experimental structures. In some exceptional cases, 
the large deviations in atomic positions and unit cell parameters result from the 
unphysical molecular conformations in the reported experimental structures (such as 
the form II of rac-ibuprofen and the orthorhombic form of diclofenac) and the failure 
in identifying water molecules during the structure determination (a falsely reported 
‘zwitterion’ of norfloxacin). This useful feature provides additional  information for 
elucidating an experimental crystal structure. In chapter 5, a mini-scale CSP, in 
which all possible molecular conformations in the experimental lattice were 




Regarding the prediction of co-crystal or salt formation, the DFT(d) method has to be 
equally accurate in treating ionic and neutral molecular species in the crystals. For 
1:1 anthranilic acid:paracetamol co-crystal, further work is needed to ensure 
complete structure searches for both the co-former and the co-crystal. The current 
results, together with the CSP results of 1:1 benzoic acid:paracetamol co-crystal, 
show that these two co-crystals are significantly less stable than their co-formers, 
providing a thermodynamic explanation why these co-crystals did not form 
experimentally. Although anthranilic acid and benzoic acid are structurally similar, 
the hydrogen bonding patterns in their predicted co-crystals are very different. The 
commonly observed supramolecular interaction in other known acid:paracetamol co-
crystals does not frequently appear in the predicted co-crystal structures. These 
findings indicate that considering the functional groups between molecules alone 
cannot reliably predict co-crystal formation. 
 
In conclusion, the GRACE software is currently the state-of-the-art program in the 
field of CSP. The combination of molecular mechanical and quantum mechanical 
based calculations effectively tackles the search problem for structures with Z'=1. 
However, a more efficient search method is needed for structures with Z'>1 when 
running CSP for co-crystal or salt systems. Regarding lattice energy calculations, the 
DFT(d) method works very well for crystals containing neutral molecules. Such 
thermodynamic calculations can be refined further by considering thermal and 
entropic effects. In any case, the CSP results provide useful insights to steer 




A1 Tailor-made force fields 
A1.1 5-cyano-3-hydroxythiophene (molecule II) 
 
Figure A1.1 Atom indices of molecule II. 
Table A1.1 Atom typing rule and the force field parameters of molecule II. 
Index Element Atom type 
0 S S2_0 
1 C C3_0 
2 C C3_1 
3 H H1_0 
4 C C3_2 
5 C C3_3 
6 C C2_0 
7 O O2_0 
8 H H1_1 
9 N N1_0 
10 H HO_0 
 
Bond stretch terms 
E = ½  ke (r – re)
2
 where r is the distance between atoms i and j. 




) re (Å ) 
S2_0 C3_0    563.32 1.76564 
S2_0 C3_1    383.882 1.80403 
C3_0 H1_0    794.976 1.09227 
C3_0 C3_2    708.265 1.37601 
C3_1 C3_3    724.927 1.35663 
C3_1 C2_0    795.068 1.40855 
C3_2 C3_3    792.704 1.36943 
C3_2 O2_0    707.885 1.37307 
C3_3 H1_1    780.856 1.09191 
C2_0 N1_0  2435.42 1.17062 
O2_0 HO_0  1122.57 0.978667 
     
Angle bend terms 
E = ½  kθ (θ – θe)
2
 where θ is the angle between bonds ij and jk. 




) θe (deg) 
C3_0 S2_0 C3_1  0.111527 104.723 
S2_0 C3_0 H1_0  0.0172811 117.159 
S2_0 C3_0 C3_2  0.0992604 117.999 
C3_2 C3_0 H1_0  0.0179538 124.842 
C3_0 C3_2 O2_0  0.00788229 143.492 
C3_0 C3_2 C3_3  0.0030936   85.2509 
O2_0 C3_2 C3_3  0.0102273 131.257 
C3_2 O2_0 HO_0  0.0329111 110.372 
C3_2 C3_3 H1_1  0.0163563 127.596 
C3_2 C3_3 C3_1  0.0694871 108.4 
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Table A1.1 (cont’d). 
Angle bend terms 
E = ½  kθ (θ – θe)
2
 where θ is the angle between bonds ij and jk. 




) θe (deg) 
H1_1 C3_3 C3_1  0.0194904 124.004 
C3_3 C3_1 S2_0  0.0339447 123.629 
C2_0 C3_1 S2_0  0.0307826 118.047 
C2_0 C3_1 C3_3  0.0161424 118.324 
N1_0 C2_0 C3_1  0.0180255 180.121 
 
Torsions overall 
Only the representative torsion φi0jkl0 is provided in this table. The actual φoverall 
involved in the energy calculation is defined in section 2.4.2. 
E = c1 cos(pφoverall) + c2 cos(2pφoverall)+c3 cos(3pφoverall)+… where p is the 
periodicity. Only the non-zero coefficients (cn) are shown in this table.  
Atom i0 Atom j Atom k Atom l0  p c1 (kcal mol
−1
) c2 (kcal mol
−1
) c3 (kcal mol
−1
) 
C3_1 S2_0 C3_0 C3_2  1 −49.1437   
S2_0 C3_0 C3_2 C3_3  1 −22.4541   
C3_0 C3_2 C3_3 C3_1  1 −39.8608   
C3_2 C3_3 C3_1 S2_0  1 −36.977   
C3_3 C3_1 S2_0 C3_0  1 −45.8283   
HO_0 O2_0 C3_2 C3_3  1   −0.406853 −1.65255 0.147246 
N1_0 C2_0 C3_1 C3_3  1     0.000204661   
 
Inversions overall 
E = c1 dijkl + c2 dijkl
2
 + c3 dijkl
3
 + … where dijkl is the out-of-plane distance of atom i 
from the plane formed by atoms j, k and l. Only the non-zero coefficients (cn) are 
shown in this table. 





C3_0 S2_0 H1_0 C3_2   44.6119  
C3_2 C3_0 O2_0 C3_3   91.7965  
C3_3 C3_2 H1_1 C3_1   57.4661  
C3_1 C3_3 S2_0 C2_0   62.9828  
 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









S2* S2*  27488.3 2.73804 2820.97 
S2* C3*  33941.5 3.05817 1296.1 
S2* H1*  3035.55 2.77731 416.705 
S2* C2*  33941.5 3.01508 1354.04 
S2* O2*  100622 3.7914 803.978 
S2* N*  10898 2.84113 1071.1 
S2* HO*  519.632 2.01789 416.705 
C3* C3*  41909.6 3.37618 603.544 
C3* H1*  3748.18 3.11049 194.042 
C3* C2*  41909.6 3.2914 629.509 
C3* O2*  124245 3.90413 383.803 
C3* N*  13456.5 3.26655 504.497 
C3* HO*  641.621 2.67117 194.042 
H1* H1*  335.218 2.99409 62.3843 
H1* C2*  3748.18 3.24198 202.39 
H1* O2*  11111.8 4.08107 123.388 
H1* N*  1203.48 2.73967 162.192 
H1* HO*  57.3833 2.76823 62.3843 
C2* C2*  41909.6 3.2603 656.726 
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Table A1.1 (cont’d). 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









C2* O2*  124245 3.97676 399.093 
C2* N*  13456.5 3.09331 525.469 
C2* HO*  641.621 2.32769 202.39 
O2* O2*  368334 4.48372 256.203 
O2* N*  39892.8 3.43537 327.901 
O2* HO*  1902.14 3.77453 123.388 
N* N*  4320.64 2.89729 425.901 
N* HO*  206.014 3.62391 162.192 
HO* HO*  9.823 1.66249 62.3843 
 
Bond increment terms 
The amount of charge transfer between two bonded atoms i and j is determined by 
the bond increment δij. Atoms i and j acquire + δij and −δij respectively. 
Atom i Atom j  δij (coulomb)   
S2_0 C3_0    0.0760525   
S2_0 C3_1    0.0798844   
C3_0 H1_0  −0.245849   
C3_0 C3_2  −0.0216852   
C3_1 C3_3  −0.240048   
C3_1 C2_0  −0.0408806   
C3_2 C3_3    0.124984   
C3_2 O2_0    0.0744056   
C3_3 H1_1  −0.12967   
C2_0 N1_0    0.502372   
O2_0 HO_0  −0.354772   
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A1.2 6-amino-2-phenylsulfonylimino-1,2-dihydropyridine (molecule VI) 
 
Figure A1.2 Atom indices of molecule VI. 
Table A1.2 Atom typing rule and the force field parameters of molecule VI. 
Index Element Atom type 
0 N N3_0 
1 H HN_0 
2 C C3_0 
3 C C3_1 
4 C C3_2 
5 N N2_0 
6 C C3_3 
7 N N3_1 
8 H H1_0 
9 C C3_4 
10 S S4_0 
11 H H1_1 
12 H HN_1 
13 H HN_1 
14 H H1_2 
15 O O1_0 
16 O O1_0 
17 C C3_5 
18 C C3_6 
19 C C3_6 
20 H H1_3 
21 C C3_7 
22 C C3_7 
23 H H1_3 
24 H H1_4 
25 C C3_8 
26 H H1_4 
27 H H1_5 
 
Bond stretch terms 
E = ½  ke (r – re)
2
 where r is the distance between atoms i and j. 




) re (Å ) 
N3_0 HN_0  697.037 1.03636 
N3_0 C3_0  488.002 1.39261 
N3_0 C3_1  796.21 1.37069 
C3_0 C3_2  677.985 1.39757 
C3_0 N2_0  630.647 1.34323 
C3_1 C3_3  754.873 1.40209 
C3_1 N3_1  662.192 1.39075 
C3_2 H1_0  795.404 1.08791 
C3_2 C3_4  818.358 1.37387 
N2_0 S4_0  254.736 1.64321 
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Table A1.2 (Cont’d). 
Bond stretch terms 
E = ½  ke (r – re)
2
 where r is the distance between atoms i and j. 




) re (Å ) 
C3_3 C3_4  707.782 1.41499 
C3_3 H1_1  778.936 1.08853 
N3_1 HN_1  1033.12 1.01172 
C3_4 H1_2  766.552 1.08597 
S4_0 O1_0  627.351 1.46408 
S4_0 C3_5  381.926 1.74606 
C3_5 C3_6  813.828 1.38287 
C3_6 H1_3  768.803 1.08742 
C3_6 C3_7  771.84 1.38287 
C3_7 H1_4  763.503 1.08879 
C3_7 C3_8  717.413 1.38005 
C3_8 H1_5  756.695 1.0893 
     
Angle bend terms 
E = ½  kθ (θ – θe)
2
 where θ is the angle between bonds ij and jk. 




) θe (deg) 
HN_0 N3_0 C3_0  0.0271331 113.94 
HN_0 N3_0 C3_1  0.020827 111.869 
C3_0 N3_0 C3_1  0.0533678 121.018 
N3_0 C3_0 C3_2  0.0183981 104.871 
N3_0 C3_0 N2_0  0.0371598 123.109 
C3_2 C3_0 N2_0  0.0123764 132.02 
N3_0 C3_1 C3_3  0.0193815 121.725 
N3_0 C3_1 N3_1  0.0475671 115.493 
C3_3 C3_1 N3_1  0.0389272 122.782 
C3_0 C3_2 H1_0  0.0214828 120.917 
C3_0 C3_2 C3_4  0.066029 117.802 
H1_0 C3_2 C3_4  0.0195159 121.281 
C3_1 C3_3 C3_4  0.0659704 122.76 
C3_1 C3_3 H1_1  0.0198919 117.819 
C3_4 C3_3 H1_1  0.0202212 119.422 
C3_2 C3_4 C3_3  0.029351 131.825 
C3_2 C3_4 H1_2  0.0182335 113.882 
C3_3 C3_4 H1_2  0.0224957 114.293 
C3_1 N3_1 HN_1  0.0229109 138.279 
HN_1 N3_1 HN_1  0.0221917 136.108 
S4_0 N2_0 C3_0  0.0214762 119.551 
N2_0 S4_0 O1_0  0.0130372 115.235 
O1_0 S4_0 O1_0  0.0403811 117.166 
C3_5 S4_0 O1_0  0.0389027 104.529 
C3_5 S4_0 N2_0  0.0190965 96.3561 
C3_6 C3_5 S4_0  0.0185587 117.324 
C3_6 C3_5 C3_6  0.0337228 125.351 
C3_7 C3_6 C3_5  0.0417097 119.4 
C3_7 C3_6 H1_3  0.0206715 121.139 
C3_5 C3_6 H1_3  0.0181293 119.461 
C3_8 C3_7 C3_6  0.040231 118.838 
C3_8 C3_7 H1_4  0.0194138 120.746 
C3_6 C3_7 H1_4  0.0216226 120.416 
C3_7 C3_8 C3_7  0.0514848 118.174 




Table A1.2 (Cont’d). 
Torsions overall 
Only the representative torsion φi0jkl0 is provided in this table. The actual φoverall 
involved in the energy calculation is defined in section 2.4.2. 
E = c1 cos(pφoverall) + c2 cos(2pφoverall)+c3 cos(3pφoverall)+… where p is the 
periodicity. Only the non-zero coefficients (cn) are shown in this table.  
Atom i0 Atom j Atom k Atom l0  p c1 (kcal mol
−1
) c2 (kcal mol
−1
) c3 (kcal mol
−1
) 
HN_0 N3_0 C3_0 N2_0  1 -28.1686   
N2_0 C3_0 C3_2 H1_0  1 -29.1648   
H1_0 C3_2 C3_4 H1_2  1 -48.4679   
H1_2 C3_4 C3_3 H1_1  1 -38.7656   
H1_1 C3_3 C3_1 N3_1  1 -23.8629   
N3_1 C3_1 N3_0 HN_0  1 -20.9409   
S4_0 C3_5 C3_6 H1_3  1 -21.1416   
H1_3 C3_6 C3_7 H1_4  1 -45.5025   
H1_4 C3_7 C3_8 H1_5  1 -45.5064   
S4_0 N2_0 C3_0 N3_0  1 -0.310026 -5.80073  
N2_0 S4_0 C3_5 C3_6  2 -0.00810435   
C3_5 S4_0 N2_0 C3_0  1 -1.89185 -0.0607585 0.028295 
N3_0 C3_1 N3_1 HN_1  2 -4.71129   
 
Inversions overall 
E = c1 dijkl + c2 dijkl
2
 + c3 dijkl
3
 + … where dijkl is the out-of-plane distance of atom i 
from the plane formed by atoms j, k and l. Only the non-zero coefficients (cn) are 
shown in this table. 









N3_0 HN_0 C3_0 C3_1   84.8542  
C3_0 N3_0 N2_0 C3_2   165.836  
C3_1 N3_0 N3_1 C3_3   101.416  
C3_2 C3_0 C3_4 H1_0   79.2637  
C3_3 C3_1 C3_4 H1_1   74.1735  
C3_4 C3_2 C3_3 H1_2   120.981  
C3_5 S4_0 C3_6 C3_6   55.8343  
C3_6 C3_5 C3_7 H1_3   99.6692  
C3_7 C3_6 C3_8 H1_4   102.438  
C3_8 C3_7 C3_7 H1_5   103.372  
N3_1 HN_1 HN_1 C3_1   -99.6426 -70.6783 
 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









N3* N3*  279201 4.02397 404.674 
HN* N3*  4983.72 3.54814 154.11 
C3* N3*  80299.5 3.65396 479.352 
N3* N2*  279201 4.02397 404.674 
H1* N3*  4983.72 3.39997 154.11 
S4* N3*  91594.3 3.28735 884.224 
O1* N3*  167784 4.04621 329.719 
HN* HN*  88.9591 2.42959 59.275 
HN* C3*  1433.34 2.96667 184.367 
HN* N2*  4983.72 4.23526 154.11 
HN* H1*  88.9591 2.40313 59.275 
HN* S4*  1634.95 3.45502 342.325 
HN_0* O1*  2994.94 4.39134 124.29 
C3* C3*  23094.5 3.15287 573.461 
C3* N2*  80299.5 3.65396 479.352 
H1* C3*  1433.34 2.82228 184.367 
 183 
Table A1.2 (Cont’d). 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









C3* S4*  26342.9 2.87293 1064.74 
C3* O1*  48255.5 3.66568 386.613 
N2* N2*  279201 4.02397 404.674 
H1* N2*  4983.72 3.69535 154.11 
S4* N2*  91594.3 7.31825 884.224 
O1* N2*  167784 4.04621 329.719 
H1* H1*  88.9591 2.37668 59.275 
H1* S4*  1634.95 2.62744 342.325 
H1* O1*  2994.94 3.45952 124.29 
S4* S4*  30048.3 3.04039 1985.57 
S4* O1*  55043.1 7.63869 708.464 
HN_1* O1*  2994.94 3.81376 124.29 
O1* O1*  100829 3.81058 271.529 
 
Bond increment terms 
The amount of charge transfer between two bonded atoms i and j is determined by 
the bond increment δij. Atoms i and j acquire + δij and −δij respectively. 
Atom i Atom j  δij (coulomb)   
N3_0 HN_0  -0.286358   
N3_0 C3_0  0.0588261   
N3_0 C3_1  -0.0595159   
C3_0 C3_2  -0.018023   
C3_0 N2_0  0.656116   
C3_1 C3_3  0.278377   
C3_1 N3_1  0.00775954   
C3_2 H1_0  -0.175739   
C3_2 C3_4  -0.230139   
N2_0 S4_0  0.0670081   
C3_3 C3_4  0.0979893   
C3_3 H1_1  -0.190372   
N3_1 HN_1  -0.345086   
C3_4 H1_2  -0.135488   
S4_0 O1_0  0.470579   
S4_0 C3_5  -0.0359133   
C3_5 C3_6  -0.00224136   
C3_6 H1_3  -0.125445   
C3_6 C3_7  -0.0299545   
C3_7 H1_4  -0.112728   
C3_7 C3_8  0.026104   
C3_8 H1_5  -0.142294   
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A1.3 Propane (molecule VII) 
 
Figure A1.3 Atom indices of molecule VII. 
Table A1.3 Atom typing rule and the force field parameters of molecule VII. 
Index Element Atom type 
0 C C4_0 
1 H H1_0 
2 H H1_0 
3 H H1_0 
4 C C4_1 
5 H H1_1 
6 H H1_1 
7 C C4_0 
8 H H1_0 
9 H H1_0 
10 H H1_0 
 
Bond stretch terms 
E = ½  ke (r – re)
2
 where r is the distance between atoms i and j. 




) re (Å ) 
C4_0 C4_1  448.934 1.52347 
H1_0 C4_0  702.828 1.09936 
H1_1 C4_1  684.565 1.10073 
 
Angle bend terms 
E = ½  kθ (θ – θe)
2
 where θ is the angle between bonds ij and jk. 




) θe (deg) 
C4_0 C4_1 C4_0  0.0372775 113.2 
C4_0 C4_1 H1_1  0.0240739 109.187 
C4_1 C4_0 H1_0  0.0255822 110.967 
H1_0 C4_0 H1_0  0.0233322 107.935 
H1_1 C4_1 H1_1  0.0218985 106.687 
 
Torsions overall 
Only the representative torsion φi0jkl0 is provided in this table. The actual φoverall 
involved in the energy calculation is defined in section 2.4.2. 
E = c1 cos(pφoverall) + c2 cos(2pφoverall)+c3 cos(3pφoverall)+… where p is the 
periodicity. Only the non-zero coefficients (cn) are shown in this table.  
Atom i0 Atom j Atom k Atom l0  p c1 (kcal mol
−1
)   
H1_0 C4_0 C4_1 C4_0  3 1.09702   
 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









C4* C4*  40119.7 3.14443 398.969 
C4* H*  7878.63 3.63752 142.73 
H* H*  1547.19 3.57206 51.1279 
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Table A1.3 (Cont’d). 
Bond increment terms 
The amount of charge transfer between two bonded atoms i and j is determined by 
the bond increment δij. Atoms i and j acquire + δij and −δij respectively. 
Atom i Atom j  δij (coulomb)   
C4_0 C4_1  -0.111255   
C4_0 H1_0  -0.0394534   
C4_1 H1_1  0.0862621   
Remark: An intramolecular scaling factor of 5.04673 is applied to the van der Waals 
interaction between atom types H1_0 and H1_1. 
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A1.4 Azetidine (molecule XI) 
 
Figure A1.4 Atom indices of molecule XI. 
Table A1.4 Atom typing rule and the force field parameters of molecule XI. 
Index Element Atom type 
0 N N3_0 
1 C C4_0 
2 C C4_0 
3 H HN_0 
4 C C4_1 
5 H H1_0+ 
6 H H1_0- 
7 H H1_0- 
8 H H1_0+ 
9 H H1_1 
10 H H1_1 
   
Note: The + and – signs assigned to H1_0 are inversion indicators. Details are discussed in ref 222. 
 
Bond stretch terms 
E = ½  ke (r – re)
2
 where r is the distance between atoms i and j. 




) re (Å ) 
N3_0 C4_0  491.383 1.25433 
N3_0 HN_0  919.151 1.02494 
C4_0 C4_1  509.715 1.755 
C4_0 H1_0+  673.773 1.10087 
C4_1 H1_1  728.838 1.09797 
 
Angle bend terms 
E = ½  kθ (θ – θe)
2
 where θ is the angle between bonds ij and jk. 




) θe (deg) 
C4_1 C4_0 N3_0  0.0443352 98.4338 
C4_1 C4_0 H1_0+  0.0097331 111.814 
N3_0 C4_0 H1_0+  0.0367704 113.421 
H1_0+ C4_0 H1_0-  0.0211458 107.835 
H1_1 C4_1 H1_1  0.0211149 99.598 
C4_0 C4_1 C4_0  0.0904072 120.943 







Table A1.4 (Cont’d). 
Torsions overall 
Only the representative torsion φi0jkl0 is provided in this table. The actual φoverall 
involved in the energy calculation is defined in section 2.4.2. 
E = c1 cos(pφoverall) + c2 cos(2pφoverall)+c3 cos(3pφoverall)+… where p is the 
periodicity. Only the non-zero coefficients (cn) are shown in this table.  
Atom i0 Atom j Atom k Atom l0  p c1 (kcal mol
−1
) c2 (kcal mol
−1
) c3 (kcal mol
−1
) 
C4_0 N3_0 C4_0 C4_1  1 -131.789 61.6318 -14.5535 
N3_0 C4_0 C4_1 C4_0  1 13.2655   
 
Inversion-angle bend coupling 
E = E(dijkl) + E(α1,α2,α3), where E(dijkl) = c1 dijkl + c2 dijkl
2
 + c3 dijkl
3
 + … and  
E(α1,α2,α3) = ½  k1 (α1 –α1,eq)
2
 + ½  k2 (α2 –α2,eq)
2
 + ½  k3 (α3 –α3,eq)
2
. dijkl is the out-of-
plane distance of atom i from the plane formed by atoms j, k and l. Only the non-zero 
coefficients (cn) are shown in this table. α1, α2 and α3 are defined in section 2.4.2. kn 
and αn,eq are their corresponding bend constants and equilibrium angles. 









N3_0 HN_0 C4_0 C4_0   -111.603 91.6043 
 
α1,eq  = 176.599 deg  k1
 
 = 0.0171269 kcal mol−1 deg−2 
α2,eq  = 91.7005 deg  k2  = 0.0161187 kcal mol−1 deg−2 
α3,eq  = 91.7005 deg  k3  = 0.0161187 kcal mol
−1 deg−2 
 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









N3* N3*  4330.49 4.36802 465.811 
N3* C4*  4756.36 2.69445 574.709 
N3* HN*  964.03 2.88311 177.392 
N3* H1_0*  964.03 2.99962 177.392 
N3* H1_1*  964.03 2.8617 177.392 
C4* C4*  5224.12 2.6867 718.266 
C4* HN*  1058.84 2.73844 221.355 
C4* H1*  1058.84 2.64672 221.355 
HN* HN*  214.607 2.72588 68.2303 
HN* H1*  214.607 2.74672 68.2303 
H1* H1*  214.607 2.76756 68.2303 
 
Bond increment terms 
The amount of charge transfer between two bonded atoms i and j is determined by 
the bond increment δij. Atoms i and j acquire + δij and −δij respectively. 
Atom i Atom j  δij (coulomb)   
N3_0 C4_0  -0.181839   
N3_0 HN_0  -0.295539   
C4_0 C4_1  0.0989066   
C4_0 H1_0+  -0.00245771   





Figure A1.5 Atom indices of 5-chloroaspirin. 
Table A1.5 Atom typing rule and the force field parameters of 5-chloroaspirin. 
Index Element Atom type 
0 C C3_0 
1 C C3_1 
2 C C3_2 
3 C C3_3 
4 C C3_4 
5 O O2_0 
6 C C3_5 
7 H H1_0 
8 O O1_0 
9 O O2_1 
10 H H1_1 
11 C C3_6 
12 C C3_7 
13 Cl Cl1_0 
14 H HO_0 
15 H H1_2 
16 C C4_0 
17 O O1_1 
18 H H1_3 
19 H H1_3 
20 H H1_3 
 
Bond stretch terms 
E = ½  ke (r – re)
2
 where r is the distance between atoms i and j. 




) re (Å ) 
C3_0 C3_1  658.903 1.40977 
C3_0 C3_2  840.936 1.38428 
C3_0 C3_3  383.752 1.50538 
C3_1 C3_4  710.791 1.41178 
C3_1 O2_0  566.448 1.40148 
C3_2 C3_5  807.969 1.3719 
C3_2 H1_0  761.887 1.08899 
C3_3 O1_0  1432.24 1.2222 
C3_3 O2_1  496.541 1.38492 
C3_4 H1_1  767.641 1.09076 
C3_4 C3_6  747.796 1.40064 
C3_5 C3_6  773.451 1.38905 
C3_5 Cl1_0  580.145 1.73306 
C3_6 H1_2  769.558 1.08793 
O2_0 C3_7  289.193 1.41135 
C3_7 C4_0  716.713 1.51609 
C3_7 O1_1  1375.72 1.21563 
O2_1 HO_0  1000.26 0.990169 
C4_0 H1_3  721.359 1.09996 
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Table A1.5 (cont’d). 
Angle bend terms 
E = ½  kθ (θ – θe)
2
 where θ is the angle between bonds ij and jk. 




) θe (deg) 
C3_1 C3_0 C3_2  0.0464551 117.583 
C3_1 C3_0 C3_3  0.00805875 123.303 
C3_2 C3_0 C3_3  0.0243807 119.116 
C3_0 C3_1 C3_4  0.0276405 126.637 
C3_0 C3_1 O2_0  0.0254568 115.688 
C3_4 C3_1 O2_0  0.0264747 117.675 
C3_0 C3_2 C3_5  0.0553937 115.66 
C3_0 C3_2 H1_0  0.0149642 120.45 
C3_5 C3_2 H1_0  0.0132634 123.89 
C3_0 C3_3 O2_1  0.00992813 113.154 
C3_0 C3_3 O1_0  0.031911 123.023 
O2_1 C3_3 O1_0  0.0333011 123.833 
C3_1 C3_4 C3_6  0.0455577 125.839 
C3_1 C3_4 H1_1  0.0140505 115.926 
C3_6 C3_4 H1_1  0.0246266 118.234 
C3_2 C3_5 C3_6  0.0106929 113.408 
C3_2 C3_5 Cl1_0  0.0382809 123.139 
C3_6 C3_5 Cl1_0  0.0358305 123.452 
C3_4 C3_6 C3_5  0.0633616 120.874 
C3_4 C3_6 H1_2  0.0217287 119.866 
C3_5 C3_6 H1_2  0.0189331 119.259 
C4_0 C3_7 O2_0  0.033454 111.502 
C4_0 C3_7 O1_1  0.0409108 128.56 
O2_0 C3_7 O1_1  0.023041 119.938 
C3_1 O2_0 C3_7  0.0383138 117.969 
C3_3 O2_1 HO_0  0.0337388 111.623 
C3_7 C4_0 H1_3  0.0251317 111.142 
H1_3 C4_0 H1_3  0.0187197 107.75 
 
Torsions overall 
Only the representative torsion φi0jkl0 is provided in this table. The actual φoverall 
involved in the energy calculation is defined in section 2.4.2. 
E = c1 cos(pφoverall) + c2 cos(2pφoverall)+c3 cos(3pφoverall)+… where p is the 
periodicity. Only the non-zero coefficients (cn) are shown in this table.  
Atom i0 Atom j Atom k Atom l0 p c1 (kcal mol−1) c2 (kcal mol−1) c3 (kcal mol−1) c4 (kcal mol−1) 
C3_2 C3_0 C3_1 C3_4 1 -18.6418    
C3_0 C3_1 C3_4 C3_6 1 -39.8801    
C3_1 C3_4 C3_6 C3_5 1 -44.8042    
C3_4 C3_6 C3_5 C3_2 1 -48.9424    
C3_6 C3_5 C3_2 C3_0 1 -46.9285    
C3_5 C3_2 C3_0 C3_1 1 -51.912    
H1_3 C4_0 C3_7 O1_1 3 -0.0742505 0.0335104   
O2_1 C3_3 C3_0 C3_1 1 -0.0237547 -3.22521  0.270205 
C3_0 C3_1 O2_0 C3_7 1 -1.70742 -2.02345 -0.254253  
C4_0 C3_7 O2_0 C3_1 1 -0.964415 -4.76869  0.24125 






Table A1.5 (cont’d). 
Inversions overall 
E = c1 dijkl + c2 dijkl
2
 + c3 dijkl
3
 + … where dijkl is the out-of-plane distance of atom i 
from the plane formed by atoms j, k and l. Only the non-zero coefficients (cn) are 
shown in this table. 





C3_0 C3_1 C3_2 C3_3   80.7488  
C3_1 C3_0 C3_4 O2_0   92.8702  
C3_2 C3_0 C3_5 H1_0   90.0034  
C3_3 C3_0 O2_1 O1_0   161.824  
C3_4 C3_1 C3_6 H1_1   110.289  
C3_5 C3_2 C3_6 Cl1_0   96.4078  
C3_6 C3_4 C3_5 H1_2   101.55  
C3_7 C4_0 O2_0 O1_1   184.931  
 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









C3* C3*  3379.52 2.59912 549.732 
C3* O2_0*  17050.5 3.36607 349.583 
C3* H1*  2744.06 3.12586 176.74 
C3* O1_0*  16242.2 3.33278 370.614 
C3* O2_1*  22904.4 3.4424 349.583 
C3* Cl*  29458.9 3.06889 1022.15 
C3* HO*  645.31 2.6303 176.74 
C3* C4*  11108.8 2.84132 493.396 
C3* O1_1*  9671.33 3.10052 370.614 
O2_0* O2_0*  86023.6 4.18181 233.359 
O2_0* H1*  13844.4 3.90902 112.386 
O2_0* O1_0*  81945.9 4.06801 246.418 
O2_0* O2_1*  115558 4.1974 233.359 
O2_0* Cl*  148627 3.61872 654.567 
O2_0* HO*  3255.74 3.91474 112.386 
O2_0* C4*  56046.3 3.60379 316.223 
O2_0* O1_1*  48794.1 3.75382 246.418 
H1* H1*  2228.08 3.7418 56.8222 
H1* O1_0*  13188.1 4.11517 119.148 
H1* O2_1*  18597.6 4.23383 112.386 
H1* Cl*  23919.6 3.67609 328.62 
H1* HO*  523.969 2.9016 56.8222 
H1* C4*  9019.94 3.55554 158.627 
H1* O1_1*  7852.79 3.83369 119.148 
O1_0* O1_0*  78061.5 4.08971 260.293 
O1_0* O2_1*  110081 4.31794 246.418 
O1_0* Cl*  141582 3.93504 693.555 
O1_0* HO*  3101.41 4.36092 119.148 
O1_0* C4*  53389.6 3.63061 335.037 
O1_0* O1_1*  46481.2 3.87217 260.293 
O2_1* O2_1*  155233 4.21815 233.359 
O2_1* Cl*  199655 3.8806 654.567 
O2_1* HO*  4373.54 4.21409 112.386 
O2_1* C4*  75288.7 3.70251 316.223 
O2_1* O1_1*  65546.7 3.94803 246.418 
Cl* Cl*  256790 3.54202 1902.49 
Cl* HO*  5625.09 3.78124 328.62 
Cl* C4*  96833.8 3.32626 918.453 
Cl* O1_1*  84303.9 3.662 693.555 
HO* HO*  123.22 2.58825 56.8222 
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Table A1.5 (cont’d). 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









HO* C4*  2121.19 3.693 158.627 
HO* O1_1*  1846.71 4.08015 119.148 
C4* C4*  36515.4 3.11133 443.403 
C4* O1_1*  31790.5 3.395 335.037 
O1_1* O1_1*  27676.9 3.49807 260.293 
 
Bond increment terms 
The amount of charge transfer between two bonded atoms i and j is determined by 
the bond increment δij. Atoms i and j acquire + δij and −δij respectively. 
Atom i Atom j  δij (coulomb)   
C3_0 C3_1  -0.0830915   
C3_0 C3_2  -0.142004   
C3_0 C3_3  -0.0521341   
C3_1 C3_4  0.112119   
C3_1 O2_0  0.181325   
C3_2 C3_5  0.0303727   
C3_2 H1_0  -0.0933846   
C3_3 O1_0  0.460063   
C3_3 O2_1  0.133192   
C3_4 H1_1  -0.157218   
C3_4 C3_6  0.00477441   
O2_0 C3_7  -0.226167   
C3_5 C3_6  -0.154589   
C3_5 Cl1_0  0.0235163   
O2_1 HO_0  -0.322334   
C3_6 H1_2  -0.123444   
C3_7 C4_0  0.0697083   
C3_7 O1_1  0.512574   
C4_0 H1_3  -0.168674   
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A1.6 Paracetamol, anthranilic acid and benzoic acid 
 
Figure A1.6 Atom indices of paracetamol (left), anthranilic acid (middle) and 
benzoic acid (right). 
 
Table A1.6 Atom typing rules and the force field parameters of paracetamol, 
anthranilic acid and benzoic acid. 
 Paracetamol Anthranilic acid Benzoic acid 
Index Element Atom type Element Atom type Element Atom type 
0 C C3_0_p C C3_0_a O O1_0_b 
1 C C3_1_p C C3_1_a C C3_0_b 
2 C C3_1_p O O2_0_a O O2_0_b 
3 N N3_0_p O O1_0_a C C3_1_b 
4 C C3_2_p C C3_2_a H HO_0_b 
5 H H1_0_p C C3_3_a C C3_2_b 
6 C C3_2_p H HO_0_a C C3_2_b 
7 H H1_0_p C C3_4_a C C3_3_b 
8 C C3_3_p H H1_0_a H H1_0_b 
9 H H1N_1_p C C3_5_a C C3_3_b 
10 C C3_4_p N N3_0_a H H1_0_b 
11 H H1_2_p C C3_6_a C C3_4_b 
12 H H1_2_p H H1_1_a H H1_1_b 
13 C C4_0_p H H1_2_a H H1_1_b 
14 O O1_0_p H HN_0_a H H1_2_b 
15 O O2_0_p H HN_0_a   
16 H H1_3_p H H1_3_a   
17 H H1_3_p     
18 H H1_3_p     
19 H H1O_4_p     
 
Bond stretch terms 
E = ½  ke (r – re)
2
 where r is the distance between atoms i and j. 




) re (Å ) 
H1_3_p C4_0_p  721.372 1.1013 
C4_0_p C3_3_p  706.779 1.54716 
C3_3_p O1_0_p  1317.77 1.24366 
C3_3_p N3_0_p  692.615 1.38329 
N3_0_p H1N_1_p  991.422 1.02533 
N3_0_p C3_0_p  643.449 1.40105 
C3_0_p C3_1_p  570.196 1.3902 
C3_1_p H1_0_p  739.348 1.08954 
C3_1_p C3_2_p  717.835 1.37702 
C3_2_p H1_2_p  761.882 1.0943 
C3_2_p C3_4_p  793.772 1.38863 
C3_4_p O2_0_p  698.111 1.38106 
O2_0_p H1O_4_p  1103.58 0.981098 
C3_0_a C3_1_a  442.491 1.43672 
C3_0_a O2_0_a  452.638 1.37472 
C3_0_a O1_0_a  970.453 1.22818 
C3_1_a C3_2_a  836.5 1.39066 
C3_1_a C3_3_a  663.184 1.41623 
O2_0_a HO_0_a  1001.33 0.982074 
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Table A1.6 (cont’d). 
Bond stretch terms 
E = ½  ke (r – re)
2
 where r is the distance between atoms i and j. 




) re (Å ) 
C3_2_a C3_4_a  871.873 1.37587 
C3_2_a H1_0_a  738.854 1.0896 
C3_3_a C3_5_a  688.203 1.41445 
C3_3_a N3_0_a  800.175 1.36559 
C3_4_a C3_6_a  716.513 1.39461 
C3_4_a H1_1_a  770.783 1.0865 
C3_5_a C3_6_a  763.764 1.37183 
C3_5_a H1_2_a  751.999 1.09437 
N3_0_a HN_0_a  1011.81 1.01574 
C3_6_a H1_3_a  768.23 1.0894 
O1_0_b C3_0_b  1187.07 1.22049 
C3_0_b O2_0_b  502.382 1.37387 
C3_0_b C3_1_b  523.232 1.45645 
O2_0_b HO_0_b  1037.87 0.986499 
C3_1_b C3_2_b  693.809 1.37623 
C3_2_b C3_3_b  700.104 1.37996 
C3_2_b H1_0_b  752.314 1.08892 
C3_3_b C3_4_b  771.125 1.38889 
C3_3_b H1_1_b  764.731 1.08843 
C3_4_b H1_2_b  761.75 1.09005 
 
Angle bend terms 
E = ½  kθ (θ – θe)
2
 where θ is the angle between bonds ij and jk. 




) θe (deg) 
H1_3_p C4_0_p H1_3_p  0.0224608 107.174 
H1_3_p C4_0_p C3_3_p  0.0260114 111.681 
C4_0_p C3_3_p O1_0_p  0.0487528 124.096 
O1_0_p C3_3_p N3_0_p  0.0673324 120.556 
C4_0_p C3_3_p N3_0_p  0.041615 115.348 
C3_3_p N3_0_p H1N_1_p  0.0236866 123.594 
C3_3_p N3_0_p C3_0_p  0.0137742 117.22 
H1N_1_p N3_0_p C3_0_p  0.0250451 119.187 
N3_0_p C3_0_p C3_1_p  0.0325836 118.995 
C3_1_p C3_0_p C3_1_p  0.0702281 122.011 
C3_0_p C3_1_p C3_2_p  0.0314559 124.137 
C3_0_p C3_1_p H1_0_p  0.0211231 117.783 
H1_0_p C3_1_p C3_2_p  0.0114181 118.08 
C3_1_p C3_2_p H1_2_p  0.0224946 118.674 
C3_1_p C3_2_p C3_4_p  0.0385812 122.128 
H1_2_p C3_2_p C3_4_p  0.0199218 119.198 
C3_2_p C3_4_p O2_0_p  0.012747 119.623 
C3_2_p C3_4_p C3_2_p  0.0455242 120.754 
C3_4_p O2_0_p H1O_4_p  0.0346175 109.411 
C3_1_a C3_0_a O2_0_a  0.000448626 106.338 
C3_1_a C3_0_a O1_0_a  0.0498807 127.848 
O2_0_a C3_0_a O1_0_a  0.0389631 125.814 
C3_0_a C3_1_a C3_2_a  0.0126112 112.525 
C3_0_a C3_1_a C3_3_a  0.0220335 125.421 
C3_2_a C3_1_a C3_3_a  0.0475179 122.053 
C3_0_a O2_0_a HO_0_a  0.0247281 107.952 
C3_1_a C3_2_a C3_4_a  0.0369511 122.707 
C3_1_a C3_2_a H1_0_a  0.0262851 116.548 
C3_4_a C3_2_a H1_0_a  0.0098567 120.745 
C3_1_a C3_3_a C3_5_a  0.0413281 116.963 
C3_1_a C3_3_a N3_0_a  0.0366579 120.419 
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Table A1.6 (cont’d). 
Angle bend terms 
E = ½  kθ (θ – θe)
2
 where θ is the angle between bonds ij and jk. 




) θe (deg) 
C3_5_a C3_3_a N3_0_a  0.0340137 122.618 
C3_2_a C3_4_a C3_6_a  0.0515541 117.74 
C3_2_a C3_4_a H1_1_a  0.0202659 120.853 
C3_6_a C3_4_a H1_1_a  0.0241176 121.407 
C3_3_a C3_5_a C3_6_a  0.0550264 120.618 
C3_3_a C3_5_a H1_2_a  0.0159484 118.971 
C3_6_a C3_5_a H1_2_a  0.023836 120.411 
C3_4_a C3_6_a C3_5_a  0.0496076 119.92 
C3_4_a C3_6_a H1_3_a  0.0213896 120.635 
C3_5_a C3_6_a H1_3_a  0.0231004 119.446 
O1_0_b C3_0_b O2_0_b  0.0201266 135.442 
O1_0_b C3_0_b C3_1_b  0.0455056 126.697 
O2_0_b C3_0_b C3_1_b  2.49959e-05 97.8614 
C3_0_b O2_0_b HO_0_b  0.033894 110.465 
C3_0_b C3_1_b C3_2_b  0.0189078 119.812 
C3_2_b C3_1_b C3_2_b  0.0522254 120.376 
C3_1_b C3_2_b C3_3_b  0.042108 118.853 
C3_1_b C3_2_b H1_0_b  0.0210085 119.141 
C3_3_b C3_2_b H1_0_b  0.0133389 122.005 
C3_2_b C3_3_b C3_4_b  0.0418762 120.524 
C3_2_b C3_3_b H1_1_b  0.0249368 119.701 
C3_4_b C3_3_b H1_1_b  0.0215203 119.774 
C3_3_b C3_4_b C3_3_b  0.0583597 120.87 
C3_3_b C3_4_b H1_2_b  0.0232171 119.565 
 
Torsions overall 
Only the representative torsion φi0jkl0 is provided in this table. The actual φoverall 
involved in the energy calculation is defined in section 2.4.2. 
E = c1 cos(pφoverall) + c2 cos(2pφoverall)+c3 cos(3pφoverall)+… where p is the 
periodicity. Only the non-zero coefficients (cn) are shown in this table.  

























H1_3_p C4_0_p C3_3_p N3_0_p 3 -0.424472 0.0194092     
C4_0_p C3_3_p N3_0_p C3_0_p 1 0.161749 -10.9958     
C3_3_p N3_0_p C3_0_p C3_1_p 2 -3.0445 -0.136075     
N3_0_p C3_0_p C3_1_p H1_0_p 1 -46.6845      
C3_0_p C3_1_p C3_2_p H1_2_p 1 43.9998      
C3_1_p C3_2_p C3_4_p C3_2_p 1 -45.4283      
C3_2_p C3_4_p O2_0_p H1O_4_p 2 -2.1978 -0.180614     
O2_0_a C3_0_a C3_1_a C3_2_a 1 -2.48555 -4.64285  -0.341067 -0.075616 -0.018974 
C3_1_a C3_0_a O2_0_a HO_0_a 1 1.12241 -4.54178 -0.176882 -0.196823   
C3_0_a C3_1_a C3_2_a C3_4_a 2 -11.7733      
C3_0_a C3_1_a C3_3_a C3_5_a 2 -4.08711      
C3_1_a C3_2_a C3_4_a C3_6_a 2 -11.8582      
C3_1_a C3_3_a C3_5_a C3_6_a 2 -7.76938      
C3_1_a C3_3_a N3_0_a HN_0_a 2 -8.59967      
C3_2_a C3_4_a C3_6_a C3_5_a 2 -9.68198      
C3_3_a C3_5_a C3_6_a C3_4_a 2 -12.8039      
O1_0_b C3_0_b O2_0_b HO_0_b 1 1.00028 -4.6978     
O1_0_b C3_0_b C3_1_b C3_2_b 2 -3.92265      
C3_0_b C3_1_b C3_2_b C3_3_b 2 -11.3401      
C3_1_b C3_2_b C3_3_b C3_4_b 2 -11.0345      
C3_2_b C3_3_b C3_4_b C3_3_b 2 -11.1734      
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Table A1.6 (cont’d). 
Inversions overall 
E = c1 dijkl + c2 dijkl
2
 + c3 dijkl
3
 + … where dijkl is the out-of-plane distance of atom i 
from the plane formed by atoms j, k and l. Only the non-zero coefficients (cn) are 
shown in this table. 





C3_3_p C4_0_p O1_0_p N3_0_p   184.935  
N3_0_p C3_3_p H1N_1_p C3_0_p   25.2823  
C3_0_p N3_0_p C3_1_p C3_1_p   108.001  
C3_1_p C3_0_p H1_0_p C3_2_p   91.9485  
C3_2_p C3_1_p H1_2_p C3_4_p   86.6842  
C3_4_p C3_2_p C3_2_p O2_0_p   121.993  
C3_0_a C3_1_a O2_0_a O1_0_a   178.415  
C3_1_a C3_0_a C3_2_a C3_3_a   72.5494  
C3_2_a C3_1_a C3_4_a H1_0_a   100.82  
C3_3_a C3_1_a C3_5_a N3_0_a   121.649  
C3_4_a C3_2_a C3_6_a H1_1_a   77.5734  
C3_5_a C3_3_a C3_6_a H1_2_a   92.8579  
C3_6_a C3_4_a C3_5_a H1_3_a   100.738  
C3_0_b O1_0_b O2_0_b C3_1_b   177.162  
C3_1_b C3_0_b C3_2_b C3_2_b   84.5474  
C3_2_b C3_1_b C3_3_b H1_0_b   97.6443  
C3_3_b C3_2_b C3_4_b H1_1_b   97.0013  
C3_4_b H1_2_b C3_3_b C3_3_b   103.341  
 
Inversion-angle bend coupling 
E = E(dijkl) + E(α1,α2,α3), where E(dijkl) = c1 dijkl + c2 dijkl
2
 + c3 dijkl
3
 + … and  
E(α1,α2,α3) = ½  k1 (α1 –α1,eq)
2
 + ½  k2 (α2 –α2,eq)
2
 + ½  k3 (α3 –α3,eq)
2
. dijkl is the out-of-
plane distance of atom i from the plane formed by atoms j, k and l. Only the non-zero 
coefficients (cn) are shown in this table. α1, α2 and α3 are defined in section 2.4.2. kn 
and αn,eq are their corresponding bend constants and equilibrium angles. 









N3_0_a C3_3_a HN_0_a HN_0_a   9.40444 46.9683 
 
α1,eq  = 120.118 deg  k1
 
 = 0.0326867 kcal mol−1 deg−2 
α2,eq  = 119.941 deg  k2  = 0.00909223 kcal mol
−1 deg−2 
α3,eq  = 119.941 deg  k3  = 0.00909223 kcal mol−1 deg−2 
 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









C3*_p C3*_p  10470.1 2.86893 689.293 
C3*_p N3*_p  27558.9 3.29063 576.175 
H1*_p C3*_p  503.131 2.41243 221.61 
C3*_p C4*_p  10470.1 2.86893 618.656 
C3*_p O1*_p  47718.3 3.55356 464.703 
C3*_p O2*_p  47718.3 3.55356 438.334 
N3*_p N3*_p  72539.4 3.71232 486.413 
H1*_p N*_p  2568.71 3.07657 185.236 
N3*_p C4*_p  27558.9 3.29063 518.975 
N3*_p O1*_p  125602 3.97526 396.319 
N3*_p O2*_p  125602 3.97526 374.49 
H1*_p H1*_p  1332.48 3.36918 71.2479 
H1*_p C4*_p  503.131 2.41243 198.898 
H1*p O1*_p  4319.26 3.4902 149.396 
H1*_p O2*_p  4319.26 3.4902 140.918 
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Table A1.6 (cont’d). 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









H1N_1_p O1_0_p  236.652 2.75075 149.396 
H1N_1_p O2_0_p  223.238 2.75075 140.918 
C4*_p C4*_p  10470.1 2.86893 555.971 
C4*_p O1*_p  47718.3 3.55356 420.094 
C4*_p O2*_p  47718.3 3.55356 396.505 
O1*_p O1*_p  217480 4.2382 326.376 
O1*_p O2*_p  217480 4.2382 308.978 
H1O_4_p O1_0_p  432.3 3.25268 149.396 
O2*_p O2*_p  217480 4.2382 292.605 
H1O_4_p O2_0_p  706.006 3.25268 140.918 
C3*_a C3*_a  16692.8 3.08913 630.403 
C3*_a O2*_a  34237.2 3.42843 400.883 
C3*_a O1*_a  34237.2 3.45436 425 
C3*_a HO*_a  1550.29 3.17539 202.676 
C3*_a H1*_a  1550.29 2.79143 202.676 
C3*_a N3*_a  23906.4 3.1901 526.95 
C3*_a HN*_a  1550.29 2.99767 202.676 
O2*_a O2*_a  70221.1 3.76774 267.604 
O2*_a O1*_a  70221.1 3.79366 282.579 
O2*_a HO*_a  6870.22 4.38675 128.88 
O2*_a H1*_a  3179.67 3.25647 128.88 
O2*_a N3*_a  49032.4 3.52941 342.495 
O2*_a HN*_a  801.125 3.05854 128.88 
O1*_a O1*_a  70221.1 3.81958 298.491 
O1*_a HO*_a  14949.3 5.34084 136.632 
O1*_a H1*_a  3179.67 3.34542 136.632 
O1*_a N3*_a  49032.4 3.55533 362.459 
O1*_a HN*_a  4003.83 3.939 136.632 
HO*_a HO*_a  143.978 3.26165 65.1606 
HO*_a H1*_a  143.978 2.87247 65.1606 
N3*_a HO*_a  840.329 2.74358 169.411 
HO*_a HN*_a  143.978 3.08393 65.1606 
H1*_a H1*_a  143.978 2.4833 65.1606 
N3*_a H1*_a  2220.23 2.92132 169.411 
H1*_a HN*_a  143.978 2.69475 65.1606 
N3*_a N3*_a  34237.2 3.29108 444.857 
N3*_a HN*_a  497.208 2.47996 169.411 
HN*_a HN*_a  143.978 2.90621 65.1606 
C3*_a C3*_p  4108.55 2.56358 859.525 
C3*_a N3*_p  132117 3.77463 719.532 
C3*_a H1*_p  1478.24 2.7767 276.338 
C3*_a C4*_p  4108.55 2.56358 771.854 
C3*_a O1*_p  3513.11 2.67218 581.199 
C3*_a O2*_p  3513.11 2.67218 548.362 
O2*_a C3*_p  3512.94 2.65797 544.819 
O2*_a N3*_p  1097.84 2.25899 466.133 
O2*_a H1*_p  2775.29 3.24784 175.151 
O2*_a H1N_1_p  10.8097 3.05054 175.151 
O2*_a C4*_p  3512.94 2.65797 493.079 
O2*_a O1*_p  5889.36 2.74484 385.18 
O2*_a O2*_p  5889.36 2.74484 364.864 
O2*_a H1O_4_p  1880.72 3.66834 175.151 
O1*_a C3*_p  3512.94 2.65676 577.745 
O1*_a N3*_p  1097.84 2.58516 493.438 
O1*_a H1*_p  2775.29 3.2067 185.737 
O1*_a H1N_1_p  1914.44 3.20437 185.737 
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van der Waals terms 
E = A*exp(−Brij) − C/rij
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 where rij is the distance between atoms i and j. 









O1*_a C4*_p  3512.94 2.65676 522.553 
O1*_a O1*_p  5889.36 2.98024 406.978 
O1*_a_ O2*_p  5889.36 2.98024 385.389 
O1*_a H1O_4_p  5357.35 3.82163 185.737 
HO*_a C3*_p  1608.74 2.94975 276.34 
HO*_a N3*_p  10.6901 2.79616 231.326 
HO*_a H1*_p  469.935 2.69577 88.8434 
HO*_a C4*_p  1608.74 2.94975 248.15 
HO*_a O1*_p  10.5077 3.87035 186.848 
HO*_a O2*_p  445.37 3.9225 176.292 
H1*_a C3*_p  1608.74 2.76737 276.34 
H1*_a N3*_p  12.0966 0.910053 231.326 
H1*_a H1*_p  469.935 2.78032 88.8434 
H1*_a C4*_p  1608.74 2.76737 248.15 
H1*_a O1*_p  3897.13 3.28277 186.848 
H1*_a O2*_p  3897.13 3.28277 176.292 
N3*_a C3*_p  43441.2 3.29339 717.411 
N3*_a N3*_p  2.10E+07 5.49046 606.54 
N3*_a H1*_p  3667.91 3.11667 230.644 
N3*_a H1N_1_p  4165.18 3.65337 230.644 
N3*_a C4*_p  43441.2 3.29339 646.532 
N3*_a O1*_p  18754.2 3.2063 494.954 
N3*_a O2*_p  18754.2 3.2063 467.819 
N3*_a H1O_4_p  7.63317 0.906387 230.644 
HN*_a C3*_p  763.847 2.56957 276.34 
HN*_a N3*_p  6.3025 0.658504 231.326 
HN*_a H1*_p  469.935 3.12288 88.8434 
HN*_a C4*_p  763.847 2.56957 248.15 
HN*_a O1*_p  10761.8 4.19326 186.848 
HN*_a O2*_p  2531.45 3.46715 176.292 
O1*_b O1*_b  118270 4.03337 291.894 
O1*_b C3*_b  62322 3.72443 415.61 
O1*_b O2*_b  118270 4.00337 276.335 
O1*_b HO*_b  3199.65 4.97699 133.613 
O1*_b H1*_b  3199.65 3.47365 133.613 
C3*_b C3*_b  32840.4 3.27711 616.473 
C3*_b O2*_b  62322 3.6758 392.027 
C3*_b HO*_b  1686.05 3.23126 198.198 
C3*_b H1*_b  1686.05 2.84292 198.198 
O2*_b O2*_b  118270 3.8941 261.692 
O2*_b HO*_b  3199.65 4.1987 126.031 
O2*_b H1*_b  3199.65 3.4045 126.031 
HO*_b HO*_b  86.5628 2.5387 63.7208 
HO*_b H1*_b  86.5628 1.89544 63.7208 
H1*_b H1*_b  86.5628 2.42462 63.7208 
O1*_b C3*_p  34483 3.49435 477.916 
O1*_b N3*_p  8274.23 2.95115 408.323 
O1*_b H1*_p  2582.72 3.17021 153.643 
O1*_b H1N_1_p  4356.76 4.36618 153.643 
O1*_b C4*_p  34483 3.79562 432.316 
O1*_b O1*_p  1040.34 2.62063 336.905 
O1*_b O2*_p  1040.34 2.18776 319.054 
O1*_b H1O_4_p  3083.04 4.10024 153.643 
C3*_b C3*_p  17266.6 3.0205 711.535 
C3*_b N3*_p  2566.07 2.50766 595.868 
C3*_b H1*_p  1825.41 2.88471 228.759 
 198 
Table A1.6 (cont’d). 
van der Waals terms 
E = A*exp(−Brij) − C/rij
6
 where rij is the distance between atoms i and j. 









C3*_b C4*_p  17266.6 3.17679 639.045 
C3*_b O1*_p  5919.88 2.88092 481.491 
C3*_b O2*_p  5919.88 2.93432 454.319 
O2*_b C3*_p  34483 3.33756 450.652 
O2*_b N3*_p  8274.23 3.03038 385.706 
O2*_b H1*_p  2582.72 3.28707 144.878 
O2*_b H1N_1_p  1337.9 3.17408 144.878 
O2*_b C4*_p  34483 3.36931 407.907 
O2*_b O1*_p  1040.34 3.18231 318.84 
O2*_b O2*_p  1040.34 2.40285 302.046 
O2*_b H1O_4_p  1290.79 3.02927 144.878 
HO*_b C3*_p  18.6274 3.05764 228.759 
HO*_b N3*_p  731.718 2.22918 191.569 
HO*_b H1*_p  368.494 2.57027 73.5468 
HO*_b C4*_p  18.6274 2.07482 205.454 
HO*_b O1*_p  7817.75 4.40939 154.795 
HO*_b O2*_p  15.1874 3.70819 146.058 
H1*_b C3*_p  1247.63 2.73782 228.759 
H1*_b N3*_p  22875.9 3.85993 191.569 
H1*_b H1*_p  459.044 2.92669 73.5468 
H1*_b C4*_p  1247.63 2.49493 205.454 
H1*_b O1*_p  876.233 2.7526 154.795 
H1*_b O2*_p  876.233 2.73348 146.058 
 
Bond increment terms 
The amount of charge transfer between two bonded atoms i and j is determined by 
the bond increment δij. Atoms i and j acquire + δij and −δij respectively. 
Atom i Atom j  δij (coulomb)   
H1_3_p C4_0_p  0.243951   
C4_0_p C3_3_p  -0.185787   
C3_3_p O1_0_p  0.514609   
C3_3_p N3_0_p  0.0147935   
N3_0_p H1N_1_p  -0.244008   
N3_0_p C3_0_p  -0.0795413   
C3_0_p C3_1_p  0.0229959   
C3_1_p H1_0_p  -0.147356   
C3_1_p C3_2_p  -0.0102292   
C3_2_p H1_2_p  -0.150559   
C3_2_p C3_4_p  -0.0543068   
C3_4_p O2_0_p  0.107925   
O2_0_p H1O_4_p  -0.338807   
C3_0_a C3_1_a  -0.110011   
C3_0_a O2_0_a  0.111817   
C3_0_a O1_0_a  0.417   
C3_1_a C3_2_a  0.0474592   
C3_1_a C3_3_a  -0.139052   
O2_0_a HO_0_a  -0.324788   
C3_2_a C3_4_a  0.000518897   
C3_2_a H1_0_a  -0.155146   
C3_3_a C3_5_a  0.135997   
C3_3_a N3_0_a  0.0897023   
C3_4_a C3_6_a  -0.0452053   
C3_4_a H1_1_a  -0.140684   
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Table A1.6 (cont’d). 
Bond increment terms 
The amount of charge transfer between two bonded atoms i and j is determined by 
the bond increment δij. Atoms i and j acquire + δij and −δij respectively. 
Atom i Atom j  δij (coulomb)   
C3_5_a C3_6_a  -0.0202516   
C3_5_a H1_2_a  -0.162219   
N3_0_a HN_0_a  -0.36366   
C3_6_a H1_3_a  -0.125642   
O1_0_b C3_0_b  -0.390904   
C3_0_b O2_0_b  0.143738   
C3_0_b C3_1_b  -0.0787931   
O2_0_b HO_0_b  -0.302318   
C3_1_b C3_2_b  -0.00767811   
C3_2_b C3_3_b  -0.0261038   
C3_2_b H1_0_b  -0.114619   
C3_3_b C3_4_b  0.0187385   
C3_3_b H1_1_b  -0.12159   
C3_4_b H1_2_b  -0.1484   
 
Intramolecular scaling factors 
Atom i Atom j  vdw energy Coulombic energy  
HO_0_a O1_0_a  0.301387 0.301387  
O1_0_a N3_0_a  0.812384 0.812384  
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